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Summary 
 Our understanding of congenital and genetic disruption to human ocular motility and 
alignment has expanded significantly over the past 15 years due in large part to advances in 
genetics.  This has permitted identification of many underlying genetic causes in several 
conditions and provided new insight into the development and function of the oculomotor 
system.  However, this information has also disturbed current classification systems based 
almost exclusively on ocular motility characteristics resulting in a knowledge gap between 
clinicians and researchers. 
As part of a team of researchers from several institutions a series of studies were conducted to 
better elucidate the clinical and genetic features in a large heterogeneous group of subjects 
with known or suspected congenital or genetic disorders affecting ocular motility and 
alignment. 
This dissertation is the outcome of this work.  It also provided an opportunity to assess the 
value of the orthoptic evaluation by critically evaluating ocular motility and alignment patterns 
in this population.  The main objective was to identify key patterns that can be used to predict 
underlying genotypes.   This could provide a more rapid, cost effective approach to these 
disorders and better define the role for the general ophthalmologist in the investigation.  
This work spans over a decade and resulted in 47 publications that provide key pieces to the 
expanding body of knowledge in this field.  Several publications served as reviews for 
knowledge translation for the ophthalmologist and one focuses on summarizing the orthoptic 
evaluation.  
In total 845 enrolled subjects received orthoptic evaluations.  This included 40 different 
diagnoses and 25 different genes with mutations identified. The orthoptic information in these 
subjects formulated part of all research team publications.  Despite only scratching the surface 
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of the entire domain of genetic ocular motility and alignment disorders, this is likely is the 
largest and broadest collection of diagnoses in one report. 
  
A new classification scheme is proposed, one that is based on the underlying pathomechanisms 
accounting for disruption to ocular motility and alignment.  A simplified clinical approach has 
been developed for the general ophthalmologist to utilize key orthoptic assessments as aids in 
appropriately classifying encountered subjects.  This is important as each diagnostic category of 
conditions generally requires different investigations and management. 
 
This research also identified significant phenotypic overlap in genetically distinct disorders and 
phenotypic variability in the same genetic disorder.  Therefore it is concluded that orthoptic 
features in isolation cannot be used to reliability predict the underlying genotype.  The addition 
of information from other medical specialties improves this prediction.  However, due to the 
currently small number of genotyped individuals in many of these rare disorders, more research 
is required before definitive genotype-phenotype spectrums can be identified.  It is also 
emphasizes the need for standardization of the orthoptic assessment and reporting of the 
findings to ensure that similarities and differences be identified accurately.      
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Opsomming (Summary in Afrikaans) 
 
Vordering met die kennis van genetika het ons instaat gestel om oor die afgelope 15 jaar beter 
insig te verkry in kongenitale en genetiese defekte in menslike okulêre motiliteit en belyning.  
Ons is in staat gestel om onderliggende genetiese oorsake in verskeie toestande te identifiseer 
sowel as om nuwe insigte te verskaf in die ontwikkeling en funksie van die okulomotoriese 
sisteem.   Aangesien huidige klassifikasiesisteme byna uitsluitlik basseer is op oog 
motiliteitseienskappe, het hierdie nuwe kennis ‘n gaping gelaat tussen klinici en navorsers. 
 
As deel van ‘n span navorsers vanuit verskeie inrigtings is ‘n reeks studies gedoen om die 
kliniese en genetiese eienskappe van ‘n groot heterogene group persone met bekende, of 
vermoede genetiese toestande van die oogmotiliteits en belyningssisteem beter te verklaar.  
 
Hierdie proefskrif is die uitkoms van daardie werk. Dié navorsing het ook die geleentheid 
geskep om krities die waarde van ortoptiese evaluasies te ondersoek deur okulêre motiliteit en 
belyningspatrone in hierdie populasie te beskryf. Die hoofdoel was om sleutelpatrone te 
identifiseer wat gebruik kan word om onderliggende genotipes te voorspel. Hierdie bevindinge 
kan ‘n vinnige en koste effektiewe benadering tot hierdie toestande wees en kan ook die rol 
van die algemene oftalmoloog in hierdie toetse vergemaklik.  
 
Hierdie proefskrif dek meer as ‘n dekade se werk en het 47 publikasies tot gevolg gehad wat 
almal stukkies in die legkaart van kennis in die veld verteenwoordig.   Verskeie publikasies dien 
as oorsigsartikels om die bestaande kennis aan te bied aan oftalmoloë en een fokus op die 
ortoptiese ondersoek metodiek.  
 
Vir dié studie is 845 patiente ortopties ondersoek. Die groep sluit 40 verskillende toestande en 
25 verskillende geïdentifiseerde genes met hulle mutasies in. Die ortoptiese inligting van al die 
pasiënte was deel van die navorsingsgroep se publikasies. Hoewel daar duidelik net op die 
oppervlakte van die omvang van die genetiese oogmotiliteits en belynings toestande gekrap is, 
is hierdie waarskynlkik die grootste en wydste versameling van diagnoses in een verslag.  
Stellenbosch University  https://scholar.sun.ac.za
viii 
‘n Nuwe klassifikasie sisteem word voorgestel. Dis gebasseer op onderliggende patologiese 
meganismes wat verantwoordelik is vir defektiewe oogbelyning en motiliteit. ‘n 
Vereenvoudigde kliniese ondersoeksisteem is ontwikkel vir die algemene oftalmoloog waar 
sleutelpunt ortoptiese ondersoeke help om die korrekte klassifisering van pasiënte te bevestig.  
Hierdie sisteem is belangrik, want elke kategorie van toestande vereis verskillende ondersoeke 
en hanterings strategië.  
Hierdie navorsing het ook betekenisvolle oorvleueling identifiseer in toestande wat geneties 
ooreenstem.  Ortoptiese bevindinge kan dus nie met absolute betroubaarheid gebruik word om 
onderliggende genotipes te indentifiseer nie. Addisionele inligting van ander mediese 
spesialiteite verbeter egter die voorspelbaarheid. Omdat daar in vele gevalle van hierdie baie 
raar toestande nog te min genotipering gedoen is, is daar addisionale navorsing nodig voordat 
onbetwisbare genotipe-fenotipe korrelasies gedoen kan word. Die belang van standardisering 
van die ortoptiese assessering en rapportering van bevindinge word beklemtoon ten einde te 
verseker dat verskille akkuraat identifiseer kan word.  
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Chapter 1: Introduction 
 
The field of genetics continues to expand with an ever increasing importance to medicine.  The 
field of Ophthalmology has already incorporated genetic advances into clinical practice.  Two 
such examples are Retinoblastoma and von Hippel-Lindau disease for which genetic testing is 
now recommended in patients, and frequently in other family members, whenever these 
conditions are suspected.1, 2  
Ocular misalignment between the visual axes of the two eyes (strabismus) is another 
ophthalmological disorder that occurs in 2-4% of the general population.3  Comitant forms are 
those in which the degree of ocular misalignment is the same in all directions of gaze, while 
incomitant or complex variants have changes in different gaze positions and are frequently 
associated with limitation of ocular movement in one or both eyes.  Congenital forms are 
present at birth or recognized by 6 months of age.  Until recently, distinctions between 
congenital or suspected familial/genetic forms of strabismus were based primarily on clinical 
and, in some cases by neuro-radiological features.4  However, genetic advances have permitted 
identification of several genes involved in a variety of components of the oculomotor system.     
A genetic distinction is extremely valuable because many of these disorders can have 
substantial clinical overlap despite differences in their underlying mechanisms.  Additionally, 
some will have associated non-ophthalmologic features that may not always be obvious during 
a routine eye exam and require investigation by other medical specialities (e.g., deafness, 
autism, cerebral vascular anomalies, scoliosis, respiratory problems, and limb weakness).5-8  
We are presently in an era where genes and genotype-phenotype correlations are being 
identified.  Despite significant advances in investigational techniques, dissemination of this 
information has lagged.  Several factors may account for this.  First, the topic of ocular motility 
dysfunction and strabismus is vast, and no one area of ophthalmology is solely dedicated just to 
this field.  Second, ocular motility dysfunction and ocular misalignment arising from congenital 
and/ or genetic problems are rare when compared to acquired causes.  Typical 
ophthalmological practice patterns with homogenous regional patient populations infrequently 
permit even the most experienced ophthalmologist the opportunity to see many of these 
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syndromes.  Finally, many of these conditions have clinical similarities.  Therefore, difficulties in 
clinical distinction often prevent conducting a cost effective genetic analysis in situations where 
a genetic diagnosis may be needed.   
 
Problem statement 
The field of congenital and genetic disorders of human ocular motility and alignment has 
increased dramatically over the past decade and will continue to expand.  Gaps have developed 
in classification systems and in the link between clinicians and researchers.   Designing solutions 
to this issue requires a comprehensive review of the field with the goal of designing a better, 
more efficient diagnostic approach utilizing published cases, clinical experiences and 
prospectively collected data including ophthalmologic, neurologic, radiologic and genetic 
information.  
 
Aim: 
To design a comprehensive bi-directional diagnostic approach for the investigation of 
disruptions to human ocular motility and alignment arising from congenital and/or genetically 
defined causes.   
 
Central research question:  Can the orthoptic evaluation be an effective tool in the elucidation 
and distinction of different congenital and/or genetic disorders resulting in disturbance of 
ocular alignment and motility?  
This will be feasible if the orthoptic evaluation can demonstrate:  
There is phenotypic difference between genetically distinct conditions – Hypothesis 1.   
There is phenotypic consistency between genetically identical conditions – Hypothesis 2.  
 
Evidence used to address the central research question will arise from achieving each of the 
following research objectives. 
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Research objectives: 
1. To design a clinical assessment protocol to assess disruptions of ocular motility and 
alignment. 
2. To identify and characterize (congenital and/or genetic) disorders affecting ocular 
motility and alignment. 
3. To consolidate the identified main phenotypes with confirmed genotypes. 
4. Provide new insight into mechanisms affecting normal development and function of the 
oculomotor system. 
5. Design a classification scheme based on mechanism accounting for disruption of ocular 
motility/alignment. 
6. Create a simplified clinical approach for the general ophthalmologist. 
 
Table 1.1 consolidates the above research statements.   
 
Methods and Ethical requirements of the research 
We conducted Institutional Review Board and Human Ethics committee approved projects at 
several institutions (Table 1.2) aimed at defining phenotypic and genetic characteristics in 
patients with suspected efferent system dysfunction.   The retrospective component involves 
work done from January 2003 to August 2011.  Prospective work began following ethics 
approval from Stellenbosch University August 5, 2011 (Ref no. N11/07/222).     
This dissertation is a compilation of work done at 11 sites in 5 countries (Canada (1), United 
States (5), Saudi Arabia (2), England (1), Northern Ireland (1), Tunisia (1) and includes 47 
publications.  It involved the examination of 845 patients.  The outcome of this has been 
summarized in the following chapters.  Chapters 3-7 involve specific clinical diagnoses.  Chapter 
8 includes a group of heterogeneous disorders.  Each chapter centers around publications 
identifying phenotype/genotype characteristics.  Chapter 9 is a discussion of the central 
research question and incorporates information from the previous chapters.  Chapter 10 are 
conclusions.    
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Tables 
 
Table 1.1 Overview of research statements 
 
Central research question: To determine if the orthoptic evaluation is an effective tool in the 
elucidation and distinction of congenital and/or genetic disturbances in ocular alignment and motility. 
 
Research aim:  To design a bi-directional diagnostic approach to the investigation of disruptions to 
human ocular motility and alignment arising from congenital and/or genetically defined causes. 
 
Hypothesis 
1 
There is phenotypic difference between genetically distinct conditions? 
(Algorithm direction 1 – Phenotype predicts Genotype) 
Hypothesis 
2 
There is phenotypic consistency between genetically identical conditions? 
(Algorithm direction 2 – Genotype predicts Phenotype) 
Objectives 
Obj. 1 Design a clinical assessment protocol to assess disruptions of ocular motility and 
alignment. 
Obj. 2 Identify and characterize (congenital and/or genetic) disorders affecting ocular motility 
and/or alignment. 
Obj. 3 Consolidate the identified phenotypes with confirmed genotypes. 
Obj. 4 Provide new insight into mechanisms affecting normal development and function of 
the oculomotor system. 
Obj. 5 Design a classification scheme based on mechanism accounting for disruption of ocular 
motility/alignment  
Obj. 6 Create a simplified clinical approach for the general ophthalmologist 
 
 
 
Table 1.2 Approved research projects for enrollment of subjects 
 
Project   Institution 
project ID  542-7 - Hereditary ocular motility 
disorders  
King Saud University, Riyadh, Saudi Arabia 
(KSU) 
project ID 0424 - Genetic evaluation of congenital 
eyelid and/or motility abnormalities  
King Khaled Eye Specialist Hospital, Riyadh, 
Saudi Arabia 
(KKESH) 
project ID 05-03-036R - Genetic studies of strabismus, 
congenital cranial dysinnervation disorders (CCDD’s) 
and their associated anomalies  
Boston Children’s Hospital, Boston, USA 
(BCH) 
  
 
 
Stellenbosch University  https://scholar.sun.ac.za
 5 
 
Chapter 2: Duane Retraction Syndrome (DRS)  
 
Duane retraction syndrome (DRS) is a form of congenital complex strabismus.  Despite its rarity 
in the general population it is considered the commonest form of complex strabismus 
presenting to the pediatric ophthalmology service.  It is one of the first specialized forms of 
strabismus taught to ophthalmology resident and orthoptic students.  It is considered to have 
consistent clinical ocular features and is generally considered a benign entity. 
This chapter summarizes publications involving clinical characterization of DRS and 
identification of phenotype-genotype correlations.  
 
This chapter has 3 main sections.   
Section 1 outlines the publications defining the orthoptic features in patients with DRS.  Section 
2 involves subjects who already had an identified genetic mutation. The focus of these reports 
were to provide a comprehensive clinical description.  Section 3 were prospective publications 
focused on genetic evaluation of subjects with DRS frequently associated with medical and 
developmental problems.  We refer to these forms as syndromic DRS.   
 
 
Section 1 - Defining DRS phenotypes 
 
Khan, A. O., & Oystreck, D. (2006). Clinical characteristics of bilateral Duane syndrome. J 
AAPOS, 10(3), 198-201.9  
doi:10.1016/j.jaapos.2006.02.001   
 Click reference above to see full PDF article 
 
 
We reported the clinical characteristics of individuals with non-operated bilateral DRS from one 
tertiary care facility in the Middle East (King Khaled Eye Specialist Hospital - KKESH).  Two 
hundred and seventy charts of patients with DRS were retrospectively reviewed. Thirty seven 
patients were identified as having bilateral Duane syndrome (14%). 
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Significance of this paper was that it identified phenotypic differences between bilateral and 
unilateral cases.  We observed a 59% male prevalence that was contrary to the 60% female 
prevalence reported in unilateral DRS.  Bilateral cases were more likely to have primary position 
strabismus (78%) than unilateral cases (62%). 
 
Findings from this regional population supported other bilateral DRS reports in the literature. 
An associated congenital ocular and non-ocular abnormalities was present in 24% of cases.  This 
was consistent with reported prevalence of 8-57%.  The breakdown was as follows: Associated 
ocular abnormality - 14%, non-ocular abnormality - 8%, both - 3%.  Other similarities to the 
literature was the presence of the same DRS type in each eye (95%), presence of positive family 
history of strabismus (22%) and presence of amblyopia (16%).  
 
Other key features included frequent utilization of an abnormal head posture (21/37- 59%).  In 
all cases it was to permit monocular fixation and never for binocularity.  No one in this series 
had a multisystem syndrome such as Okihiro syndrome, Wildervanck syndrome, or Holt-Oram 
syndrome.  This was felt to be due to the referral pattern of the facility in which this study was 
undertaken.  Patients referred to this eye hospital cannot have any serious medical issues.  
Those individuals are instead referred to the local University hospital (King Saud University).   
Key elements from this study were that it provided a comparison of DRS phenotype in an Arab 
population to other literature involving bilateral cases.  It also highlighted some contrasts to 
unilateral cases (gender and strabismus patterns).  Our study had a surprising low report of 
positive family history of strabismus and a low association of other congenital ocular and non-
ocular anomalies.  
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Khan, A. O., & Oystreck, D. T. (2006). Fixation preference for the affected eye in patients with 
unilateral Duane syndrome. J AAPOS, 10(3), 275-276.10  
doi:10.1016/j.jaapos.2006.01.009   
 Click reference above to see full PDF article 
 
Here we reported a small series of patients with unilateral DRS that preferred fixation with the 
involved eye.  In 7/8 cases the reason was due to decreased vision in the non-DRS eye.  In each 
case there was either uncorrected anisometropia and/or amblyopia. A literature review 
revealed there had only been 3 previously reported cases but no details were provided as to 
the reason.  Another unique feature was that 2 patients had superimposed intermittent 
exotropia. In both cases the deviation decompensated into exotropia resulting in the patient 
adopting a small face turn towards the DRS eye to maintain fixation with the eye held in 
adduction (unable to abduct) while the contralateral non-DRS eye deviated out due to the 
exotropia tendency and full ocular motility.  The other case with intermittent exotropia also had 
uncorrected anisometropia.  The fixation preference could again be explained by better visual 
acuity in the DRS eye.    
 
The significance of this paper brought attention to a rare feature of preferring fixation with the 
affected eye in the setting of a monocular motility deficit when binocular single vision cannot 
be achieved.  It emphasizes the importance of a careful evaluation of the sensory and vision 
features on patients with strabismus.  This will later be used as the frame work in a future 
publication that standardizes the orthoptic evaluation.11  
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Khan, A. O., Oystreck, D. T., Wilken, K., & Akbar, F. (2007). Duane retraction syndrome on the 
Arabian Peninsula. Strabismus, 15(4), 205-208.12  
doi:10.1080/09273970701632023   
 Click reference above to see full PDF article  
 
This publication was the largest series of DRS reported to date and the first large series from 
the Middle East. It summarized the clinical findings in 404 DRS patients from the Arabian 
Peninsula and provided a comparison to other large studies. 
Main findings: 
 Gender: Females 55%; Males 45% 
 Laterality: unilateral 86%; bilateral 14% 
 Affected eye: Left 79%; Right 35% (included bilateral cases) 
 Types: I 78%; II 19%; III 19% 
 A further breakdown of findings in unilateral and bilateral were also given 
 
The significance of this paper was that it confirmed the clinical features of an almost exclusively 
non-syndromic DRS Arab population. It also determined that the high number of patients from 
consanguineous marriage in this region did not affect the clinical presentation.  Clinical features 
were comparable to those of other large series from other parts of the world.  Table 2.1 shows 
clinical similarities between 196 patients identified globally through the Orbit international E-
consultation program and our retrospective cohort of 404 patients.  In both series left eye 
involvement, affecting females, and limitation of abduction (Type 1) were the commonest 
presentations. 
 
This publication also increased the number of reported bilateral cases in 20059 from 37 to 57 
with findings still supporting a preponderance for male involvement (56% vs 44% M-F).  We also 
encouraged other authors to carefully report clinical characteristics of bilateral cases and to use 
clearly-defined diagnostic criteria to do so.  
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 Outstanding issues related to this paper was that the population was likely skewed to sporadic 
non-syndromic forms of DRS.  Therefore a complete picture of DRS was not possible given the 
referral pattern to the institution where the study was conducted (KKESH).  Strabismic patients 
with associated medical or neurologic disease are referred to the local University hospital (King 
Saud University).  Despite consistency of the ocular features to other studies, it highlights how 
reported variation in prevalence of associated anomalies can arise from how intensely patients 
are investigated and the referral base from which these patients come.   Despite this limitation 
the ocular features provided the context for later publications that specifically involved 
syndromic and genetic forms. 
 
During work on our retrospective papers it became evident we would need to work 
collaboratively with other researchers and institutions to adequately define the full phenotypic 
spectrum of subjects with DRS that would include medical and eventual genetic investigations.   
 
 
Section 2 – Reporting Genotype – Phenotype correlation.  
 
In 2002, just prior to our publications in section 1, a new classification system emerged for 
certain forms of congenital ocular motility disorders.  DRS was one of several forms included.   
These disorders were termed the Congenital Cranial Dysinnervation Disorders (CCDDs).13  This 
inception paper marked the cusp of the genetic era in the field of congenital ocular motility 
disorders.  Advances in genetic technology were starting to seed the expansion of our 
understanding of many of these disorders, including DRS.  The timing of this was ideal for our 
Middle East team as we just began a collaboration with the Engle lab in Boston, USA.  This 
group was able to conduct genetic evaluations in patients we identified from our previous 
work.  My role in this collaboration was to create a standardized clinical approach to confirm 
the ocular diagnosis and identify fields in which similar subjects and their families would be 
categorized as we moved forward with additional medical and genetic investigations.    
This effort led to three publications between 2005 and 2008 defining a new monogenic CCDD 
with DRS as a main feature.5, 14, 15  This was my first opportunity to define orthoptic features, 
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and our research team’s first opportunity to define the clinical spectrum of a genetically 
defined population of subjects with DRS.  These publications contributed to increasing our 
understanding of underlying the pathophysiology of cranial nerve and human development.  
 
These publications are summarized here: 
 
Tischfield, M. A., Bosley, T. M., Salih, M. A., Alorainy, I. A., Sener, E. C., Nester, M. J., Oystreck, 
D.T., . . . Engle, E. C. (2005). Homozygous HOXA1 mutations disrupt human brainstem, inner 
ear, cardiovascular and cognitive development. Nat Genet, 37(10), 1035-1037.14  
doi:10.1038/ng1636  
 Click reference above to see full PDF article 
  
At this time it was reported that most forms of DRS are sporadic, with 5-10% being inherited in 
an autosomal dominant fashion with previous reports of families with bilateral horizontal gaze 
anomalies.16 Mutations in one gene (SALL4) was already known to result in autosomal 
dominant DRS.17 A locus for bilateral DRS was known and referred to as DURS2.18  The 
phenotype would be expanded to include other ocular associations19, 20 and the gene would 
later be identified as CHN1.21  
 
Here we reported 9 individuals with syndromic bilateral DRS from 5 families in whom were 
found to have homozygous mutations in the HOXA1 gene.  It demonstrated the absence of 
cranial nerve six bilaterally in the one appropriately imaged subject with thin sliced MRI. It also 
included the genetic analysis of another geographically distinct population with a similar 
reported phenotype. The clinical features of these Native American subjects had previously 
been described and referred to as the Athabascan Brainstem Dysgenesis Syndrome (ABDS).16   
Our genetic elucidation paper was the first report of a human homozygous HOX gene mutation, 
the first report of a new gene causing syndromic DRS, and the first autosomal recessive form of 
DRS.  This report identified another monogenic CCDD and provided further evidence that 
CCDDs are due to primary cranial nerve maldevelopment.     
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The paper provided a brief overview of the phenotype. Main clinical features included bilateral 
DRS (9/9) associated with profound sensorineural deafness (8/9) with external ear defects 
(3/9).  Delayed motor milestones (7/9) and Autism spectrum disorder (2/3).  This syndrome also 
included significant neuro-imaging features.  Imaging was obtained in 8 individuals and 
demonstrated the cerebrum, cerebellum and brainstem were normal.  In the one patient that 
was appropriately studied Cranial nerve 6 was absent.  In 7 individuals with deafness all had 
inner ear abnormalities that included common cavity deformity (5/7) or cochlea aplasia (2/7).  
The one patient with normal hearing had normal inner ear anatomy.  Skull base imaging with 
computed tomography was obtained in 3 individuals.  One had bilateral absence of the carotid 
canal and two had unilateral absence of the carotid canal.  Magnetic resonance angiography 
(MRA) of the head and neck was obtained in 4/8 and head only in 3/8.  All were found to have 
an internal carotid artery (ICA) malformation that ranged from unilateral hypoplasia to bilateral 
agenesis. 
This article also provided the opportunity to directly compare two geographical distinct subject 
with the same genetic mutation.  A notable observation was that the ABDS patients had central 
hypoventilation syndrome, mental retardation, some had with facial weakness, vocal cord 
paralysis and contruncal heart defects (e.g. Tetrology of Fallot and double aortic arch) that were 
not present in the BSAS subjects.  Confirmation of HOXA1 mutations in two similar but at times 
phenotypically distinct conditions resulted in the coining of a new condition now referred to as 
HOXA1-related syndromes.  
Arising from this publication was the identification of consistent features of HOXA1 syndrome 
namely horizontal gaze restriction, although reported as bilateral DRS in BSAS and horizontal 
gaze palsy-like in ABDS, and sensorineural hearing loss in almost all patients.  However, marked 
phenotypic variability could also be present.  Further evaluation of more genotyped individuals 
needed to better define the phenotypic spectrum.  This paper also identified previously 
unknown developmental function of HOXA1. More investigation would be needed to determine 
its role in vasculo or angiogenesis, inner ear development, and cognitive and behavioral 
impairment that included autism (BSAS) and mental retardation (ABDS).  The gene was thought 
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to only be expressed in developing hindbrain. These anomalies suggest role in forebrain and 
cerebellar development. 
The final point is that the reporting of horizontal gaze restriction needs to be standardized as 
the mechanism underlying DRS and true horizontal gaze palsy were very different.  The absence 
of Cranial nerve 6 in the one BSAS patient suggests DRS rather than horizontal gaze palsy. 
 
 
Bosley, T. M., Salih, M. A., Alorainy, I. A., Oystreck, D. T., Nester, M., Abu-Amero, K. K., 
Tischfield, M.A., Engle, E. C. (2007). Clinical characterization of the HOXA1 syndrome BSAS 
variant. Neurology, 69(12), 1245-1253.5  
doi:10.1212/01.wnl.0000276947.59704.cf   
 Click reference above to see full PDF article 
 
Here we reported a more detailed clinical description of the 8 individuals from the 2005 paper 
and 1 new patient. In this report there was an emphasis to more clearly define the ocular 
phenotype by including an in depth description of the motor, sensory and visual aspects of the 
orthoptic evaluation.11   
This was important for several reasons.  There were several poor clinical descriptions in genetic 
reports of subjects with presumed DRS.   A recent report had just come out describing novel 
neuro-imaging findings in DRS subjects (DURS2 phenotype) identifying wide spread orbital 
dysinnervation where 7/8 affected individuals had bilateral DRS in addition to other orbital 
involvement.22  We also knew homozygous mutations in HOXA1 can result in two phenotypes – 
BSAS and ABDS, each involving a geographically distinct population, with ABDS individuals 
appearing to have more severe medical phenotypes.  We also previously highlighted the 
discrepancy in ocular motility description of subjects with ABDS for versus BSAS.   
 
This 2007 publication reported the BSAS variant found in Saudi Arabian and Turkish populations 
can be summarized as having Bilateral DRS Type 3, deafness and inner ear malformations, 
cerebrovascular anomalies, and cognitive dysfunction. The ABDS variant found in Native 
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American population are reported as having horizontal gaze restriction, deafness, internal 
carotid artery abnormalities with extra features that include Central hypoventilation, facial and 
bulbar weakness, conotruncal heart defects, and mental retardation.   
 
Significance of this paper: 
This comprehensive phenotypic report of a genetically defined syndromic Duane condition 
(synDRS) provided distinctions between other genetic forms of DRS and other overlapping 
congenital eye movement disorders within the CCDD domain.  Provided is a Table emphasizing 
genetic, clinical, and neuro-imaging features important to distinguish between three 
overlapping conditions - BSAS, ABDS, and HGPPS (described in Chapter 8).  It also confirmed 
lack of other orbital dysinnervation reported in DURS2. 
This paper also extended the BSAS phenotype and highlighted several non-ophthalmic 
associations requiring medical investigation.  This includes evaluation for deafness, delayed 
motor milestones, behavioral abnormalities, and cerebrovascular and cardiac anomalies.    
It also documented the clinical variability that can occur in identical HOXA1 mutations within an 
isolated ethnic population.  This could specifically involve ocular motility. Despite all individuals 
meeting the criteria for bilateral DRS the extent of horizontal eye movements could vary 
between individuals and between eyes.  
This variability was also shown to extend beyond ocular motility.  For example, subject 8 had a 
mild phenotype with bilateral DRS with modest adduction, normal hearing, only left ICA 
hypoplasia, and normal cognition. Subject 5 had a severe phenotype with no observed 
horizontal eye movements, deafness, common cavity deformity bilaterally, absent ICA 
bilaterally, and autism.   
Several significant orthoptic features were identified.  We confirmed ocular motility deficit is 
always bilateral and limited to horizontal movements. All strabismus patterns can be classified 
as bilateral DRS Type 3.  Ocular alignment includes orthotropic and esotropic eye positions. 
Subjects have normal afferent visual functioning with 3 patients demonstrating Fusion. 
Some nuances to the cardinal features of DRS were also identified.  Six subjects had obvious 
bilateral globe retraction on attempted adduction.  However, 1 had unilateral globe retraction 
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despite having bilateral motility deficit and an older sister with unequivocal globe retraction 
bilaterally, and two patients did not have observed globe retraction.  Both of these individuals 
had severe autism that may have interfered with ability to cooperate.  Globe retraction with 
convergence was observed in 3 subjects.   
One patient had an element of accommodative esotropia superimposed on DRS. At the time of 
publication this may have been the first report of the coexistence of these two strabismic 
conditions.  The only report that could be found in the literature came in 2014.23  
Significant Neuro-imaging (CT, MRI, MRA) features included normal appearing orbits and extra-
ocular muscles (eoms).  The latter suggests the lateral rectus muscle is receiving sufficient 
innervation for myofiber survival.    
Clinical, radiological, and mouse model studies suggest partial or complete absence of the 
abducens nucleus and nerve bilaterally.  Differences in residual adduction and presence of mild 
abduction in two patients may imply variable depletion of abducens motoneurons and 
interneurons in addition to degree of anomalous innervation from CN3 to the lateral rectus.   
Vascular defects in BSAS appeared to be clinically silent but probably put patients at increased 
risk of cerebrovascular compromise. Delayed motor development may be explained by lack of 
vestibular system.  Presence of autism or autistic features implies this disorder extends beyond 
the brainstem. 
Similarities with thalidomide embryopathy suggest that the teratogenic effects of early 
thalidomide exposure may be due to interactions with the HOX cascade.   
 
Outstanding issues: 
Identification of 1 patient with normal hearing and normal inner ear anatomy highlights the 
need for full investigations of all genotyped individuals.  This comes back to the issue of 
requiring a genetic diagnosis and served as a main reason to establish a formal ophthalmic 
genetics program at King Saud University where the majority of work on the dissertation was 
completed.   
The absence of globe retraction raised an interesting issue. Does the absence of globe 
retraction in the setting of significant horizontal gaze limitation suggest another etiological 
Stellenbosch University  https://scholar.sun.ac.za
 15 
 
mechanism may be responsible?  This was addressed in another publication in which I 
examined 25/40  subjects included but was not involved in the writing of the manuscript.24  
(See appendix chapter 2 for full article) 
All patients we identified to date came through our neuro-ophthalmology clinic as a result of 
their ocular motility disturbance.  At this time the prevalence of HOXA1 mutations in a deafness 
clinic was unknown.  This was later addressed in another publication.25  (See appendix chapter 2 
for full article) 
 
Bosley, T. M., Alorainy, I. A., Salih, M. A., Aldhalaan, H. M., Abu-Amero, K. K., Oystreck, D. T., 
Tischfield, M.A., Engle, E.C., Erickson, R. P. (2008). The clinical spectrum of homozygous HOXA1 
mutations. Am J Med Genet A, 146A(10), 1235-1240.15  
doi:10.1002/ajmg.a.32262  
 Click reference above to see full PDF article 
 
This article further increased our understanding of the phenotypic presentation.  It confirmed 
certain features were consistently present such as abnormal horizontal ocular motility and 
deafness.  However the ocular motility phenotype was expanded by identifying two patients 
with full horizontal ocular motility, one of whom had mild unilateral ptosis and limitation of 
elevation. All ABDS patients were reported as having bilateral horizontal gaze palsy.  It should 
be noted I did not examine the ABDS individuals.  
 
Publication summary and significant findings: 
This article further increased our understanding of the phenotypic presentation in genetically 
confirmed cases of HOXA1.  Here we report the clinical findings in 9 new individuals (6 families) 
with HOXA1 mutations having BSAS or ABDS.  This included 6 individuals from 3 Saudi families 
and 3 individuals from 3 Native American families.  Noteworthy documentation included a 
Table outlining the HOXA1 mutations, cardiac defects, cognitive problems, and medical features 
for this syndrome, the frequency of clinical characteristics, and an illustration of the spectrum 
of horizontal gaze deficits. 
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Additional features were identified in the BSAS population.  This included identification of 
cardiac defects, facial twitching and grimacing (but not facial weakness), another 3 individuals 
with absent horizontal gaze without observed globe retraction, two individuals with full 
horizontal gaze and normal hearing of which one was also the only patient to demonstrate a 
unilateral elevation deficit with ipsilateral ptosis. Prior to this 1 subject had been found to have 
normal hearing but did have bilateral DRS.  Given these findings it was felt abnormal ocular 
motility and deafness were considered absolute and essential for this diagnosis.  This report 
also confirmed the absence of cranial nerve 6 bilaterally in another BSAS patient.  
Inclusion of these 9 new individuals blurred the distinction between homozygous HOXA1 BSAS 
and ABDS variants.  Identification of more individuals with absent horizontal gaze and absence 
of globe retraction suggests that the same genetic mutation can result in an ocular motility 
phenotype of either horizontal gaze palsy or DRS. In both cases cranial nerve 6 is absent but 
with variable dysinnervation of the lateral rectus.   
This report also expanded the severity gradient.  ABDS seems to represent the severe end of 
HOXA1 clinical spectrum while the other end has milder versions of BSAS including isolated 
bilateral DRS5, 14 and isolated mild congenital hearing loss (see subject C4).  It also highlighted 
features that are more consistent with a particular variant.  Facial and bulbar weakness and 
symptomatic central hypoventilation still only present among ABDS population, while autism 
and somatic abnormalities are only observed in BSAS.  
The major clinical features may arise when the gene fails to be expressed correctly in the 
hindbrain neuroectoderm and notochord early in gestation. This results, at least at times, in the 
loss of rhombomere 5 (and the abducens nuclei, leading to aberrant innervation of the lateral 
rectus muscles and bilateral DRS), abnormal vasculogenesis (and congenital cerebrovascular 
and cardiovascular anomalies), and possibly disturbed development of serotonergic neurons in 
the brainstem (resulting in autistic behavior). It may also lead to defective induction of otic 
vesicle development and abnormal or absent development of the inner ear. 
The HOXA1 spectrum was further summarized into the context of other CCDDs in a 2011 review 
article26 with an update in 2013.27 PDFs of these publications are included in the appendix for 
Chapter 9. 
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Summary of the HOXA1-related syndromes  
Homozygous HOXA1 mutations were first detected in our Saudi Arabian subjects with bilateral 
DRS, bilateral deafness, and cerebrovascular and/or cardiovascular congenital anomalies.  
Subsequent evaluation of additional subjects determined that homozygous HOXA1 mutations 
may occur without deafness and DRS. Other features are also variable, including the degree of 
DRS (type 1 versus type 3), the presence of dysmorphism, or autism.   
Two follow up publications were done investigating the role of HOXA1 in individuals with 
Moebius syndrome24 (Chapter 4) and with non-syndromic isolated deafness.25  Full articles 
available in appendix chapter 2.  
 
Rankin, J. K., Andrews, C., Chan, W. M., & Engle, E. C. (2010). HOXA1 mutations are not a 
common cause of Mobius syndrome. J AAPOS, 14(1), 78-80.24.24  
doi:10.1016/j.jaapos.2009.11.007 
 Candidate was not involved in the writing of this manuscript, however I did examine all 
individuals to confirm ocular motility phenotype. 
 Click reference above to see full PDF article 
 
The HOXA1-related syndromes result from autosomal-recessive truncating mutations in the 
homeobox transcription factor, HOXA1. Limited horizontal gaze and sensorineural deafness are 
the most common features; affected individuals can also have facial weakness, mental 
retardation, autism, motor disabilities, central hypoventilation, carotid artery, and/or 
conotruncal heart defects. Mobius syndrome is also phenotypically heterogeneous, with 
minimal diagnostic criteria of nonprogressive facial weakness and impaired ocular abduction; 
mental retardation, autism, motor disabilities, additional eye movements restrictions, hearing 
loss, hypoventilation, and craniofacial, lingual, and limb abnormalities also occur. We asked, 
given the phenotypic overlap between these syndromes and the variable expressivity of both 
disorders, whether individuals with Mobius syndrome might harbor mutations in HOXA1. Our 
results suggest that HOXA1 mutations are not a common cause of sporadic Mobius syndrome in 
the general population. 
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Abu-Amero, K. K., Hagr, A. A., Almomani, M. O., Azad, T. A., Alorainy, I. A., Oystreck, D. T., & 
Bosley, T. M. (2014). HOXA1 Mutations are Not Commonly Associated with Non-Syndromic 
Deafness. Can J Neurol Sci, 41(4), 448-451.25.25  
PMID: 24878468 
 
OBJECTIVE: Homozygous homeobox A1 (HOXA1) mutations cause a spectrum of abnormalities 
in humans including bilateral profound deafness. This study evaluates the possible role of 
HOXA1 mutations in familial, non-syndromic sensorineural deafness. METHODS: Forty-eight 
unrelated Middle Eastern families with either consanguinity or familial deafness were identified 
in a large deafness clinic, and the proband from each family was evaluated by chart review, 
audiogram, neuroimaging, and HOXA1 sequencing. RESULTS: All 48 probands had normal 
neuro-ophthalmologic and general medical examinations except for refractive errors. All had 
congenital non-syndromic sensorineural hearing loss that was symmetric bilaterally and 
profound (>90 dBHL) in 33 individuals and varied from 40 to 90 dBHL in the remainder. Thirty-
nine of these individuals had neuroimaging studies, all documenting normal internal carotid 
arteries and normal 6th, 7th, and 8th cranial nerves bilaterally. Of these, 27 had normal internal 
ear structures with the remaining 12 having mild to modest developmental abnormalities of the 
cochlea, semicircular canals, and/or vestibular aqueduct. No patient had homozygous HOXA1 
mutations. CONCLUSIONS: None of these patients with non-syndromic deafness had HOXA1 
mutations. None had major inner ear anomalies, obvious cerebrovascular defects, or 
recognized congenital heart disease. HOXA1 is likely not a common cause of non-syndromic 
deafness in this Middle Eastern population. 
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Section 3 – Genetic investigation of DRS 
Following the publications in Section 2 we focused on further investigating the genetics of DRS.   
This section is an overview of our results. 
 
From January 2011 - July 2013 a total of 111 subjects met the clinical characteristics for DRS.  All 
subjects were enrolled either at KSU or KKESH.  Table 2.2 is an overview of this population.  
Subjects were divided into three groups.  Group 1 are those with DRS as an isolated finding, 
referred to as non-syndromic DRS (nsDRS).  Group 2 are subjects in which DRS is not an isolated 
finding.  Here DRS is found in association with at least one other non-ocular motility anomaly.  
This could include a medical diagnosis, e.g. Duchene muscular dystrophy, deafness, or an 
associated developmental anomaly such as clinodactyly, club foot etc. This group is referred to 
as syndromic DRS (synDRS).  Group 3 had nsDRS associated with another congenital cranial 
dysinnervation disorder (CCDD) phenotype.  This group is referred to as DRS plus. 
 
Table 2.2 provides a summary of the genetic analysis for all DRS groups. DNA samples were 
obtained in 58% (64/111) of subjects.  Confirmation of a suspected mutation or discovery of a 
novel genetic mutation occurred in 55% of these (35/64).  Twenty-five percent (16/64) were 
negative for mutations for known CCDD genes at that time, or following chromosomal analysis 
with array CGH technology.  Results of genetic analysis are still pending in the remaining 25% 
(16/64).   
  
Subjects were identified at the time of their initial visit to either the pediatric ophthalmology or 
neuro-ophthalmology service.  Subjects were then enrolled into an IRB approved research study 
at the appropriate institution. This occurred at the initial visit or during a subsequent 
evaluation.  After enrollment and informed consent, subjects underwent a full orthoptic 
evaluation.  As part of our clinical protocol subjects also underwent a pediatric ophthalmology 
or neuro-ophthalmology assessment or both.  Some subjects also had neuro-imaging and 
additional medical investigations.  
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In total 33 subjects with genetic results were reported in 12 publications.5, 14, 15, 28-37 Ten were 
reported prior to initiation of the dissertation.5, 14, 15, 37  These publications are shown in Table 
2.3.   Abstracts of the prospective publications for 21 subjects are provided here. 
 
 
Abu-Amero, K. K., Kondkar, A. A., Salih, M. A., Alorainy, I. A., Khan, A. O., Oystreck, D.T., & 
Bosley, T. M. (2013). Partial chromosome 7 duplication with a phenotype mimicking the HOXA1 
spectrum disorder. Ophthalmic Genet, 34(1-2), 90-96.28.28  
doi:10.3109/13816810.2012.718850 
 Click reference above to see full PDF article 
 
Purpose: To evaluate possible monogenic and chromosomal anomalies in a subject with 
bilateral Duane retraction syndrome and hearing impairment resulting in a phenotype 
resembling the HOXA1 spectrum disorder. 
 
Methods: Sequencing HOXA1 and performing high resolution array comparative genomic 
hybridization (array CGH). 
 
Results: The proband had bilateral Duane retraction syndrome (DRS) with severe hearing loss 
bilaterally and an absent right vertebral artery, mimicking the major features of the Bosley-
Salih-Alorainy variant of the HOXA1 spectrum. However, he also had developmental delay, mild 
mental retardation, and seizures. His parents were not related, but his father had milder 
sensorineural hearing loss bilaterally, and two paternal uncles and a paternal cousin had 
seizures. Neuroimaging revealed moderate maldevelopment of inner ear bony anatomy 
bilaterally. HOXA1 sequencing was normal, but array CGH revealed a small partial duplication of 
chromosome 7 encompassing only the PTPRN2 gene (protein tyrosine phosphatase, receptor 
type, N polypeptide 2) that was not present in his parents, an unaffected brother, or 53 normal 
ethnically-matched individuals. 
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Conclusions: PTPRN2 is not yet linked to a genetic syndrome, although its expression has been 
identified in the adult human brain, in certain tumors, and in association with type 1 diabetes 
mellitus. The phenotype of this patient is strikingly similar to, but not identical to, that of the 
HOXA1 spectrum disorder. The findings in this patient raise the possibility that PTPRN2 may be 
active during early development of the human brainstem and that its overexpression may cause 
bilateral DRS with hearing loss as occurs in patients with homozygous HOXA1 mutations. 
 
 
Abu-Amero, K. K., Kondkar, A. A., Alorainy, I. A., Khan, A. O., Al-Enazy, L. A., Oystreck, D. T., & 
Bosley, T. M. (2014). Xq26.3 microdeletion in a male with Wildervanck Syndrome. Ophthalmic 
Genet, 35(1), 18-24.29.29  
doi:10.3109/13816810.2013.766218 
 Click reference above to see full PDF article 
 
Background:  Wildervanck Syndrome (WS; cervico-oculo-acoustic syndrome) consists of Duane 
retraction syndrome (DRS), the Klippel-Feil anomaly, and congenital deafness. It is much more 
common in females than males and could be due to an X-linked mutation that is lethal to 
hemizygous males. We present the genetic evaluation of a male with WS and his family. 
 
Materials and Methods: Clinical evaluation and neuroimaging, sequencing of candidate genes, 
and array comparative genomic hybridization. 
 
Results: The patient had bilateral type 1 DRS, fusion of almost the entire cervical spine, and 
bilateral severe sensorineural hearing loss due to bilateral cochlear dysplasia; he also had 
congenital heart disease requiring surgery. His parents were unrelated, and he had eight 
unaffected siblings. The patient had no mutation found by Sanger sequencing of HOXA1, 
KIF21A, SALL4, and CHN1. He had a 3kB deletion in the X-chromosome at Xq26.3 that was not 
found in his mother, one unaffected sibling, or 56 healthy controls of matching ethnicity. 
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This deletion encompassed only one gene, Fibroblast Growth Factor Homologous Factor 13 
(FGF13), which encodes a 216-amino acid protein that acts intracellularly in neurons 
throughout brain development. 
 
Conclusions: Analysis of this patient’s phenotype and genotype open the possibility that X-
chromosome deletions may be a cause of WS with larger deletions being lethal to males and 
that FGF13 mutations may be a cause of WS. 
 
 
Abu-Amero, K. K., Kondkar, A. A., Al Otaibi, A., Alorainy, I. A., Khan, A. O., Hellani, A. M., 
Oystreck, D.T., and Bosley, T. M. (2015). Partial duplication of chromosome 19 associated with 
syndromic duane retraction syndrome. Ophthalmic Genet, 36(1), 14-20.30.30  
doi:10.3109/13816810.2013.827218 
 Click reference above to see full PDF article 
 
Background: To evaluate possible monogenic and chromosomal anomalies in a patient with 
unilateral Duane retraction syndrome, modest dysmorphism, cerebral white matter 
abnormalities, and normal cognitive function. 
 
Materials and Methods: Performing high-resolution array comparative genomic hybridization 
(array CGH) and sequencing of HOXA1, KIF21A, SALL4, and CHN1 genes. 
 
Results: The proband had unilateral Duane retraction syndrome (DRS) type III on the right with 
low-set ears, prominent forehead, clinodactyly, and a history of frequent infections during early 
childhood. Motor development and cognitive function were normal. Parents were not related, 
and no other family member was similarly affected. MRI revealed multiple small areas of high 
signal on T2 weighted images in cerebral white matter oriented along white matter tracts. 
Sequencing of HOXA1, KIF21A, SALL4, and CHN1 did not reveal any mutation(s). Array CGH 
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showed a 95Kb de novo duplication on chromosome 19q13.4 encompassing four killer cell 
immunoglobulin-like receptor (KIR) genes. 
 
Conclusions: KIR genes have not previously been linked to a developmental syndrome, although 
they are known to be expressed in the human brain and brainstem and to be associated with 
certain infections and autoimmune diseases, including some affecting the nervous system. DRS 
and brain neuroimaging abnormalities may imply a central and peripheral oligodendrocyte 
abnormality related in some fashion to an immunomodulatory disturbance. 
 
 
Abu-Amero, K. K., Kondkar, A., Hellani, A. M., Oystreck, D. T., Khan, A. O., & Bosley, T. M. 
(2015). Nicotinic Receptor Mutation in a Mildly Dysmorphic Girl with Duane Retraction 
Syndrome. Ophthalmic Genet, 36(2), 99-104.31.31  
doi:10.3109/13816810.2013.835431 
 Click reference above to see full PDF article 
 
Background: To evaluate possible monogenic and chromosomal anomalies in a patient with 
unilateral Duane retraction syndrome and modest dysmorphism. 
 
Materials and Methods: Clinical evaluation, sequencing of candidate genes, and array 
comparative genomic hybridization (array CGH). 
 
Results: The proband had unilateral Duane retraction syndrome (DRS) with low-set ears 
bilaterally, a high arched palate, and clinodactyly. Motor development and cognitive function 
were normal. Parents were first cousins, but no other family member was similarly affected. No 
mutations were detected in the HOXA1, KIF21A, SALL4, TUBB3, and CHN1 genes. Array CGH 
revealed a 16Kb de novo deletion at chromosome 8p11.2 that encompassed a portion of only 
one gene, the Cholinergic Receptor, Nicotinic, Beta-3 (CHRNB3, Neuronal). This gene encodes a 
protein that is involved in the nicotinic acetylcholine receptor on neurons. It interacts 
functionally with other genes that code components of the acetylcholine receptor. 
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Conclusions: This patient’s chromosomal abnormality affected only one gene that is highly 
expressed in the brainstem and brain, involved in neurotransmission, and could be related to 
her Duane retraction syndrome. 
 
 
Abu-Amero, K. K., Bosley, T. M., Kondkar, A. A., Oystreck, D. T., & Khan, A. O. (2015). CCDD 
Phenotype Associated with a Small Chromosome 2 Deletion. Semin Ophthalmol, 30(5-6), 435-
442.32.32  
doi:10.3109/08820538.2013.874474 
 Click reference above to see full PDF article 
 
Purpose:  Some individuals are born with congenital limitation of ocular motility, often 
associated with ptosis and retraction of the globe. Many of these disorders are now known as 
the congenital cranial dysinnervation disorders (CCDDs). While several genes have been 
associated with CCDD phenotypes, there are still patients for whom the genetic basis has not 
been identified.  
 
Methods: Clinical evaluation and neuroimaging, sequencing of candidate genes, and array 
comparative genomic hybridization (array CGH).  
 
Results: The patient was a four year- old girl with mild dysmorphism; bilateral mild ptosis; 
substantial limitation of abduction OS with milder limitations of abduction OD, adduction OS, 
and vertical gaze OS; and retraction OS>OD on attempted adduction. No mutations were 
detected in the HOXA1, KIF21A, SALL4, TUBB3, and CHN1 genes. Array CGH revealed a 8 Kb de 
novo deletion on chromosome 2 (2q24.3) that encompassed a portion of only one gene, the Xin 
Actin-binding Repeat containing 2 (Gene Symbol XIRP2; NM_001079810). This gene encodes a 
protein that is involved in muscle development and protecting actin filaments from 
depolymerization. It interacts functionally with 10 other proteins playing a similar role in 
muscle development.  
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Conclusions: This patient’s chromosomal abnormality affected only one gene that currently 
seems involved only in muscle development. All other genes currently associated with the 
CCDDs affect neurologic development. Genetic information from this patient implies that genes 
involved in development and maintenance of extraocular muscles can cause congenital 
ocular motility disorders as well.  
 
 
Abu-Amero, K. K., Kondkar, A. A., Oystreck, D. T., Khan, A. O., & Bosley, T. M. (2014). 
Microdeletions involving chromosomes 12 and 22 associated with syndromic Duane retraction 
syndrome. Ophthalmic Genet, 35(3), 162-169.33.33  
doi:10.3109/13816810.2014.921317 
 Click reference above to see full PDF article 
 
Background: Duane retraction syndrome (DRS) is the most common of the congenital cranial 
Dysinnervation disorders (CCDDs). CCDDs can be monogenic or chromosomal in origin. 
Identification of the genetic cause(s) in patients and families with DRS facilitates definitive 
diagnosis and provides insights into these developmental errors. 
 
Materials and Methods: This study described a young girl with DRS on the left and several 
additional developmental abnormalities. Clinical examination including neuroimaging, 
sequencing of candidate genes associated with DRS, and array comparative genomic 
hybridization (array CGH) were performed. 
 
Results: The proband had unilateral DRS type 3 on the left with somewhat low-set ears, mild 
motor delay with normal intelligence, and an asymmetric neck without a palpable right 
sternocleidomastoid muscle. Spine X-rays revealed a Klippel-Feil syndrome (KFS) and an MRI 
showed a webbed neck. She also had spina bifida at C8-T1 and a submucosal cleft palate. The 
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parents of the proband were related with no other family member affected similarly. 
Sequencing of SALL4, CHN1, HOXA1, and TUBB3 did not show any mutation. Array CGH 
revealed de novo deletions of 21 Kb on chromosome 12q24.31 and 11 Kb on chromosome 
22q13.31, each encompassing only one gene, ring finger protein 34, E3 ubiquitin protein ligase 
(RNF34) and peroxisome proliferator-activated receptor alpha (PPARA) respectively. 
 
Conclusions: This patient presents an unusual phenotype associated with a unique combination 
of two chromosomal microdeletions. 
 
 
Bosley, T. M., Salih, M. A., Alkhalidi, H., Oystreck, D. T., El Khashab, H. Y., Kondkar, A. A., & Abu-
Amero, K. K. (2016). Duane retraction syndrome in a patient with Duchenne muscular 
dystrophy. Ophthalmic Genet, 37(3), 276-280.34.34  
doi:10.3109/13816810.2015.1039139 
 Click reference above to see full PDF article 
 
PURPOSE: We describe the clinical features of a boy with bilateral Duane retraction syndrome 
(DRS), Duchenne muscular dystrophy (DMD), and other medical problems.  
 
METHODS: The child was followed-up for five years; his chart was reviewed, including the 
results of a muscle biopsy and genetic testing. Multiplex ligation-dependent probe amplification 
(MLPA) was used to interrogate deletions/duplications in the dystrophin gene.  
 
RESULTS: The proband had bilateral DRS with otherwise normal ocular motility; he also had 
developmental delay, mild mental retardation, and seizures. Clinical diagnosis of DMD included 
progressive proximal weakness, highly elevated creatine kinase levels, and a muscle biopsy 
showing significant dystrophic changes including contracted, degenerative, and regenerative 
fibers, and negative dystrophin immunostaining. MLPA documented duplication of exons 3 and 
4 of the dystrophin gene.  
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CONCLUSIONS: This boy is the third patient to be reported with DRS and DMD, the second with 
bilateral DRS and the only one with other neurologic features. Mutated dystrophin is present in 
extraocular muscles and in the central nervous system (CNS) in DMD, leaving open the question 
of whether this co-occurrence is the result of the genetic muscle abnormality, CNS effects 
caused by dystrophin mutations, or chance. 
 
 
Abu-Amero, K. K., Kondkar, A. A., Odan, H. A., Khan, A. O., Oystreck, D. T., & Bosley, T. M. 
(2016). Duane Retraction Syndrome Associated with a Small X Chromosome Deletion. Can J 
Neurol Sci, 43(3), 445-447.35  
doi:10.1017/cjn.2015.358 
 Click reference above to see full PDF article 
 
Overview: 
This was a single case of 16 year old female with syndromic bilateral DRS type 3.  Her main 
features in addition to the DRS were cleft palate and mildly reduced hearing.  All CCDD 
appropriate genes were screened and found to be negative.  As a result this patient underwent 
high-resolution array-comparative genomic hybridization (array CGH) analysis and found to 
have a 12-kb deletion in chromosome X encompassing part of only the dystrophin gene (DMD). 
 
This is another report in which a chromosomal anomaly involving a single gene was isolated in 
an individual with congenital complex strabismus.  However complex congenital strabismus was 
not isolated in this family.  Two other members were examined and confirmed to have 
disturbance of ocular alignment and motility.  The proband’s mother had a history of previous 
strabismus surgery.  Her right eye had a marked abduction deficit with globe retraction on 
adduction. Her left eye had a substantial adduction deficit with a mild abduction deficit and 
globe retraction on attempted adduction.  The proband’s younger brother had clinical features 
most consistent with a congenital left superior oblique palsy.    
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Significance of this paper: 
 This is another report where a mutation in a gene linked to myopathic processes is 
present.  We previously reported another case of congenital eye movement disorder 
associated with the gene XIRP232 that is involved predominantly in muscle development, 
implying that the primary genetic abnormality in some subjects with congenital ocular 
motility abnormalities may be related to muscle development. 
 This is the first report describing mutation in dystrophin gene in a female with DRS.  
Three previous reports were males. Of interest subject had a cleft palate as mutations in 
dystrophin gene have been associated with oral clefts. 
 This report suggests further evaluation on a larger group of subjects with syndromic or 
non-syndromic DRS may be required to determine changes in the dystrophin gene.  
 Argument given for dystrophin to play a potential role in DRS is as follows: 
o In DMD functional dystrophin is missing in postsynaptic regions of cerebellum 
and cerebral cortex. 
o CNS involvement is confirmed by presence of cognitive deficits and increased 
cortical excitability 
o Presence of dystrophin mutations in either neurologic or ocular muscle tissue (or 
both) might play a role in this subject. 
o In particular, dystrophin in the embryonic lateral rectus muscle could be a factor 
at times in the process of establishing normal development of eom function and 
innervation, and dystrophin mutations at times may disturb that process. 
 Re-introduces the possibility that at times, some CCDD phenotypes may be related to 
both myopathic and neurogenic factors. 
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Abu-Amero, K. K., Khan, A. O., Oystreck, D. T., Kondkar, A. A., & Bosley, T. M. (2016). The 
genetics of nonsyndromic bilateral Duane retraction syndrome. J AAPPOS, 20(5), 396-400 
e392.36 
 doi:10.1016/j.jaapos.2016.06.008 
 Click reference above to see full PDF article 
 
Purpose: To assess the importance of monogenic mutations and chromosomal copy number 
variants (CNVs) in the occurrence of nonsyndromic bilateral Duane retraction syndrome 
(bilateral nsDRS). 
 
Methods: The medical records of 12 patients with bilateral nsDRS were reviewed. Genes 
associated with DRS and associated congenital cranial dysinnervation disorders (SALL4, CHN1, 
HOXA1, TUBB3, and KIF21A) were sequenced in the standard fashion in each patient. Array 
comparative genomic hybridization (array CGH) was performed using Affymetrix Cytogenetics 
Whole-Genome 2.7M array, and the results were analyzed using Affymetrix Chromosome 
Analysis Suite v1.2. CNVs were assessed as unlikely to be pathologic if they were also present in 
the Database of Genomic Variants (DGV) or our local database of array CGH results in 150 
normal individuals of Middle Eastern ethnicity. 
 
Results: No patient had a sequence mutation in SALL4, CHN1, HOXA1, TUBB3, or KIF21A. 
These 12 patients each had 36-42 chromosomal deletions and/or duplications (mean with 
standard deviation, 26.25 +/- 6.77), but all of these CNVs were present either in the DGV or in 
our local database of normal individuals of similar ethnicity and, therefore, are considered 
nonpathogenic. 
 
Conclusions: The results reported here suggest that bilateral nsDRS is not usually associated 
with mutations in these genes or with chromosomal CNVs. Current evidence suggests other 
factors such as epigenetic and/or teratogenic abnormalities may be a potential cause of 
bilateral nsDRS. 
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Tables 
 
Table 2.1. Geographical consistency in DRS 
 
Site 
Orbis international E-consultation 
program 
King Khaled Eye Specialist Hospital 
Number 196 404 
Laterality Unilateral = 90% 
 34% RE 
 66% LE 
Bilateral   = 10% 
Unilateral = 86% 
 24% RE 
 76% LE 
Bilateral   = 14% 
Gender Male     = 34% 
Female = 66% 
Male     = 45% 
Female = 55% 
Type I > III > II I (78%) > III (19%) > II (4%)  
  
 
 
 
 
Table 2.2 Genetic results of subjects with DRS 
 
Group Dx. No. 
Sample 
obtained 
Genetic results 
Known Screen negative Pending 
1 nsDRS 57 19 0 12 7 
2 synDRS 53 44 35* 3 10 
3 DRS plus 1 1  1  
Total 111 64 35 16 16 
Dx = Clinical category; No. = number of subjects; nsDRS = non-syndromic Duane retraction syndrome; 
synDRS = syndromic Duane retraction syndrome; DRS plus = nsDRS with other ocular dysmotility 
phenotype.*Genetics confirmed in a similarly affected family member. 
 
 
  
Stellenbosch University  https://scholar.sun.ac.za
 31 
 
Table 2.3 Published DRS subjects 
 
No. Notes Ref 
8/9 Genetic mutation confirmed subjects 
1 subject not phenotyped by DTO.  
14 
9/9 Genetic mutation confirmed in subjects 
Contains 8 subjects reported in 2005 Tischfield and 1 new 
subject 
5 
4/9 Genetic mutation confirmed in subjects.   
Only 4 subjects determined to have DRS. Of the 
remaining 5, 2 had full ocular movements and 3 were 
reported as having horizontal gaze palsy but were not 
phenotyped by DTO  
15 
1/3 1 subject with bilateral DRS and synergistic divergence 
was mutation negative when screened for known CCDD 
genes. 
(See chapter 8.2.1) 
37 
1/1 Genetic mutation confirmed in subject 28 
1/1 Genetic mutation confirmed in subject 29 
1/1 Genetic mutation confirmed in subject 30 
1/1 Genetic mutation confirmed in subject 31 
1/1 Genetic mutation confirmed in subject 33 
1/1 Genetic mutation confirmed in subject 32 
1/1 Genetic mutation confirmed in subject 34 
1/1 Genetic mutation confirmed in subject 35 
12/12 All subjects with bilateral nsDRS were negative for 
genetic mutation 
36 
33pts   
No. = number of subjects with DRS; Ref = Reference number 
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Chapter 3: Moebius syndrome (MBS) 
 
Moebius syndrome is a complex developmental disorder of the hindbrain with a broad 
phenotype often overlapping with other syndromes. It is felt to have multiple etiological 
mechanisms with a yet unknown genetic component.  
The major impact of our work has been to improve the clinical diagnostic criteria for this 
condition permitting better distinction of subjects with MBS from those having similar but 
etiologically distinct conditions.   
 
As of 2016, a total of 123 subjects have been examined with a presumed diagnosis of MBS.  An 
additional 45 subjects have since been examined but are not included in this dissertation.  The 
investigations of these 123 subjects has resulted in 5 publications to date.  Table 3.1 
summarizes these reports.   
 
Important findings were that it is not uncommon for patients presenting with a diagnosis of 
with MBS to actually not have the condition.  The genetic basis of MBS remains unknown 
however the phenotypic and genetic distinction of MBS from other overlapping disorders is 
now better elucidated as illustrated in the PDF article included this chapter. 
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Tables 
 
Table 3.1. Publications arising from the assessment of MBS subjects. 
 
Publication Significant findings Chapter 
discussed 
Rankin 201024 Reports 25 subjects that would later be included in MacKinnon 2014.   
Due to phenotypic overlap with HOXA1 spectrum, these subjects 
were analyzed for mutations in HOXA1 gene.  All were mutation 
negative for HOXA1 mutations. 
Chapter 2 
Webb 201238 Reported 2 siblings that would be later included in MacKinnon 2014. 
Both were found to have mutations in HOXB1 gene and did not meet 
minimum diagnostic criteria for MBS. 
Chapter 8 
Chew 201339 Report includes 2 subjects that would later be included in 
MacKinnon 2014. 
Both were found to have TUBB3 – E410K mutations and did not 
meet minimum diagnostic criteria for MBS.  
Chapter 4 
MacKinnon 
201440 
See full article below. 
 
Summary of non-MBS subjects identified: 
2 patients – mother and son with autosomal dominant congenital 
facial palsy (HCFP) 
2 siblings with comitant strabismus, facial palsy and sensorineural 
hearing loss who were positive for mutation in HOXB1 (see Webb 
2012) 
 
4 unrelated subjects found to have mutations in TUBB3.  
 2 subjects with TUBB3-E410K mutations (see Chew 2013) 
 1 subject with TUBB3-262H mutation 
 1 subject with TUBB3-E410V mutation 
Chapter 3 
2017 Di 
Gioia41 
Identifies Carey-Fineman-Ziter syndrome (CFZS), a congenital 
myopathy, as another explanation for an atypical MBS phenotype.  
Chapter 8 
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MacKinnon, S., Oystreck, D. T., Andrews, C., Chan, W. M., Hunter, D. G., & Engle, E. C. (2014). 
Diagnostic distinctions and genetic analysis of patients diagnosed with moebius syndrome. 
Ophthalmology, 121(7), 1461-1468.40  
doi:10.1016/j.ophtha.2014.01.006 
 
OBJECTIVE: To improve diagnostic assessment in Moebius syndrome by (1) creating more 
selective diagnostic subgroups and (2) conducting genetic evaluation in a large patient cohort.  
 
DESIGN: Prospective, observational study.  
 
PARTICIPANTS: Attendees of 3 consecutive Moebius syndrome conferences held in the United 
States, with a prior diagnosis of Moebius syndrome, were invited to participate.  
 
METHODS: Participants underwent standardized ophthalmologic examination for Moebius 
syndrome minimum diagnostic criteria (MDC) (congenital, nonprogressive facial palsy, and 
abduction deficit) and genetic testing for HOXA1, HOXB1, and TUBB3 mutations.  
 
MAIN OUTCOME MEASURES: The number of patients meeting MDC and the number of patients 
with confirmed genetic mutation.  
 
RESULTS: A total of 112 participants from 107 families enrolled. Nineteen percent of 
participants (21/112) did not meet accepted MDC for Moebius syndrome because they had 
abduction deficits without facial palsy or facial palsy with full ocular motility. All 5 families with 
2 affected individuals had at least 1 family member in this category, including 2 siblings with 
comitant strabismus who harbored a HOXB1 mutation. Four unrelated participants, also not 
meeting MDC, had large-angle exotropia, vertical gaze deficiency, and ptosis consistent with 
congenital fibrosis of the extraocular muscles type 3 (CFEOM3); 1 patient harbored a novel 
TUBB3 mutation, and 3 patients harbored previously reported de novo TUBB3 mutations. Three 
percent of participants (3/112) met MDC but also had restricted vertical gaze. The remaining 88 
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participants (79%) met MDC and had full vertical gaze. This group had relatively homogeneous 
findings, and none had a family history of Moebius syndrome. Two previously undescribed 
phenomena were observed in this category: (1) volitional Bell's phenomenon and (2) intorsion 
with fixation.  
 
CONCLUSIONS: Although the genetic contributors to classic Moebius syndrome remain elusive, 
accuracy in clinical evaluation will properly subdivide patients to facilitate genetic testing as 
new candidate genes are identified. Failure to test ocular motility may lead to misdiagnosis of 
Moebius syndrome, especially in patients who have facial palsy with full ductions. Patients with 
exotropia, vertical gaze limitation, and ptosis do not have classic Moebius syndrome and may 
have TUBB3 mutations associated with CFEOM3. To optimize genetic analysis, we propose 
adding "full vertical motility" to the MDC for Moebius syndrome. 
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Chapter 4: Congenital Fibrosis of the Extraocular muscles (CFEOM) 
 
This chapter involves a heterogeneous group of disorders defined by having congenital non-
progressive ocular motility deficits associated with ptosis.  These are referred to as congenital 
fibrosis of the extraocular muscles (CFEOM).   
The work presented here summarizes the enrolled subject population.  It includes publications 
that enhance clinical descriptions in genetically confirmed variants as well as report new 
genetic syndromes that include CFEOM.  At initiation of the dissertation three main phenotypes 
were reported, each already having an identified monogenic cause. CFEOM1 was an autosomal 
dominant form arising from mutations in KIF21A, CFEOM2 was autosomal recessive arising 
from mutations in PHOX2A, while CFEOM3 was autosomal dominant but had a greater 
phenotypic spectrum. Mutations in two different genes could lead to a CFEOM3 phenotype. 
First was KIF21A, but found to rarely be the cause of CFEOM1.  The second gene was TUBB3 
and could result in isolated CFEOM or CFEOM associated with neurologic, cognitive, or medical 
problems.  As a result there was a need to expand the classification of CFEOM3 to include 
CFEOM3A and CFEOM3A plus when due to mutations in TUBB3, and CFEOM3B in the setting of 
KIF21A mutations.  This expansion started the unravelling of a classification system, which up to 
that point, had good phenotype-genotype correlations.  This became more evident as 
additional individuals were genotyped.  An overview of the status of CFEOM at this time was 
reported as part of a textbook chapter in 201042 (link to full PDF) and in 2011 as part of a review 
article26 (link to full PDF).  These in part led to the development of the KSU ophthalmic genetics 
program as it was clear more phenotypes and genotypes were yet to be identified.    
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Summary of CFEOM research 
A total of 105 subjects (13% total population) met criteria for CFEOM.  A genetic diagnosis was 
confirmed in 47/105 subjects (45%). Results are still pending 28/105 (27%).  Three individuals 
given a diagnoses of CFEOM were negative for a mutation in the known CFEOM genes and the 
currently known CCDD genes.  This suggests most CFEOM phenotypes arise from mutations in 
previously identified genes, highlighting the importance of a careful clinical evaluation.  It also 
indicates additional genotypes still need to be identified.  Table 4.1 provides a breakdown of 
the CFEOM type and the results of the genetic analysis.  Given that two genes accounted for 
98% of all CFEOM this should be ideal for genotype-phenotype correlations.  However, this 
would not be the case. 
 
Thirty-five subjects were reported in 8 publications of which the candidate was an author in 7 
(Table 4.2).26, 39, 40, 42-46  The 28 subjects reported prior to initiation of the dissertation were 
instrumental in identifying orthoptic features to better distinguish CFEOM variants from other 
congenital eye movement disorders, as well as the CFEOM subtypes from each other.        
These are summarized below and organized by clinical diagnosis and any accompanying 
publication.  
 
CFEOM1 
A total of 20 subjects were given a CFEOM1 phenotype.  Four members from 1 family were 
found to have mutation in KIF21A.  Features of this family were included in review articles 
outlining phenotypic distinctions from other CFEOM variants.26, 42, 45 Full articles are included in 
appendix section for chapter 442 and in chapter 9.26, 45  Genetic results are pending in the 
majority of these individuals (14/20).    
 
CFEOM2 
Twenty-eight subjects were found to have a CFEOM2 phenotype of which 22 undergoing 
genetic analysis were confirmed to have mutations in the same gene (PHOX2A).  A cohort of 
this group was extensively studied and reported in the following two publications. 
Stellenbosch University  https://scholar.sun.ac.za
 39 
 
Bosley, T. M., Oystreck, D. T., Robertson, R. L., al Awad, A., Abu-Amero, K., & Engle, E. C. (2006). 
Neurological features of congenital fibrosis of the extraocular muscles type 2 with mutations in 
PHOX2A. Brain, 129(Pt 9), 2363-2374.44  
doi:10.1093/brain/awl161  
  Click reference above to see full PDF article 
 
Congenital fibrosis of the extraocular muscles type 2 (CFEOM2) is a complex strabismus 
syndrome that results from mutations in the homeodomain transcription factor PHOX2A. To 
define the clinical and neuroimaging features of patients with this autosomal recessive 
syndrome, we studied 15 patients with genetically defined CFEOM2. All patients underwent full 
neurological, neuro-ophthalmological and orthoptic assessments. Twelve patients had pupillary 
pharmacological testing and nine had 3.0 tesla MRI of the brain, brainstem and orbits. Patients 
were born with severe bilateral ptosis and exotropia with almost complete bilateral absence of 
adduction, elevation, depression and intorsion. Variable abduction was present prior to 
strabismus surgery in 14 patients, and central ocular motility reflexes (smooth pursuit, 
saccades, vestibulo-ocular reflex and optokinetic reflex) were intact except for convergence. 
Pupillary light and near reflexes were not present, but irises were anatomically normal and 
responded to pupillary pharmacology. Neuroimaging of brain and brainstem was remarkable 
for the anatomical absence of cranial nerve (CN) 3 and probably CN 4 bilaterally. Therefore, the 
CFEOM2 phenotype and neuroimaging are both consistent with the congenital absence of CNs 
3 and 4. Additional features included presence of most central ocular motility reflexes, a central 
lack of pupillary responsiveness of uncertain etiology and modest phenotypic variability that 
does not correlate with specific PHOX2A mutations. Clinical presentation, neuroimaging and 
Phox2a-/- animal models all support the concept that CFEOM2 is a primary neurogenic 
abnormality with secondary myopathic changes. 
 
Significance of publication:  
This was the first formal phenotypic description of individuals with PHOX2A mutations.  
Characterization of orthoptic features and neuro-imaging findings confirmed CFEOM2 due to 
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PHOX2A mutations fall within in the category of CCDD and that PHOX2A does not affect 
supranuclear or central horizontal gaze mechanisms.  It also confirmed a lack of mutation-
phenotype correlations and verified that mutations to date result in complete loss of function.  
It also determined these individuals do not have major somatic anomalies or other autonomic, 
cognitive or focal neurological abnormalities.  
The complex strabismus patterns in these individuals led to further refinement of an ocular 
alignment and motility scoring template that would be applied to all future subjects.  This 
included modification of traditional scoring method to include deficits greater than -4 and the 
need to document ‘resting’ globe positions.   This was also the first CCDD confirmed to have 
pupil involvement and led to the development of a pupil testing protocol when evaluating other 
CCDDs.  
 
 
Khan, A. O., Almutlaq, M., Oystreck, D. T., Engle, E. C., Abu-Amero, K., & Bosley, T. (2016). 
Retinal Dysfunction in Patients with Congenital Fibrosis of the Extraocular Muscles Type 2. 
Ophthalmic Genet, 37(2), 130-136.46  
doi:10.3109/13816810.2014.926942  
 Click reference above to see full PDF article 
 
INTRODUCTION: Congenital fibrosis of the extraocular muscles type 2 (CFEOM2) is a distinct 
non-syndromic form of congenital incomitant strabismus secondary to orbital dysinnervation 
from recessive mutations in the gene PHOX2A. The phenotype includes bilateral ptosis, very 
large angle exotropia, ophthalmoplegia, and poorly-reactive pupils. Other than amblyopia, 
afferent visual dysfunction has not been considered part of CFEOM2; however, we have 
repeatedly observed non-amblyopic subnormal vision in affected patients. The purpose of this 
study was to document this recurrent feature of the phenotype.  
 
METHODS: A retrospective case series (2002-2012).  
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RESULTS: Eighteen patients (four families) were identified; all affected individuals had 
confirmed homozygous recessive PHOX2A mutations except one individual for whom genetic 
testing was not done because of multiple genetically confirmed family members. Age at 
assessment ranged from 5-62 years old (median 10 years old). All patients had decreased best-
corrected visual acuity not completely explainable by amblyopia in both the preferred and non-
preferred eye. In those patients who had further ancillary testing, visual fields (five patients) 
and electroretinography (10 patients) confirmed abnormalities not ascribable to amblyopia.  
 
CONCLUSIONS: In addition to a distinct form of congenital incomitant strabismus, the 
phenotype of CFEOM2 includes subnormal vision consistent with retinal dysfunction. This could 
be the direct result of PHOX2A mutations or a secondary effect of orbital dysinnervation. 
 
Significance of publication:  
This study demonstrated this CFEOM subtype may have afferent system defect in conjunction 
with significant efferent system dysfunction.  Therefore individuals with suspected or confirmed 
CCDDs should have a complete ophthalmological evaluation.  
 
 
 
CFEOM3 
Fifty-seven subjects had a phenotype consistent with CFEOM3.  Eighteen subjects were 
confirmed to have a mutation in one of two genes, TUBB3 (n=10) or KIF21A (n=8) while 3 
individuals were mutation negative for all known CCDD genes.   Twelve patients were reported 
in 6 publications.26, 39, 40, 42, 43, 45 Three of these publications are outlined below, another 3 are 
discussed later in Chapter 8.  
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Yamada, K., Chan, W. M., Andrews, C., Bosley, T. M., Sener, E. C., Zwaan, J. T., et al (2004). 
Identification of KIF21A mutations as a rare cause of congenital fibrosis of the extraocular 
muscles type 3 (CFEOM3). Invest Ophthalmol Vis Sci, 45(7), 2218-2223.43   
PMID: 15223798 
 No PDF provided 
 
PURPOSE: Three congenital fibrosis of the extraocular muscles phenotypes (CFEOM1-3) have 
been identified. Each represents a specific form of paralytic strabismus characterized by 
congenital restrictive ophthalmoplegia, often with accompanying ptosis. It has been 
demonstrated that CFEOM1 results from mutations in KIF21A and CFEOM2 from mutations in 
PHOX2A. This study was conducted to determine the incidence of KIF21A and PHOX2A 
mutations among individuals with the third CFEOM phenotype, CFEOM3.  
 
METHODS: All pedigrees and sporadic individuals with CFEOM3 in the authors' database were 
identified, whether the pedigrees were linked or consistent with linkage to the FEOM1, FEOM2, 
and/or FEOM3 loci was determined, and the appropriate pedigrees and the sporadic individuals 
were screened for mutations in KIF21A and PHOX2A.  
 
RESULTS: Twelve CFEOM3 pedigrees and 10 CFEOM3 sporadic individuals were identified in the 
database. The structures of eight of the pedigrees permitted the generation of meaningful 
linkage data. KIF21A was screened in 17 probands, and mutations were identified in two 
CFEOM3 pedigrees. One pedigree harbored a novel mutation (2841G-->A, M947I) and one 
harbored the most common and recurrent of the CFEOM1 mutations identified previously 
(2860C-->T, R954W). None of CFEOM3 pedigrees or sporadic individuals harbored mutations in 
PHOX2A.  
 
CONCLUSIONS: The results demonstrate that KIF21A mutations are a rare cause of CFEOM3 and 
that KIF21A mutations can be nonpenetrant. Although KIF21A is the first gene to be associated 
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with CFEOM3, the results imply that mutations in the unidentified FEOM3 gene are the more 
common cause of this phenotype. 
 
Significance of publication:  
The candidate was not part of this publication.  However affected individuals from the Saudi 
family were later examined by myself and confirmed to have a CFEOM3 phenotype.   
Two of five affected members from a second Saudi family (not published - ID 322987-7, 
322969-6) were also found to have CFEOM3 phenotypes further weakening the once definitive 
CFEOM1-KIF21A phenotype-genotype correlation.   
 
Oystreck 201126 p70-71 provides a full description of one member from each CFEOM-KIF21A 
family.  Full article is provided in chapter 9. (link to full PDF)  
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Chew, S., Balasubramanian, R., Chan, W. M., Kang, P. B., Andrews, C., Webb, B. D., MacKinnon, 
S.E., Oystreck, D.T., Rankin, J, Crawford, T.O., Geraghty, M., Pomeroy, S.L., Crowley Jr, W.F., 
Jabs, E.W., Hunter, D.G., Grant, P, Engle, E.C. (2013). A novel syndrome caused by the E410K 
amino acid substitution in the neuronal beta-tubulin isotype 3. Brain, 136(Pt 2), 522-535.39  
doi:10.1093/brain/aws345  
 Click reference above to see full PDF article 
 Briefly discussed in chapter 3  
 
Missense mutations in TUBB3, the gene that encodes the neuronal-specific protein beta-tubulin 
isotype 3, can cause isolated or syndromic congenital fibrosis of the extraocular muscles, a form 
of complex congenital strabismus characterized by cranial nerve misguidance. One of the eight 
TUBB3 mutations reported to cause congenital fibrosis of the extraocular muscles, c.1228G>A 
results in a TUBB3 E410K amino acid substitution that directly alters a kinesin motor protein 
binding site. We report the detailed phenotypes of eight unrelated individuals who harbour this 
de novo mutation, and thus define the 'TUBB3 E410K syndrome'. Individuals harbouring this 
mutation were previously reported to have congenital fibrosis of the extraocular muscles, facial 
weakness, developmental delay and possible peripheral neuropathy. We now confirm by 
electrophysiology that a progressive sensorimotor polyneuropathy does indeed segregate with 
the mutation, and expand the TUBB3 E410K phenotype to include Kallmann syndrome 
(hypogonadotropic hypogonadism and anosmia), stereotyped midface hypoplasia, intellectual 
disabilities and, in some cases, vocal cord paralysis, tracheomalacia and cyclic vomiting. 
Neuroimaging reveals a thin corpus callosum and anterior commissure, and hypoplastic to 
absent olfactory sulci, olfactory bulbs and oculomotor and facial nerves, which support 
underlying abnormalities in axon guidance and maintenance. Thus, the E410K substitution 
defines a new genetic aetiology for Moebius syndrome, Kallmann syndrome and cyclic 
vomiting. Moreover, the c.1228G>A mutation was absent in DNA from approximately 600 
individuals who had either Kallmann syndrome or isolated or syndromic ocular and/or facial 
dysmotility disorders, but who did not have the combined features of the TUBB3 E410K 
syndrome, highlighting the specificity of this phenotype-genotype correlation. The definition of 
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the TUBB3 E410K syndrome will allow clinicians to identify affected individuals and predict the 
mutation based on clinical features alone. 
 
Significance of publication:  
Further confirmation CFEOM arises from mutation in TUBB3. Also confirms another syndromic 
CFEOM3 phenotype and supports the increasing information that there are mutation-specific 
TUBB3 phenotypes.   
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MacKinnon, S., Oystreck, D. T., Andrews, C., Chan, W. M., Hunter, D. G., & Engle, E. C. (2014). 
Diagnostic distinctions and genetic analysis of patients diagnosed with moebius syndrome. 
Ophthalmology, 121(7), 1461-1468.40  
doi:10.1016/j.ophtha.2014.01.006   
 See chapter 3 for full article   
 
OBJECTIVE: To improve diagnostic assessment in Moebius syndrome by (1) creating more 
selective diagnostic subgroups and (2) conducting genetic evaluation in a large patient cohort. 
DESIGN: Prospective, observational study.  
 
PARTICIPANTS: Attendees of 3 consecutive Moebius syndrome conferences held in the United 
States, with a prior diagnosis of Moebius syndrome, were invited to participate. METHODS: 
Participants underwent standardized ophthalmologic examination for Moebius syndrome 
minimum diagnostic criteria (MDC) (congenital, nonprogressive facial palsy, and abduction 
deficit) and genetic testing for HOXA1, HOXB1, and TUBB3 mutations.  
 
MAIN OUTCOME MEASURES: The number of patients meeting MDC and the number of patients 
with confirmed genetic mutation.  
 
RESULTS: A total of 112 participants from 107 families enrolled. Nineteen percent of 
participants (21/112) did not meet accepted MDC for Moebius syndrome because they had 
abduction deficits without facial palsy or facial palsy with full ocular motility. All 5 families with 
2 affected individuals had at least 1 family member in this category, including 2 siblings with 
comitant strabismus who harbored a HOXB1 mutation. Four unrelated participants, also not 
meeting MDC, had large-angle exotropia, vertical gaze deficiency, and ptosis consistent with 
congenital fibrosis of the extraocular muscles type 3 (CFEOM3); 1 patient harbored a novel 
TUBB3 mutation, and 3 patients harbored previously reported de novo TUBB3 mutations. Three 
percent of participants (3/112) met MDC but also had restricted vertical gaze. The remaining 88 
participants (79%) met MDC and had full vertical gaze. This group had relatively homogeneous 
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findings, and none had a family history of Moebius syndrome. Two previously undescribed 
phenomena were observed in this category: (1) volitional Bell's phenomenon and (2) intorsion 
with fixation.  
 
CONCLUSIONS: Although the genetic contributors to classic Moebius syndrome remain elusive, 
accuracy in clinical evaluation will properly subdivide patients to facilitate genetic testing as 
new candidate genes are identified. Failure to test ocular motility may lead to misdiagnosis of 
Moebius syndrome, especially in patients who have facial palsy with full ductions. Patients with 
exotropia, vertical gaze limitation, and ptosis do not have classic Moebius syndrome and may 
have TUBB3 mutations associated with CFEOM3. To optimize genetic analysis, we propose 
adding "full vertical motility" to the MDC for Moebius syndrome. 
 
Significance of publication:  
Careful orthoptic evaluations identified CFEOM3 phenotypes in a large population of individuals 
with presumed MBS (see Chapter 3).  In all four cases a mutation in TUBB3 was found showing 
evidence that the term MBS-like used in previous reports are likely patients with CFEOM due to 
TUBB3 mutations.  
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Tables 
 
Table 4.1 Genetic results of subjects with CFEOM 
 
Dx No. Sample 
obtained 
Genetic results 
Known Screen negative Pending 
CFEOM1 20 16 4 0 12 
CFEOM2 28 23 22* 0 3 
CFEOM3 57 35 18* 3 13 
Total 105 74 47 0 28 
Dx = Clinical diagnosis; No. = number of subjects; CFEOM1, 2, or 3 = congenital fibrosis of the extraocular 
muscles type 1, 2, or 3. 
*Genetic mutations were presumed in 1 patient with CFEOM2 and 6 patients with CFEOM3 due to 
having a similarly affected sibling with confirmed mutation in the gene.  
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Table 4.2 Published CFEOM subjects 
 
No. Significant findings Ref Chapter 
discussed 
6/63 Subjects reported as part of large multisite study investigating 
KIF21A as the cause of CFEOM3.  
 
1st paper to report KIF21A mutations can result in CFEOM3 
phenotype. 
 
Candidate not an author but would later phenotype all 6 of 
these individuals (family 1) and report two members in future 
publications focusing on phenotype-genotype correlations.26, 
45 
  
43 Chapter 4 
15/15 Detailed neurologic and orthoptic reports on subjects with 
mutations in PHOX2A.  
44 Chapter 4 
5/12 Report of CFEOM1,2, and 3 phenotypes as part of textbook 
chapter. 
42 Chapter 4 
6/9 Report of CFEOM1,2, and 3 phenotypes as part of a Review 
article. 
26 Chapter 9 
1/5 Describes subject with CFEOM3 due to mutation in KIF21A.  45 Chapter 9 
2/8 Reports new syndrome arising from novel de novo mutation 
in TUBB3. 
39 Chapter 4 
4/112 Reports subjects with atypical MBS phenotype have CFEOM 
due to specific TUBB3 mutations. 
40 Chapter 3 
14/18 Investigation of afferent visual functioning in genetically 
confirmed subjects with CFEOM2 
46 Chapter 4 
35pts†    
No. = number of patients with CFEOM examined by candidate/total number of subjects in publication; 
Ref = Reference; † = Subjects counted only once.  Several have been reported in more than 1 
publication. 
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Chapter 5: Orbitofacial neurofibromatosis type 1 (OFNF)  
 
Neurofibromatosis is an autosomal dominant, neurocutaneous disorder.  We examined 96 
subjects with NF1 and noticed some individuals had a more severe phenotype consisting of 
neurofibromas involving the lid, brow, face, and orbit.  We referred to this group as orbitofacial 
neurofibromatosis type 1 (OFNF).  The original intent of our research was to perform expression 
studies in families with multiple affected members with OFNF and/or NF1.  All individuals 
enrolled into this study were screened for neurofibromas and received an orthoptic 
examination to determine their binocular vision status.  
 
The following publications arose from the assessment of 62 individuals with OFNF.  Reported 
here were the clinical features and treatment outcomes,47 afferent system disorders,48 and 
disruptions to ocular motility and alignment49 in this unique population. 
 
 
Chaudhry, I. A., Morales, J., Shamsi, F. A., Al-Rashed, W., Elzaridi, E., Arat, Y. O., Jacquemin, C., 
Oystreck, D.T., Bosley, T. M. (2012). Orbitofacial neurofibromatosis: clinical characteristics and 
treatment outcome. Eye (Lond), 26(4), 583-592.47  
doi:10.1038/eye.2011.336  
 Click reference above to see full PDF article 
 
PURPOSE: To report clinical observations and surgical management in a large series of patients 
with orbitofacial neurofibromatosis type 1 (OFNF).  
PATIENTS AND METHODS: Patients were identified and medical records reviewed for 
demographic data, ophthalmologic examinations, surgical interventions, and procedure 
outcome to create a retrospective, non-comparative case series of patients with OFNF seen at 
one medical centre over a 23-year period.  
RESULTS: Sixty patients with OFNF (31 females and 29 males; mean age, 14 years) were 
followed for an average of 5.7 years. Presenting signs and symptoms included eyelid swelling in 
all patients, ptosis in 56 (93.3%), proptosis in 34 (56.6%), dystopia or strabismus in 30 (50%), 
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and decreased visual acuity in 50 (83.3%). Surgical intervention included ptosis repair in 54 
(90%; mean 1.6 surgical procedures), facial and orbital tumour debulking in 54 (90%; mean 2.3 
surgeries), and canthoplasty in 28 (46.6%) patients. Eleven patients required enucleation or 
exenteration of a blind eye.  
CONCLUSION: Patients with OFNF often require multiple procedures to preserve vision, prevent 
additional disfigurement, and achieve cosmetic rehabilitation. Patients need regular 
ophthalmological monitoring given the potential for progressive visual and cosmetic 
consequences. 
 
Significance of publication:  
This retrospective study led to formal prospective research projects that would eventually 
include multiple institutions and several sub-specialties within ophthalmology as well as 
radiology, and genetics.   
 
 
Oystreck, D. T., Morales, J., Chaudhry, I., Alorainy, I. A., Elkhamary, S. M., Pasha, T. M., & 
Bosley, T. M. (2012). Visual loss in orbitofacial neurofibromatosis type 1. Ophthalmology, 
119(10), 2168-2173.  
doi:10.1016/j.ophtha.2012.04.032 
 Full article provided below 
 
PURPOSE: On occasion, neurofibromas in neurofibromatosis type 1 may be present on the lid, 
brow, or face of an infant or child, a circumstance commonly referred to as "orbitofacial 
neurofibromatosis" (OFNF). The present study evaluates the causes and extent of visual loss in 
a group of patients with OFNF.  
 
DESIGN: Case series. PARTICIPANTS: Fifty-five patients with OFNF. METHODS: Retrospective 
medical record review and reexamination of selected patients from one institution. MAIN  
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OUTCOME MEASURES: Visual acuity and identification of underlying cause of reduced vision.  
 
RESULTS: Fifty patients with unilateral OFNF (23 male, 27 female, aged 4-48 years at last visit) 
and 5 patients with bilateral OFNF (2 male, 3 female, aged 15-43 years) had adequate 
information available to assess afferent visual functioning. Nine patients (4 male, 5 female, 
aged 4-28 years) had optic pathway glioma (OPG) in addition to OFNF. Patients were followed 
as long as 27 years (mean 8.4 years). Thirty-nine patients (71% of total) had visual acuity of 
</=20/60 on the side of OFNF involvement (or the side of worse OFNF involvement in patients 
with bilateral disease). One or more causes of amblyopia were present in 29 of these patients, 
19 patients had organic disease of the eye (e.g., glaucoma or retinal detachment) or the 
afferent system (e.g., OPG), and 12 patients had correctable refractive errors.  
 
CONCLUSIONS: Visual loss in this OFNF cohort was common, typically profound, and usually 
multifactorial. Some causes of visual loss (including congenital glaucoma with buphthalmos and 
retinal detachment, disconjugate gaze due in part to distorted skull development causing 
strabismic amblyopia, and OPG) were difficult to treat adequately and tended to cause 
progressive, profound visual loss. Therefore, careful observation should be made during the 
period of visual immaturity for possible causes of amblyopia that might be treatable, such as 
refractive changes, occlusion of the visual axis, or congenital glaucoma. As affected individuals 
get older, physicians must be vigilant for the progression of optic nerve disease due to 
glaucoma or OPG and to the possibility that vision might be improved by refraction. 
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Oystreck, D. T., Alorainy, I. A., Morales, J., Chaudhry, I. A., Elkhamary, S. M., & Bosley, T. M. 
(2014). Ocular motility abnormalities in orbitofacial neurofibromatosis type 1. J AAPOS, 18(4), 
338-343.  
doi:10.1016/j.jaapos.2014.02.018 
 Full article provided below 
 
PURPOSE: To evaluate the causes of ocular motility disturbances in a group of patients with 
orbitofacial neurofibromatosis (OFNF) with neurofibromas on the lid, brow, face, or in the orbit 
from infancy or early childhood.  
 
METHODS: The medical records of patients with OFNF from one institution were retrospectively 
reviewed; selected patients were reexamined.  
 
RESULTS: A total of 45 patients with unilateral OFNF and 4 with bilateral OFNF were included. 
Of these, 14 had no strabismus and relatively good vision, with no ductional abnormalities on 
either side despite large globes, sphenoid dysplasia, and neurofibromas in the orbit and/or 
cavernous sinus in many. The 8 patients with comitant strabismus also had no ductional 
abnormalities with a similar constellation of anatomic abnormalities, but these patients all had 
poor vision in at least one eye. The 27 patients with incomitant strabismus all had downward 
displacement of the globe and limited ductions.  
 
CONCLUSIONS: The pathologic anatomic changes associated with OFNF do not always cause 
ocular motility abnormalities: strabismus generally was not present when ocular motility was 
full and visual acuity was good. Comitant strabismus occurred in the setting of full ocular 
motility with reduced vision in at least one eye. Incomitant strabismus was always accompanied 
by reduced vision and a ductional abnormality in one or both eyes due to anatomic 
abnormalities of the orbit and skull. 
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Chapter 6: Congenital Myasthenic Syndrome (CMS) 
 
In some circumstances ocular motility can be disturbed by dysfunction at the neuromuscular 
junction (NMJ). The commonest reason is acquired autoimmune myasthenia gravis and 
Lambert-Eaton syndromes.  
However, there are genetic variants referred to as Congenital Myasthenic Syndromes (CMS).  
CMS is a heterogeneous group of inherited disorders in which there is impairment of 
neuromuscular transmission due to dysfunction of the structure or functionality of the 
neuromuscular synapse.  Several responsible mechanisms have been identified; however, in all 
cases appropriate achievement of muscle depolarization is compromised. 
Identification of specific clinical clues are used to help suggest a diagnosis of CMS.  A diagnosis 
of CMS should be considered in infants with feeding difficulties that include poor suck and 
swallow, respiratory failure that may include apneic crisis, and hypotonia8 all of which may be 
variable.50  Age at onset is typically in the neonatal period but it can be late childhood or 
beyond depending on the variant.  Description of ocular motility features are limited in the 
literature, and when given subjects are generally described as having variable ptosis and 
ophthalmoparesis.   
At present, determining the underlying mechanism has not been reliable, although accuracy 
can be improved with the addition of morphologic examination of the NMJ and with 
neurophysiological studies.  However, these are time consuming, prone to artifact and not 
feasible in neonates that are generally unwell.8   
The advent of new genetic tools has permitted a classification of CMS based on molecular 
details.  This affords the opportunity to answer several important questions:  
 Elucidating phenotypic characteristics for each genetically distinct variant.   
 To investigate unique features to a specific gene mutation or the presence of a mutation 
specific phenotypes, both of which could be used to make a clinical diagnosis which in 
turn may predict the molecular diagnosis in other subjects.  
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CMS research overview: 
With these questions in mind our team set out to identify and investigate subjects with CMS.  
This chapter includes 3 publications involving 4 subjects.     
 
Salih, M. A., Oystreck, D. T., Al-Faky, Y. H., Kabiraj, M., Omer, M. I., Subahi, E. M., Beeson, D., 
Abu-Amero, K.K., Bosley, T. M. (2011). Congenital myasthenic syndrome due to homozygous 
CHRNE mutations: report of patients in Arabia. J Neuroophthalmol, 31(1), 42-47.51  
doi:10.1097/WNO.0b013e3181f50bea    
 Click reference above to see full PDF article 
 
We describe the clinical characteristics of 3 siblings from 1 family with congenital myasthenic 
syndrome due to homozygous mutations of the gene coding for the epsilon subunit of the 
acetylcholine receptor (CHRNE). Onset of symptoms occurred in the first few months of life 
with ptosis, restricted ocular motility, mild proximal weakness, and difficulty swallowing. 
Multiple hospital admissions were required due to recurrent pulmonary infections. There was 
no decremental conduction on repetitive nerve stimulation, but jitter was increased on single 
fiber electromyography. Since early childhood, our patients have done well without pulmonary 
or bulbar symptoms and with partial improvement on pyridostigmine therapy. Response of 
ptosis to diagnostic ice pack test was striking. Although these siblings have a clinical history and 
examination findings typical of homozygous CHRNE mutations, the clinical presentation of 
congenital myasthenia subtypes is variable, and accurate genotyping is essential in choosing the 
appropriate treatment. 
 
Significance of Publication: 
This paper reported the clinical features in the first family from the Arabian Peninsula 
confirmed to have autosomal recessive mutations in CHRNE.  This afforded the opportunity to 
assess orthoptic features in a group of patients in which a molecular diagnosis was already 
known.  This study was instrumental in shaping the concept of using an orthoptic evaluation to 
identify conditions with differing pathomechanisms affecting ocular alignment and motility.      
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The homozygous mutations in CHNRE reported in this paper are responsible for coding the 
epsilon subunit of the receptor and result in deficient postsynaptic AChR (MIM 608931).  
However different mutations in the same gene can result in a fast channel syndrome 
(abnormally brief channel opening; MIM 616324) that can have autosomal recessive or 
dominant inheritance.  Other mutations can result in autosomal recessive slow channel 
syndrome (prolonged synaptic current; MIM 605809) leading to depolarization block.  
Therefore the CMS-CHRNE variant in this paper highlighted the importance of needing to 
identify the specific mutation.  This information is crucial to administrating appropriate medical 
therapy.  Mutations leading to AChR deficiency and fast channel syndrome respond to 
anticholinesterase therapy while this must be avoided in the slow channel syndrome variant.   
 
This paper also provided information about key clinical features.   
 A positive response to the ice pack test can be present in at least CMS due to CHNRE 
mutation.      
 Demonstrated history and clinical features were not diagnostic for CMS arising from 
CHRNE mutations as many of these features also overlap with other CMS subtypes. 
 Presence of normal pupillary response to light helps distinguish this variant from CMS 
due to COLQ mutation.   
 
Following this publication, the candidate as part of the research team, set out to systematically 
conduct orthoptic evaluations in future patients diagnosed with CMS.  Over the next 3 years 
another 7 subjects would be enrolled for genetic analysis.   Table 6.1 outlines the total 
population of CMS subjects.   
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Salih, M. A., Salih, M. A., Mustafa, A. A., Oystreck, D. T., Attia, K. M., El-Sadig, S. M., Hamed, 
A.A., Hajjar, W.M., Bosley, T. M. (2013). Ocular Neostigmine Drops for Diagnosing Myasthenia 
Gravis. J Neurol Neurophysiol (S11:004).51  
doi:10.4172/2155-9562.S11-004  
 Click reference above to see full PDF article 
 
Introduction: A variety of tests have been devised for the diagnosis of myasthenia gravis (MG). 
The best known of these (Tensilon test, using intravenous edrophonium chloride) may cause 
serious complications (bradycardia and syncope) dictating cardiac monitoring during the 
procedure. Ocular neostigmine drops, a simple procedure, may significantly reduce the risk of 
diagnostic testing for possible MG.  
Method: To investigate its efficacy, the miotic effect of neostigmine was explored using 30 
rabbits. One drop of sterile neostigmine solution (2.5 mg/ml) was instilled into the right eye 
(RE) of each rabbit using the left eye (LE), which received sterile normal saline, as control. Serial 
assessments of pupillary size were done. One drop of neostimine was instilled daily for 7 days 
to investigate its safety. Six patients (aged 4.5–55y, median=42y, mean=36.4y) with MG had the 
same test and were observed for increase of the palpebral fissure height (documented by 
photography).  
Results: At baseline there was no significant difference in the mean [SD] pupillary size of the 
rabbits between the RE (7 mm [1.07]) and LE (7 mm [1.07]), p=0.63). Significant miotic effect 
was observed in the RE compared to the LE at 30, 60 and 90 minutes (respectively, 4.8 mm 
[1.86] vs 7.0 mm [1.09], p=0.0001; 4.8 mm [1.86] vs 7.0 mm [1.09], p=0.0001; and 3.2 [0.76] vs 
7.0 [0.0], p=0.013). Administration of one drop of neostigmine daily for 7 days caused no ocular 
inflammation. All six patients with MG had an observable increase of the palpebral fissure 
height (documented by photography) of at least 2 mm, 30 minutes after neostigmine 
instillation. The response was dramatic in the three patients with no prior treatment for MG.  
Conclusion: Ocular neostigmine drops is a safe, simple and efficient diagnostic test for MG. 
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Overview of the publication: 
This paper investigated the safety and efficacy of using a novel topical agent (IV neostigmine 
solution) to aid in the clinical diagnosis of autoimmune MG.  The first part of the study involved 
30 New Zealand white rabbits to determine effectiveness of the drop.  This was confirmed by 
documenting the miotic effect on the pupil and duration of action.  The rabbits were also 
monitored for any adverse effects such as ocular irritation or obvious systemic effects.   The 
second part of the study included 6 patients with symptomatic autoimmune MG.  One drop of 
IV neostigmine solution (2.5 mg/ml) was applied to each eye with appropriate manual punctal 
occlusion. Effect was determined as a change in ptosis 15 minutes after application. Subjects 
were also monitored for cholinergic systemic or ocular irritation.   
 
Significance of the publication: 
Reduction of ptosis in subjects with autoimmune MG following single drop topical instillation of 
IV neostigmine solution to the eyes confirmed this method could be added to other clinical 
methods already employed such as IV edrophonium and ice pack test. All 6 subjects in this 
study had a minimum 2 mm reduction of ptosis after 30 minutes.  None had ocular or systemic 
side effects.  Patients receiving no prior pharmacological treatment are expected to have a 
greater response.  IV edrophonium has been abandoned by many ophthalmological clinics due 
to potential serious cholinergic effects, the need to have staff trained in cardiac resuscitation 
and availability of atropine, and lack of availability in hospitals within developing countries.  
Additionally, certain CMS variants can have a significant deterioration with the use of 
acetylcholinesterase and therefore this method should be avoided if CMS is suspected.  The ice 
pack test required lid cooling for 2-5 minutes is not generally tolerated by children.  Ocular 
neostigmine drops could provide a safe, simple and efficient alternative diagnostic method for 
MG.   This method still requires careful investigated in CMS variants in which systemic 
anticholinesterase agents are contraindicated such as mutations in COLQ, MUSK, DOK7, and 
those resulting in slow channel syndromes.52, 53 
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Alaraj, A. M., Oystreck, D. T., & Bosley, T. M. (2013). Variable ptosis after botulinum toxin type a 
injection with positive ice test mimicking ocular myasthenia gravis. J Neuroophthalmol, 33(2), 
169-171.77  
doi:10.1097/WNO.0b013e31828bb19b   
 Click reference above to see full PDF article 
 
We describe a patient who received cosmetic botulinum toxin type A injections to the brow and 
subsequently developed unilateral ptosis that was variable during examination and was 
transiently improved after the ice pack test. Ptosis gradually resolved spontaneously over 
approximately 3 months. This is the third patient to have variable ptosis documented after 
botulinum toxin type A injection to the brow and the second to have a positive ice test. The ice 
test is not completely specific for myasthenia gravis but may, at times, improve ptosis resulting 
from other defects at the neuromuscular junction. Wound botulism now is much more 
common because of illicit drug use, and the ice test also might be positive in this setting. 
 
Overview of the publication: 
This report included a single subject with variable unilateral ptosis that included Cogan lid 
twitch and worsening with sustained up gaze due to recent botulinum toxin type A injection to 
the ipsilateral forehead.  
 
Significance of publication: 
 Botulism is a differential diagnosis for infants with presumed abnormal neuromuscular 
transmission not due to CMS.   
 We previously reported a positive response to the ice pack test in at least CMS due to 
autosomal recessive CHRNE variant.  A positive response in this subject with botulinum 
paralysis reduces the specificity of the ice pack test which needs to be kept in mind.  
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Discussion 
Despite the limited number of enrolled patients with a diagnosis of CMS, the resulting 
publications identified features to help the clinician distinguish this rare group of disorders from 
other categories of congenital and/or genetic eye movement disorders.   It also provides a 
detailed description about orthoptic features specific to CHRNE mutations.  This has not been 
reported before.  However, it does not permit a definitive statement about motility features 
that may be used to distinguish between various CMS subtypes.  Affected family members 
reported in Salih et al. 201051 had consistent ocular features, however additional affected 
individuals from other families would be need to be examined to determine the full spectrum 
of involvement.    
Appendix Table 6.3 highlights ophthalmological features in various CMS sub-types.  Most 
descriptions are vague with suggestion that pupils may play a small role.      
Engel 2015 outlined a set of clinical features to guide clinicians to assist predicating the 
molecular diagnosis (see Appendix Table 6.3).54  The inclusion of ocular phenotypes by these 
authors was only mentioned in COLQ mutations and Laminin β2 highlighting a need for more 
investigations to determine the benefit of assessing ocular features to aid in distinguishing 
between CMS subtypes.  Differences, if found, may be related to a structural difference and 
gene expression within the extraocular muscle endplates.55 
 
A final note is that additional material has been included in the appendix section for this 
chapter.  It contains a summary of a literature review done by the candidate in preparation for 
proposed prospective research projects in this topic.  This information has been included only 
for interest.  
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Tables 
 
Table 6.1 Genetic results of subjects with CMS 
 
Genetic results* No. 
CHRNE 3 (3 sibs) 
COLQ 1 
MUSK 2 
Unknown 4 
*confirmed mutation in the gene listed.  
No. = number of enrolled subjects 
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Chapter 7: Horizontal Gaze Palsy and Progressive Scoliosis (HGPPS) 
 
 
HGPPS is a unique autosomal recessive disorder defined by congenital horizontal gaze palsy 
associated with scoliosis.  However it is generally described in the context of an ocular 
myopathy, namely progressive external ophthalmoplegia.56 
Identification of the loci confirmed the association of congenital horizontal gaze palsy and early 
onset progressive scoliosis.57  The mutated gene was identified (ROBO3) and the phenotype 
expanded to include evidence of uncrossed corticospinal and dorsal column-medial lemniscus 
pathways.58   
 
Summary of HGPPS research: 
At the start of my research HGPPS was already known as a monogenic ocular motility disorder 
with profound anatomic maldevelopment of brainstem, including failure of at least two long 
neuronal tracts to decussate.  
The candidate examined a total of 33 subjects with a diagnosis of HGPPS.  Of these, 24 had 
genetic confirmation of the diagnosis and 21 were included in 3 publications focused on 
elucidating the phenotype.  This was important as it was one of the first conditions in which our 
team could study genotype-phenotype correlations.   
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Bosley, T. M., Salih, M. A., Jen, J. C., Lin, D. D., Oystreck, D., Abu-Amero, K. K., MacDonald, M.D., 
al Zayed, Z., al Dhalaan, H., Kansue, T., Stigsby, B., Baloh, R. W. (2005). Neurologic features of 
horizontal gaze palsy and progressive scoliosis with mutations in ROBO3. Neurology, 64(7), 
1196-1203.6  
doi:10.1212/01.WNL.0000156349.01765.2B   
 Click reference above to see full PDF article 
 
OBJECTIVE: To review the neurologic, neuroradiologic, and electrophysiologic features of 
autosomal recessive horizontal gaze palsy and progressive scoliosis (HGPPS), a syndrome 
caused by mutation of the ROBO3 gene on chromosome 11 and associated with defective 
decussation of certain brainstem neuronal systems.  
 
METHODS: The authors examined 11 individuals with HGPPS from five genotyped families with 
HGPPS. Eight individuals had brain MRI, and six had electrophysiologic studies.  
 
RESULTS: Horizontal gaze palsy was fully penetrant, present at birth, and total or almost total in 
all affected individuals. Convergence, ocular alignment, congenital nystagmus, and vertical 
smooth pursuit defects were variable between individuals. All patients developed progressive 
scoliosis during early childhood. All appropriately studied patients had hypoplasia of the pons 
and cerebellar peduncles with both anterior and posterior midline clefts of the pons and 
medulla and electrophysiologic evidence of ipsilateral corticospinal and dorsal column-medial 
lemniscus tract innervation. Heterozygotes were unaffected.  
 
CONCLUSIONS: The major clinical characteristics of horizontal gaze palsy and progressive 
scoliosis were congenital horizontal gaze palsy and progressive scoliosis with some variability in 
both ocular motility and degree of scoliosis. The syndrome also includes a distinctive brainstem 
malformation and defective crossing of some brainstem neuronal pathways. 
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Significance of the publication: 
This paper was the first major clinical description of genetically defined individuals with HGPPS.  
Prior to this the best clinical description was from 1975 involving a single family with multiple 
affected individuals with presumably the same congenital disorder.59  
This is also the largest series of genetically defined individuals to date and the first cohort 
having detailed orthoptic evaluations.  This paper expanded the phenotype.  It was first 
description of the binocular vision status; first report of intermittent vertical strabismus, that 
when present dampened the nystagmus; and reported absence of facial weakness that had 
been reported in previous series.60 
 
This report set the template for future ocular motility descriptions of this disorder.    
It also further confirmed known genetic, clinical and neuroanatomical features specific to 
HGPSS.  This includes mutations in both copies of ROBO3; congenital complete or almost 
complete absence of conjugate horizontal gaze; followed by progressive scoliosis during 
childhood; and a developmental malformation of the brainstem that consists at least in part of 
uncrossed corticospinal and dorsal column pathways. 
The report also suggested this is a central ocular motility defect arising from hypoplasia of the 
pons.  Lower efferent system is intact as noted by the presence of cranial nerve 3 and 6 and 
normal extraocular muscle anatomy on neuro-imaging.  We were also able to confirm the 
congenital onset of the ocular motility deficit by parental history and examination of two 
infants less than 1 year of age; normal afferent and overall normal ophthalmological exam; 
normal forced ductions; and that scoliosis remains the most important reason for making an 
early diagnosis.   
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Khan, A. O., Oystreck, D. T., Al-Tassan, N., Al-Sharif, L., & Bosley, T. M. (2008). Bilateral 
synergistic convergence associated with homozygous ROB03 mutation (p.Pro771Leu). 
Ophthalmology, 115(12), 2262-2265.61  
doi:10.1016/j.ophtha.2008.08.010  
 Click reference above to see full PDF article 
 
OBJECTIVE: To document the phenotype and determine the genotype of a child with synergistic 
convergence. DESIGN: Interventional case report.  
PARTICIPANTS: Patient and nuclear family (7 members total).  
METHODS: Ophthalmologic, neurologic, and radiologic examination of the proband; venous 
blood sampling for candidate gene testing of the proband; venous blood sampling for 
confirmatory testing in other family members.  
MAIN OUTCOME MEASURES: Clinical and radiologic observations in proband and candidate 
gene results. RESULTS: The proband, a 9-year-old girl, substituted convergence for horizontal 
gaze (synergistic convergence) since birth. She also had conjugate pendular nystagmus, 
asynchronous blinking, and high myopia. No family member had ophthalmologic or medical 
symptoms. Neuroradiologic imaging revealed hindbrain dysplasia and modest scoliosis. 
Sequencing of ROB03, the gene associated with horizontal gaze palsy and progressive scoliosis, 
revealed a novel missense mutation (p.Pro771Leu) that altered an evolutionarily conserved 
amino acid. Screening the family for this mutation confirmed that both parents were carriers 
and identified 2 sisters as carriers and 2 brothers as noncarriers.  
CONCLUSIONS: This is the second reported patient with synergistic convergence and the first 
associated with a documented pathologic genotype. Unlike the previously reported case (which 
occurred in the setting of the cranial dysinnervation disorder congenital fibrosis of the 
extraocular muscles), our patient presumably has a supranuclear cause.   
Significance of the publication: 
First report of a central etiology for synergistic convergence in a genetically confirmed subject 
with HGPPS.   
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Amouri, R., Nehdi, H., Bouhlal, Y., Kefi, M., Larnaout, A., & Hentati, F. (2009). Allelic ROBO3 
heterogeneity in Tunisian patients with horizontal gaze palsy with progressive scoliosis. J Mol 
Neurosci, 39(3), 337-341.62  
doi:10.1007/s12031-009-9217-4    
 Click reference above to see full PDF article 
 
Horizontal gaze palsy with progressive scoliosis (HGPPS) is a rare autosomal recessive disorder 
characterized by the congenital absence of horizontal gaze, progressive scoliosis, and failure of 
the corticospinal and somatosensory axon tracts to decussate in the medulla. HGPPS is caused 
by mutations of the ROBO3 gene, which encodes a protein that shares homology with the 
roundabout family of transmembrane receptors that are important in axon guidance and 
neuronal migration. To date, over 15 mutations have been found in consanguineous families of 
Greek, Italian, Turkish, Pakistani, Saudi Arabian, and Indian descent. To detail clinical, cerebral 
magnetic resonance imaging (MRI) and genetic findings of ten HGPPS patients from four 
unrelated Tunisian families. Four unrelated consanguineous Tunisian families with a total of ten 
patients suffering from horizontal gaze palsy with progressive scoliosis. Genetic linkage analysis 
and direct sequencing of the ROBO3 gene. All patients shared similar clinical gaze movement 
abnormalities and variable degrees of scoliosis. Four distinct homozygous mutations were 
identified. This study extends the molecular spectrum of the ROBO3 gene and the geographic 
origin of patients with ROBO3 gene mutations, and underlines the homogeneity of the motor 
ocular syndrome whatever type of mutation is encountered. 
 
Comment about Amouri 2009.  
The candidate performed all orthoptic evaluations on these individuals during an invited 
research trip to Tunisia.  The objective was to help the local research team evaluate individuals 
and confirm the clinical diagnosis prior to conducting expensive genetic evaluations.  These 
evaluations were later used in this publication.  This work was only acknowledged in the 
publication by thanking our research lead Dr. Thomas Bosley.  The publication has been 
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included in the Appendix as it represents the first group of individuals with genetically 
confirmed HGPPS not having severe scoliosis.  Our figures were not published. 
Chapter 8: Other disorders disrupting ocular motility and alignment 
 
Each of the previous chapters addressed a single clinical diagnosis that was often the focus of 
specific research project.  This chapter encompasses several additional diagnoses encountered.  
These have been categorized into groups with similar mechanisms accounting for ocular 
motility and/or alignment dysfunction. 
 
8.1 Myopathic disorders 
 
A total of 12 subjects fall into this category.  Six were published in 3 articles.   
An additional 3 subjects with synDRS, published as cases studies (see chapter 2), have been 
included here as well (section 8.1.1) as genetic analysis revealed mutations in genes associated 
with muscle function and development.   
 
8.1.1 CCDD phenotype 
 
Three subjects with synDRS had mutations in genes associated with muscle development.  Each 
subject was reported in a different publication.32, 34, 35  These reports were presented in chapter 
2.   
 
Abu-Amero, K. K., Bosley, T. M., Kondkar, A. A., Oystreck, D. T., & Khan, A. O. (2015). CCDD 
Phenotype Associated with a Small Chromosome 2 Deletion. Semin Ophthalmol, 30(5-6), 435-
442.32 
doi:10.3109/08820538.2013.874474  
 Click reference above to see full PDF article 
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Bosley, T. M., Salih, M. A., Alkhalidi, H., Oystreck, D. T., El Khashab, H. Y., Kondkar, A. A., & Abu-
Amero, K. K. (2016). Duane retraction syndrome in a patient with Duchenne muscular 
dystrophy. Ophthalmic Genet, 37(3), 276-280.34  
doi:10.3109/13816810.2015.1039139 
 Click reference above to see full PDF article 
 
Abu-Amero, K. K., Kondkar, A. A., Odan, H. A., Khan, A. O., Oystreck, D. T., & Bosley, T. M. 
(2016). Duane Retraction Syndrome Associated with a Small X Chromosome Deletion. Can J 
Neurol Sci, 43(3), 445-447.35  
doi:10.1017/cjn.2015.358 
 Click reference above to see full PDF article 
 
These papers suggest some forms of DRS may arise from mutations in genes related to muscle 
development, or a developmental insult affecting multiple systems.  One should also consider 
these may represent unrelated co-existing cases of DRS.  However the associated syndromic 
features warrants suspicion for a unifying mechanism. 
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8.1.2 Carey-Fineman-Ziter syndrome (CFZS) 
 
Di Gioia, S. A., Connors, S., Matsunami, N., Cannavino, J., Rose, M. F., Gilette, N. M., et al.  
(2017). A defect in myoblast fusion underlies Carey-Fineman-Ziter syndrome. Nat Commun, 8, 
16077.41  
doi:10.1038/ncomms16077   
 Click reference above to see full PDF article 
 Discussed briefly in chapter 3 
 
Multinucleate cellular syncytial formation is a hallmark of skeletal muscle differentiation. 
Myomaker, encoded by Mymk (Tmem8c), is a well-conserved plasma membrane protein 
required for myoblast fusion to form multinucleated myotubes in mouse, chick, and zebrafish. 
Here, we report that autosomal recessive mutations in MYMK (OMIM 615345) cause Carey-
Fineman-Ziter syndrome in humans (CFZS; OMIM 254940) by reducing but not eliminating 
MYMK function. We characterize MYMK-CFZS as a congenital myopathy with marked facial 
weakness and additional clinical and pathologic features that distinguish it from other 
congenital neuromuscular syndromes. We show that a heterologous cell fusion assay in vitro 
and allelic complementation experiments in mymk knockdown and mymkinsT/insT zebrafish in 
vivo can differentiate between MYMK wild type, hypomorphic and null alleles. Collectively, 
these data establish that MYMK activity is necessary for normal muscle development and 
maintenance in humans, and expand the spectrum of congenital myopathies to include cell-cell 
fusion deficits. 
 
Significance of the publication: 
This represents one of the identified phenotypes that overlapped with MBS, i.e. Atypical MBS, 
MBS-like disorder.  The genetic and phenotypic elucidation of this disorder arose from the 
identification of a subject that did not meet our designated criteria for MBS.   
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8.1.3 Oculopharnygeal muscular dystrophy (OPMD) 
 
Oystreck, D. T., Salih, M. A., & Bosley, T. M. (2011). When straight eyes won't move: phenotypic 
overlap of genetically distinct ocular motility disturbances. Can J Ophthalmol, 46(6), 477-480.45 
doi:10.1016/j.jcjo.2011.09.009   
 Click link to see full PDF Straight eyes 2011 
 
OBJECTIVE: To describe the phenotypic similarity in a series of patients with genetically distinct 
ocular motility disturbances involving straight eyes and different ocular motor pathology. 
DESIGN: Retrospective case series.  
 
PARTICIPANTS: Clinical and genetic evaluation of 5 patients with straight eyes in the primary 
position and abnormalities of ocular motility. RESULTS: Patients with oculopharyngeal muscular 
dystrophy, congenital myasthenic syndrome, congenital fibrosis of the extraocular muscles type 
3, Bosley-Salih-Alorainy syndrome, and horizontal gaze palsy and progressive scoliosis all had 
straight eyes in primary position and restricted ocular motility. History, ocular motility patterns, 
systemic features of individual syndromes, and genetic screening were important 
diagnostically.  
 
CONCLUSIONS: A number of congenital and genetic ocular motility syndromes may result in 
substantial phenotypic overlap, particularly when eyes are straight in primary position and 
nonophthalmologic features are not apparent or not observed. The range of disorders that may 
fall into this category is discussed. 
 
Significance of the publication: 
This was patient 1 from the above publication.  It highlighted specific phenotypic overlap (i.e. 
straight eyes) in genetically distinct conditions.  
  
  
Stellenbosch University  https://scholar.sun.ac.za
 73 
 
8.1.4 Kearns-Sayre Syndrome 
 
Kozak, I., Oystreck, D. T., Abu-Amero, K. K., …, Bosley, T. M. (2016). New Observations 
Regarding the Retinopathy of Genetically Confirmed Kearns-Sayre Syndrome. Retin Cases Brief 
Rep.79  
doi:10.1097/ICB.0000000000000503 
 Click reference above to see full PDF article 
 
PURPOSE: To report novel retinal findings in Kearns-Sayre syndrome and correlate degree of 
retinopathy with other clinical findings.  
 
METHODS: Observational case series of patients from Saudi Arabia with retinal and 
neuroophthalmologic examinations, medical chart review, and mitochondrial genetic 
evaluation.  
 
RESULTS: The three unrelated patients had progressive external ophthalmoplegia and 
pigmentary retinopathy bilaterally. Muscle biopsy in two of the cases revealed mitochondrial 
myopathy. All three had abnormal findings on neuroimaging and modestly reduced visual 
acuity in both eyes with a variable pigmentary retinopathy. One of the patients had bilateral 
subretinal fibrosis with a full-thickness macular hole in the right eye. All three patients had 
single, large-scale mitochondrial DNA (mtDNA) deletions (5.0-7.6 kb in size) with blood mtDNA 
heteroplasmy levels ranging from below 20% to 57%. Severity of pigmentary retinopathy did 
not correlate with severity of progressive external ophthalmoplegia, but did correspond grossly 
with electroretinographic abnormalities, just as the degree of ocular motility restriction and 
ptosis in each patient correlated with the size of their extraocular muscles on neuroimaging. In 
addition, the size of the single, large-scale mtDNA deletion and level of mtDNA heteroplasmy 
corresponded with degree of ocular motility restriction but not with severity of retinopathy.  
 
CONCLUSION: Subretinal fibrosis and macular hole are novel retinal observations which expand 
clinical profile in Kearns-Sayre syndrome. Genetic testing for mtDNA deletions and 
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heteroplasmy in blood, muscle biopsy, careful ocular and retinal examination including 
electroretinography, and imaging are indispensable tests for this condition. 
 
Significance of the publication: 
Attempted to construct phenotype-genotype correlation.  Numbers of subjects were too small.  
Disorder represents a progressive and severe form of external ophthalmoplegia.  Muscle 
weakness is not restricted to eyes.  It is one of the few conditions included that also has 
afferent system dysfunction.  Genetics involve mutations in the mitochondrial DNA. 
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8.2 Maldevelopment of cranial nerve development 
 
This section includes subjects with confirmed congenital maldevelopment of extraocular innervation 
that does not fit in with any of the previous diagnosis discussed, e.g., DRS, CFEOM, MBS, or HGPPS.  This 
includes 7 subjects reported in 5 publications.  Two of these publications are presented here.     
 
8.2.1 Synergistic Divergence 
 
Oystreck, D. T., Khan, A. O., Vila-Coro, A. A., Oworu, O., Al-Tassan, N., Chan, W. M., Engle, E.C.,  
Bosley, T. M. (2009). Synergistic divergence: a distinct ocular motility dysinnervation pattern. 
Invest Ophthalmol Vis Sci, 50(11), 5213-5216.37  
doi:10.1167/iovs.08-2928 
  Click reference above to see full PDF article 
 
PURPOSE: To summarize the clinical, neuroradiologic, and genetic observations in a group of 
patients with unilateral synergistic divergence (SD).  
 
METHODS: Five unrelated patients with unilateral SD underwent ophthalmic and orthoptic 
examinations; three of them also had magnetic resonance imaging of the brain and orbits. 
Three patients underwent genetic evaluation of genes known to affect ocular motility: KIF21A, 
PHOX2A, HOXA1, and ROBO3.  
 
RESULTS: The patients did not meet the clinical criteria for CFEOM types 1, 2, or 3.  Each patient 
had severe adduction weakness on the affected side and large-angle exotropia in primary gaze 
that increased on attempted contralateral gaze because of anomalous abduction. Magnetic 
resonance imaging revealed a much smaller medial rectus muscle in the involved SD orbit. 
Oculomotor cranial nerves were present in the one patient imaged appropriately. Genetic 
sequencing in three patients revealed no mutations in KIF21A, PHOX2A, HOXA1, or ROBO3.  
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CONCLUSIONS: SD should be classified as a distinct congenital ocular motility pattern within 
congenital cranial dysinnervation disorders. It may be caused by denervation of the medial 
rectus with dysinnervation of the ipsilateral lateral rectus by the oculomotor nerve precipitated 
by genetic abnormalities (some currently identified) or by local environmental, teratogenic, or 
epigenetic disturbances. 
 
Significance of the publication: 
Highlighted the importance of careful phenotyping similarly affected individuals.  It also 
represented the limitation of genetic elucidation of disorders and importance of waiting.  
Patient 2 was later described in two additional publications. One that confirmed an autosomal 
recessive mutation in COL25A1, a gene involved in axonal guidance and cytoskeletal 
microtubule function.63 The second describe the phenotype in more detail reporting that when 
this gene is mutated it can lead to abnormal ocular motor neuron development resulting in a 
variable combination of phenotypes including, synergistic divergence, congenital ptosis and/or 
DRS.64   
  
Stellenbosch University  https://scholar.sun.ac.za
 77 
 
 
8.2.2 Hereditary Congenital Facial Paresis-3 (HCFP3-HOXB1) 
 
Webb, B. D., Shaaban, S., Gaspar, H., Cunha, L. F., Schubert, C. R., Hao, K., Robson, C.D., Chan, 
W., Andrews, C., MacKinnion, S., Oystreck, D.T., Hunter, D.G., Iacovelli, A.J., Ye X., Camminady, 
A., Engle, E.C.,  Jabs, E. W. (2012). HOXB1 founder mutation in humans recapitulates the 
phenotype of Hoxb1-/- mice. Am J Hum Genet, 91(1), 171-179.38  
doi:10.1016/j.ajhg.2012.05.018   
 Click reference above to see full PDF article 
 Discussed briefly in chapter 3 
 
Members of the highly conserved homeobox (HOX) gene family encode transcription factors 
that confer cellular and tissue identities along the antero-posterior axis of mice and humans. 
We have identified a founder homozygous missense mutation in HOXB1 in two families from a 
conservative German American population. The resulting phenotype includes bilateral facial 
palsy, hearing loss, and strabismus and correlates extensively with the previously reported 
Hoxb1(-/-) mouse phenotype. The missense variant is predicted to result in the substitution of a 
cysteine for an arginine at amino acid residue 207 (Arg207Cys), which corresponds to the highly 
conserved Arg5 of the homeodomain. Arg5 interacts with thymine in the minor groove of DNA 
through hydrogen bonding and electrostatic attraction. Molecular modeling and an in vitro 
DNA-protein binding assay predict that the mutation would disrupt these interactions, 
destabilize the HOXB1:PBX1:DNA complex, and alter HOXB1 transcriptional activity. 
 
Significance of the publication: 
Represents another phenotype originally mistaken as MBS.  Two siblings in this report were 
identified during our examination of subjects at the International Moebius conference as not 
having minimum diagnostic criteria.40  This paper reports the identified mutation as being 
pathogenic.  This identifies the third HCFP3 phenotype (OMIM 614744).   
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8.3. Neurologic/CNS related disorders predominantly affecting ocular motility 
 
The candidate had the opportunity to conduct orthoptic evaluations patients with various 
neurological disorders.  In total this included 5 disorders involving 30 subjects.  This resulted in 
two publications addressing the effect of cerebellar dysfunction on the ocular motility 
phenotype.   
 
 
8.3.1 Ataxia Telangiectasia-like disorder 
 
Khan, A. O., Oystreck, D. T., Koenig, M., & Salih, M. A. (2008). Ophthalmic features of ataxia 
telangiectasia-like disorder. J AAPOS, 12(2), 186-189.65  
doi:10.1016/j.jaapos.2007.09.016 
 Click reference above to see full PDF article 
 
INTRODUCTION: Ataxia telangiectasia (AT) is a recessive neurodegenerative disease due to a 
faulty repair mechanism for breaks in double-stranded DNA (ATM mutation). Ophthalmic 
features of AT include conjunctival telangiectasia, strabismus, saccadic dysfunction with head 
thrusts, and convergence insufficiency. Ataxia telangiectasia-like syndrome (ATLD) is a more 
recently recognized condition due to homozygous mutation in MRE11, a gene also involved in 
the cellular repair response to double-stranded DNA breaks; ophthalmic features of ATLD are 
not well described. The purpose of this article is to describe the ophthalmic features of ATLD.  
 
METHODS: Full ophthalmologic and orthoptic evaluations were obtained in 13 individuals: 10 
previously reported ATLD patients, an additional related ATLD patient, and 3 nonaffected 
relatives. All individuals were from three unrelated consanguineous Saudi Arabian families 
harboring an MRE11 mutation (W210C). Age range was from 2 to 40 years of age.  
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RESULTS: No affected patient had structural ocular abnormality (eg, conjunctival 
telangiectasia), manifest strabismus at distance, or duction limitation. All but one (the 
youngest) had saccadic dysfunction (without head thrusts). Most patients had abnormal 
convergence. Older patients had nystagmus with abnormalities in smooth pursuit and 
vestibular ocular reflex. All patients had cerebellar atrophy by neuroimaging and slowly 
progressive ataxia. The unaffected heterozygous relatives had unremarkable ophthalmic and 
neurologic examinations.  
 
CONCLUSIONS: Saccadic dysfunction without head thrusts and convergence abnormality are 
common in ATLD secondary to homozygous W210C MRE11 mutation. Older patients have 
nystagmus with abnormalities in smooth pursuit and vestibular ocular reflex. Eye movement 
control systems apparently deteriorate with time in this rare neurological disease. Ophthalmic 
features of AT that were not observed in any of our ATLD patients include conjunctival 
telangiectasia, head thrusting, and manifest strabismus at distance. 
 
 
8.3.2 Joubert syndrome 
 
Khan, A. O., Oystreck, D. T., Seidahmed, M. Z., AlDrees, A., Elmalik, S. A., Alorainy, I. A., & Salih, 
M. A. (2008). Ophthalmic features of Joubert syndrome. Ophthalmology, 115(12), 2286-2289.66  
doi:10.1016/j.ophtha.2008.08.005   
 Click reference above to see full PDF article 
 
PURPOSE: Joubert syndrome (Online Mendelian Inheritance in Man 213300) is a rare autosomal 
recessive congenital malformation of the brainstem and cerebellar vermis. Diagnosis is based 
on characteristic clinical features (e.g., hypotonia, episodic hyperpnea, developmental delay, 
progressive ataxia) and is confirmed by distinctive neuroradiologic findings (e.g., the "molar 
tooth" sign). Variable ophthalmic features have been mentioned in prior reports; however, 
most do not detail eye findings and the few that do were before the publication of suggested 
diagnostic criteria. The objective of the current study is to describe the ophthalmic phenotype 
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in a cohort of patients with Joubert syndrome for whom the diagnosis was made using current 
diagnostic criteria.  
 
DESIGN: Prospective case series.  
 
PARTICIPANTS: Eight children diagnosed clinically with radiologic confirmation.  
 
METHODS: Ophthalmic examination and visual electrophysiology.  
 
MAIN OUTCOME MEASURES: Ocular and oculomotor examination (as allowed by patient 
cooperation), electroretinography, flash visual-evoked potential (fVEP). 
 
RESULTS: Patients' ages ranged from 7 months to 10 years. Saccadic dysfunction was observed 
in all cooperative patients (6/6); compensatory head thrusts or turns were present in all except 
the youngest patient (7 months of age). Most patients (5/8) had primary-position nystagmus 
(see-saw in 3/5). Abnormal pursuit (3/7) and a dystrophic retinal appearance (3/8) were also 
seen. One patient had bilateral asymmetric ptosis with unilateral lid elevation during ipsilateral 
abduction. Electroretinography findings were normal for all 8 patients. Seven patients 
underwent fVEP; 6 were abnormal (asymmetric) and one was not interpretable because of 
study artifact.  
 
CONCLUSIONS: Ophthalmologists should be aware that saccadic dysfunction (typically with 
head thrusts) and primary position nystagmus (typically see-saw) in a developmentally delayed 
child suggest the diagnosis of Joubert syndrome, especially if a dystrophic retinal appearance is 
also present. Our findings of asymmetric fVEPs and see-saw nystagmus suggest an abnormality 
in optic nerve decussation, consistent with the concept that impaired axonal guidance occurs in 
patients with Joubert syndrome.  
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Discussion: 
Subjects with either Ataxia-Oculomotor Apraxia 2 (AOA2), Ataxia Teleganectasia (AT), or 
Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) were also examined, 
demonstrating a similar effect on the ocular motor system due to cerebellar dysfunction.  These 
disorders suggests the need for a specific category in which to group such conditions.   
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8.4 Neurologic disorders predominantly affecting ocular alignment (Strabismus) 
 
This section represents subjects with neurological abnormalities involving abnormal ocular 
alignment but with intact ocular motility.   
This group involves 46 subjects with 7 different neurological disorders.  A total of 41 subjects 
were published in 5 papers that included mutations in 4 different genes and 1 chromosomal 
anomaly.  It is was felt the genetic mutation was not directly responsible for the strabismus.  
However it highlights secondary effects that may occur in genetic disorders affecting the brain.  
The vast majority of subjects had full ocular excursions, however the associated comitant 
strabismus present in most subjects was proposed to be secondary to sensory strabismus from 
organic anterior visual pathway defects, or from abnormal posterior visual pathway deficits 
inhibiting normal binocular function.  One group included here did have normal ocular 
alignment and motility but were included to illustrate the need for careful orthoptic testing. 
 
8.4.1 Lipoid Proteinosis 
 
Salih, M. A., Abu-Amero, K. K., Alrasheed, S., Alorainy, I. A., Liu, L., McGrath, J. A., Van 
Maldergem, L., Al-Faley, Y.H., AlSuhaibani, A.H., Oystreck, D.T., Bosley, T. M. (2011). Molecular 
and neurological characterizations of three Saudi families with lipoid proteinosis. BMC Med 
Genet, 12, 31.67  
doi:10.1186/1471-2350-12-31  
 Click reference above to see full PDF article 
 
BACKGROUND: Lipoid proteinosis is a rare autosomal recessive disease characterized by 
cutaneous and mucosal lesions and hoarseness appearing in early childhood. It is caused by 
homozygous or compound heterozygous mutations in the ECM1 gene. The disease is largely 
uncharacterized in Arab population and the mutation(s) spectrum in the Arab population is 
largely unknown. We report the neurologic and neuroradiologic characteristics and ECM1 gene 
mutations of seven individuals with lipoid proteinosis (LP) from three unrelated 
consanguineous families.  
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METHODS: Clinical, neurologic, and neuro-ophthalmologic examinations; skin histopathology; 
brain CT and MRI; and sequencing of the full ECM1 gene.  
RESULTS: All seven affected individuals had skin scarring and hoarseness from early childhood. 
The two children in Family 1 had worse skin involvement and worse hoarseness than affected 
children of Families 2 and 3. Both children in Family 1 were modestly mentally retarded, and 
one had typical calcifications of the amygdalae on CT scan. Affected individuals in Families 2 
and 3 had no gross neurologic, neurodevelopmental, or neuroimaging abnormalities. Skin 
histopathology was compatible with LP in all three families. Sequencing the full coding region of 
ECM1 gene revealed two novel mutations in Family 1 (c.1300-1301delAA) and Family 2 
(p.Cys269Tyr) and in Family 3 a previously described 1163 bp deletion starting 34 bp into intron 
8.  
CONCLUSIONS: These individuals illustrate the neurologic spectrum of LP, including variable 
mental retardation, personality changes, and mesial temporal calcification and imply that 
significant neurologic involvement may be somewhat less common than previously thought. 
The cause of neurologic abnormalities was not clear from either neuroimaging or from what is 
known about ECM1 function. The severity of dermatologic abnormalities and hoarseness 
generally correlated with neurologic abnormalities, with Family 1 being somewhat more 
affected in all spheres than the other two families. Nevertheless, phenotype-genotype 
correlation was not obvious, possibly because of difficulty quantifying the neurologic 
phenotype and because of genetic complexity. 
 
Significance of the publication: 
All subjects were referred to our neuro-ophthalmology service because of strabismus.  Careful 
orthoptic investigation revealed all genotyped individuals had normal ocular alignment and 
motility.  This publication has been included to illustrate the importance of including the 
orthoptic evaluation.  These individuals may have inappropriately been reported as having 
strabismus by investigators who were not able to appropriately assess the ocular alignment.  It 
also represents a gene we determined is not pathogenic for strabismus.     
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8.4.2 Carbonic anhydrase type II deficiency syndrome 
 
Bosley, T. M., Salih, M. A., Alorainy, I. A., Islam, M. Z., Oystreck, D. T., Suliman, O. S., al Malki,S., 
Suhaibani, A.H., Khiari, H., Beckers, S., van Wesenbeeck, L., Perdu, B., AlDrees, A., Elmalik, S.S., 
Van Hul, W., Abu-Amero, K. K. (2011). The neurology of carbonic anhydrase type II deficiency 
syndrome. Brain, 134(Pt 12), 3499-3512.68  
doi:10.1093/brain/awr302   
 Click reference above to see full PDF article 
 
Carbonic anhydrase type II deficiency syndrome is an uncommon autosomal recessive disease 
with cardinal features including osteopetrosis, renal tubular acidosis and brain calcifications. 
We describe the neurological, neuro-ophthalmological and neuroradiological features of 23 
individuals (10 males, 13 females; ages at final examination 2-29 years) from 10 unrelated 
consanguineous families with carbonic anhydrase type II deficiency syndrome due to 
homozygous intron 2 splice site mutation (the 'Arabic mutation'). All patients had 
osteopetrosis, renal tubular acidosis, developmental delay, short stature and craniofacial 
disproportion with large cranial vault and broad forehead. Mental retardation was present in 
approximately two-thirds and varied from mild to severe. General neurological examinations 
were unremarkable except for one patient with brisk deep tendon reflexes and two with severe 
mental retardation and spastic quadriparesis. Globes and retinae were normal, but optic nerve 
involvement was present in 23/46 eyes and was variable in severity, random in occurrence and 
statistically correlated with degree of optic canal narrowing. Ocular motility was full except for 
partial ductional limitations in two individuals. Saccadic abnormalities were present in two, 
while half of these patients had sensory or accommodative strabismus, and seven had 
congenital nystagmus. These abnormalities were most commonly associated with afferent 
disturbances, but a minor brainstem component to this disorder remains possible. All internal 
auditory canals were normal in size, and no patient had clinically significant hearing loss. 
Neuroimaging was performed in 18 patients and repeated over as long as 10 years. Brain 
calcification was generally progressive and followed a distinct distribution, involving 
predominantly basal ganglia and thalami and grey-white matter junction in frontal regions 
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more than posterior regions. At least one child had no brain calcification at age 9 years, 
indicating that brain calcification may not always be present in carbonic anhydrase type II 
deficiency syndrome during childhood. Variability of brain calcification, cognitive disturbance 
and optic nerve involvement may imply additional genetic or epigenetic influences affecting the 
course of the disease. However, the overall phenotype of the disorder in this group of patients 
was somewhat less severe than reported previously, raising the possibility that early treatment 
of systemic acidosis with bicarbonate may be crucial in the outcome of this uncommon 
autosomal recessive problem. 
 
 
8.4.3 Autosomal Recessive C12orf57 
  
Salih, M. A., Tzschach, A., Oystreck, D. T., …, Bosley, T. M. (2013). A newly recognized autosomal 
recessive syndrome affecting neurologic function and vision. Am J Med Genet A, 161A(6), 1207-
1213.69  
doi:10.1002/ajmg.a.35850   
 Click reference above to see full PDF article 
 
Genetic factors represent an important etiologic group in the causation of intellectual disability. 
We describe a Saudi Arabian family with closely related parents in which four of six children 
were affected by a congenital cognitive disturbance. The four individuals (aged 18, 16, 13, and 2 
years when last examined) had motor and cognitive delay with seizures in early childhood, and 
three of the four (sparing only the youngest child) had progressive, severe cognitive decline 
with spasticity. Two affected children had ocular malformations, and the three older children 
had progressive visual loss. The youngest had normal globes with good functional vision when 
last examined but exhibited the oculodigital sign, which may signify a subclinical visual deficit. A 
potentially deleterious nucleotide change (c.1A>G; p.Met1Val) in the C12orf57 gene was 
homozygous in all affected individuals, heterozygous in the parents, and absent in an 
unaffected sibling and >350 normal individuals. This gene has no known function. This family 
manifests an autosomal recessive syndrome with some phenotypic variability that includes 
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abnormal development of brain and eyes, delayed cognitive and motor milestones, seizures, 
and a severe cognitive and visual decline that is associated with a homozygous variant in a 
newly identified gene. 
 
 
8.4.4 Partial mosaic trisomy 8 
 
Abu-Amero, K. K., Kondkar, A. A., Salih, M. A., Al-Husain, M., Al Shammari, M., Zeidan, G., 
Oystreck, D.T., Hellani, A.M., Kentab, A.Y., Bosley, T. M. (2013). Ophthalmologic observations in 
a patient with partial mosaic trisomy 8. Ophthalmic Genet, 34(4), 249-253.70 
doi:10.3109/13816810.2012.762933   
 Click reference above to see full PDF article 
 
BACKGROUND: To carefully assess the phenotype and genotype of a patient with partial mosaic 
trisomy 8 with particular attention to ophthalmologic features.  
 
METHODS: Ophthalmologic and neuro-ophthalmologic examination; neuroimaging; 
conventional karyotyping; and array comparative genomic hybridization (CGH).  
 
RESULTS: The proband was the only affected child of a non-consanguineous family. At birth she 
was noted to have facial dysmorphism including telecanthus, low set ears, prominent nares, 
and an everted lower lip. She had an accommodative esotropia with otherwise normal globes, 
optic nerves, retinae, and orbits. She also had delayed motor milestones and mild mental 
retardation associated with agenesis of the corpus callosum. Both karyotyping and array CGH 
documented mosaic partial trisomy of chromosome 8 that included all of the "q" arm and part 
of the proximal "p" arm.  
 
CONCLUSIONS: This girl had a number of the classic features of mosaic trisomy 8, including an 
accommodative esotropia with none of the other ocular and orbital anomalies described in 
patients with mosaic trisomy 8. This report constitutes an initial effort to create a virtual 
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database of patients with mosaic chromosome 8 in which careful phenotype-genotype 
correlation employing high resolution array CGH may help identify clues regarding the genetic 
etiology of ophthalmologic features of this syndrome. 
 
 
8.4.5 Isolated sulfite oxidase deficiency 
 
Bosley, T. M., Alorainy, I. A., Oystreck, D. T., Hellani, A. M., Seidahmed, M. Z., Osman Mel, F., 
Sabry, M.A., Rashed, M.S., Al-Yamani, E.A., Abu-Amero, K.K., Salih, M. A. (2014). Neurologic 
injury in isolated sulfite oxidase deficiency. Can J Neurol Sci, 41(1), 42-48.71  
PMID: 24384336   
 Click reference above to see full PDF article 
 
Background: We review clinical, neuroimaging, and genetic information on six individuals with 
isolated sulfite oxidase deficiency (ISOD).  
 
Methods: All patients were examined, and clinical records, biochemistry, neuroimaging, and 
sulfite oxidase gene (SUOX) sequencing were reviewed.  
 
Results: Data was available on six individuals from four nuclear families affected by ISOD. Each 
individual began to seize within the first week of life. neurologic development was arrested at 
brainstem reflexes, and severe microcephaly developed rapidly. neuroimaging within days of 
birth revealed hypoplasia of the cerebellum and corpus callosum and damage to the 
supratentorial brain looking like severe hypoxic-ischemic injury that evolved into cystic 
hemispheric white matter changes. Affected individuals all had elevated urinary S-sulfocysteine 
and normal urinary xanthine and hypoxanthine levels diagnostic of ISOD. Genetic studies 
confirmed SUOX mutations in four patients.  
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Conclusions: ISOD impairs systemic sulfite metabolism, and yet this genetic disease affects only 
the brain with damage that is commonly confused with the clinical and radiologic features of 
severe hypoxic-ischemic encephalopathy. 
 
 
Notes: 
Orthoptic assessment was conducted on 3 of the 6 individuals. Ocular motility was grossly full 
but alignment was variable with poor or no attention to visual targets. Biochemical diagnosis 
was confirmed in 6, genetic confirmation in 4.  
 
Significance of this publication: 
These individuals represented a group in which ocular alignment and excursion of ocular 
motility was variable due to profound brain dysfunction.  Subjects did not have visually guided 
eye movements but rather roving movements.  The publication highlights brain development 
conditions resulting in cortical blindness with subsequent effects on the oculomotor system, 
e.g. roving eye movements, variable strabismus, and sensory nystagmus.  
 
  
Stellenbosch University  https://scholar.sun.ac.za
 89 
 
8.5 Strabismus with full ocular motility in neurologically normal  
 
This section represents a large group of subjects who were neurologically normal, full ocular 
motility, and comitant strabismus who also have at least two other similarly affected family 
members.   
 
This comprises two populations of subjects and represents on-going work as a member of the 
international Strabismus Genetics Research Consortium. 
 
One group was enrolled into the KSU project 542-7 where all examinations were done in 
Riyadh, Saudi Arabia.  However genetic investigations were done with a collaborating research 
team at Boston Children’s Hospital (Engle lab) who were also investigating the genetics of 
familial forms of simple strabismus.   We enrolled a total of 204 subjects from 50 Arab families.  
DNA samples were obtained in 160 subjects.  Two siblings were found to have a mutation in 
HOXA1, one of whom was published in a previous HOXA1 publication5.   Results are pending on 
the remaining samples.  
 
A second group involves roughly 50 subjects I examined at Boston Children’s Hospital who were 
enrollment into their Simple strabismus project. 
 
One publication has recently been published.   
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8.5.1 Comitant esotropia 
 
Shaaban, S., MacKinnon, S., Andrews, C., Staffieri, S. E., Maconachie, G. D. E., Chan, W. M., et al. 
(2018). Genome-Wide Association Study Identifies a Susceptibility Locus for Comitant Esotropia 
and Suggests a Parent-of-Origin Effect. Invest Ophthalmol Vis Sci, 59(10), 4054-4064.72  
doi:10.1167/iovs.18-24082  002  
 Click reference above to see full PDF article 
 Candidate was not involved in the writing of this publication but was involved in the 
examination and classification of subjects enrolled in this project.  This is discuss in more 
detail in chapter 9. 
 An update to the genetic findings in this population has just been accepted as a poster 
at the 2019 AAPOS conference in San Diego, CA, USA.   
 
Purpose: To identify genetic variants conferring susceptibility to esotropia. Esotropia is the 
most common form of comitant strabismus, has its highest incidence in European ancestry 
populations, and is believed to be inherited as a complex trait.  
 
Methods: White European American discovery cohorts with nonaccommodative (826 cases and 
2991 controls) or accommodative (224 cases and 749 controls) esotropia were investigated. 
White European Australian and United Kingdom cohorts with nonaccommodative (689 cases 
and 1448 controls) or accommodative (66 cases and 264 controls) esotropia were tested for 
replication. We performed a genome-wide case-control association study using a mixed linear 
additive model. Meta-analyses of discovery and replication cohorts were then conducted.  
 
Results: A significant association with nonaccommodative esotropia was discovered (odds ratio 
[OR] = 1.41, P = 2.84 x 10-09) and replicated (OR = 1.23, P = 0.01) at rs2244352 [T] located 
within intron 1 of the WRB (tryptophan rich basic protein) gene on chromosome 21 (meta-
analysis OR = 1.33, P = 9.58 x 10-11). This single nucleotide polymorphism (SNP) is differentially 
methylated, and there is a statistically significant skew toward paternal inheritance in the 
discovery cohort. Meta-analysis of the accommodative discovery and replication cohorts 
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identified an association with rs912759 [T] (OR = 0.59, P = 1.89 x 10-08), an intergenic SNP on 
chromosome 1p31.1.  
 
Conclusions: This is the first genome-wide association study (GWAS) to identify significant 
associations in esotropia and suggests a parent-of-origin effect. Additional cohorts will permit 
replication and extension of these findings. Future studies of rs2244352 and WRB should 
provide insight into pathophysiological mechanisms underlying comitant strabismus. 
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Chapter 9: Phenotypic-genotypic bi-directional algorithm overview & 
Summary 
 
Project design 
 
All subjects were enrolled into an REB approved institutional project. (see chapter 1 Table 1.2) 
The research was conducted under several grants and different principal investigators. (Table 
9.0)  The central focus of these institutional research projects, and the resultant publications, 
varied.  Main topics included genetic, radiologic, neurologic and medical domains.   
The candidate was a member of these international research teams and was involved in the 
assessment of all subjects.  My contribution was as a certified orthoptist having expertise in the 
evaluation of ocular motility disorders.  This afforded a unique opportunity to study the 
orthoptic features in a large cohort of subjects with rare and heterogeneous conditions in 
which disturbance of ocular motility and alignment were common features.   
The central research question was whether the orthoptic evaluation can be an effective tool in 
the elucidation and distinction of congenital and/or genetic disorders with disturbance of 
ocular alignment and motility.   If true, this could lead to designing a bi-directional diagnostic 
algorithm in which orthoptic features serve as the starting point in the investigation of these 
subjects.  Therefore all studies done by our research teams required conducting an orthoptic 
evaluation.  In most cases this was administered in conjunction with additional assessments as 
part of a larger institutional study.  These assessments most often included neuro-
ophthalmology, pediatric ophthalmology and genetics; frequently included radiology, pediatric 
neurology; and as needed ENT, audiology, pediatrics, and psychology as per study protocols.  
The method of genetic investigations were determined by the research lab conducting the 
assessment and the study protocol in which the subject was enrolled.  Molecular investigation 
techniques included sequencing of candidate genes, array comparative genomic hybridization 
(array CGH) and whole exome or genome screening. 
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Table 9.0. Research grants in which candidate work was performed 
 
Agency Grant ID PI 
KSU Deanship scientific research RGP-VPP-301 Salih 
KACST AT-30-20 
AT-29-31 
07-581 
Abu-Amero 
 
NEI R01 EY 15298 Engle 
KSU = King Saud University; KACST = King Abdulaziz City for Science and  
Technology; NEI = National Eye Institute. 
 
 
 
Addressing the main research question and proposed aim of the research 
 
The central research question: Is the orthoptic evaluation an effective tool in the elucidation 
and distinction of congenital and/or genetic disturbances in ocular alignment and motility?  
Research aim:  To design a bi-directional diagnostic clinical algorithm in which identified 
phenotypes can accurately predict the genotype (direction 1 – phenotype predicts genotype), 
conversely to identify genotypes that will allow the clinician to accurately predict an expectant 
phenotype (direction 2 – genotype predicts phenotype).   
The benefits of such an algorithm would improve accuracy of the diagnosis, permit earlier and 
more appropriate referrals to other medical specialists, ensure cost effective genetic 
investigations, and permit more targeted management strategies with clearer outcome goals. 
The central research question and aim are explored through two hypothesis and developed 
through addressing 6 objectives. (Fig 9.1) 
This chapter presents evidence for each objective.  
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Figure 9.1.  Construction of a bi-directional algorithm
Hypothesis 1: 
There is phenotypic difference between genetically distinct conditions
(Algorithm direction 1 – Phenotype predicts Genotype)
Hypothesis 2: 
There is phenotypic consistency between genetically identical conditions
(Algorithm direction 2 – Genotype predicts Phenotype
Objectives
Design clinical assessment protocol to assess disruptions of ocular motility 
and alignment
Identify and characterize congenital and/or genetic disorders affecting 
ocular motility and/ or alignment
Provide new insight into mechanisms affecting normal development and 
function of the oculomotor system
Create a simplified clinical approach for the general ophthalmic clinician
Bi-directional algorithm
Design a classification scheme based on mechanisms accounting for 
disurption of ocular motility and/or alignment
Consolidate identified phenotypes with confirmed genotypes
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Objective 1:  Design a clinical assessment protocol to assess disruptions of ocular 
alignment and motility. 
 
Outcome: Met with regards to current knowledge and understanding of the conditions. 
Evidence: 
 RP 0424 datasheet   (link to document) 
 NANOS/CHB datasheet  (link to document) 
 Example of MBS datasheet  (link to document)  
 Textbook Chapter – The Orthoptic evaluation (link to PDF) 
 
 
Discussion: 
Chapter 2 includes early publications that led to my involvement in this topic. This was the start 
of a conscious effort by a team of clinicians to further pursue research in the field of congenital 
ocular motility disorders by elucidating the clinical spectrum of newly identified genetic 
syndromes.  Early success with key publications led to the creation of a larger multidisciplinary 
team that included myself as the ocular motility expert.  This in turn resulted in the eventual 
initiation of the ophthalmic genetics research program at King Saud University in Riyadh, Saudi 
Arabia that I would join in 2008.  
My involvement within these research teams included standardizing the clinical approach to 
evaluating and documenting ocular involvement.  
 
Outcome: 
Candidate designed data collection forms; standardized the assessment, scoring and 
terminology used in the evaluation of subjects.  This permitted consistent, detailed descriptions 
for disorders encountered, which proved useful to identify important similarities and 
distinctions within this population. 
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Identified limitations: 
Despite great efforts, a single standard investigation on all subjects was not achieved.  This was 
due in large part to the different requirements for each project and the different services and 
clinical specialists available at the various institutions. However, the basic orthoptic evaluation 
was consistent.  Modification was required in situations of poor cognitive ability or bilateral 
visual deficits.  An unabridged approach was published as a textbook chapter.11  A PDF of the 
editor’s final copy has been provided in appendix section for chapter 9.  
 
No single data collection form or database could be utilized.  Most projects required use of a 
specific form and data storage location. The candidate adapted to the needs and requests of 
different stakeholders.  Examples are provided in appendix chapter 9.   
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Objective 2:  Identification and characterization of congenital and/or genetic disorders 
affecting ocular motility and alignment   
 
Outcome: Met 
 
The total number of subjects examined and charts reviewed (retrospective reports) related to 
the dissertation is estimated at 1409.   
Of these, 564 were excluded for the following reasons: 
 404 subjects reviewed as part of the DRS retrospective publications9, 12 
 60 OFNF subject reported in the retrospective OFNF treatment publication.47  
 ~50 subjects examined as part of the Boston Children’s Hospital Simple Strabismus 
study72 
 50 subjects (15 families) with at least two family members having congenital motor 
nystagmus with apparent normal afferent visual functioning.  It was decided to not 
include this group as full investigations were not complete at the time of this writing.   
 
This left a total of 845 subjects enrolled with 40 different clinical diagnoses identified. 
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Objective 3:  To consolidate the identified main phenotypes with confirmed genotypes 
 
Outcome: Met 
Evidence: Table 9.3.1, 9.3.2, 9.3.3 
 
Phenotyping: 
All subjects underwent substantial investigations that involved multiple specialties to provide as 
much phenotypic information as possible.  My role was to perform an orthoptic evaluation to 
identify strabismus and/or ocular motility abnormalities.  In most cases the orthoptic exam was 
done as part of a subject’s regular ophthalmological visit to Pediatric ophthalmology or Neuro-
ophthalmology.  In other cases it was conducted as part of a research clinic.    
 
Genotyping: 
All institutional approved research projects that subjects were enrolled involved genetic 
investigations.  DNA samples were obtained in 72% (609/845) of subjects.  However a genetic 
diagnosis was confirmed in 33% (281/845) of all subjects, either by analysis of DNA or by 
confirmation in a similarly affected family member.  Table 9.3.1 lists the outcomes.   
 
Consolidating confirmed genotypes to phenotypes: 
A total of 25 genes were identified as having a mutation.  Two show evidence for mutation-
specific phenotypes (TUBB3, CHRNE), one had marked variable expression (NF1). One condition 
involved mitochondrial DNA deletions.  Several subjects had a chromosomal anomalies, which 
in all but one case (partial chromosome 8 trisomy) involved a single gene. Table 9.3.2 provides 
a full list of the genetic results linked to the pertinent diagnosis.  
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Characterization of disorders and genetics:     
The candidate authored 43 peer reviewed articles, 1 textbook chapter, and participated in two 
publications as a consortium member that described the clinical, and when known, genetic 
details of 349 subjects.  Included in this list are 5 invited publications.27, 42, 73-75  A textbook 
chapter defining the orthoptic evaluation also arose from work on defining the best approach 
to the assessment of binocular vision disorders.11    Tables 9.3.3 list the publications by date of 
acceptance.    
 
 
 
Table 9.3.1 Genetic results in subject population n= 845 
 
 n total 
population 
% total 
population 
Sample obtained 609 72% 
Results pending* 378/609  
Initial results negative 21/609  
Results known¥ 281/865 33% 
*Awaiting DNA analysis; ¥ Genetics confirmed by DNA analysis or by genetic  
confirmation in similarly affected family member.  
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Table 9.3.2 Summary of genetic results in subject population 
 
Chapter 2  - DRS 
Gene/  
Locus 
Gene full name Gene 
MIM 
Inher Cyto loc. No. 
genotyped 
Dx linked in 
dissertation 
HOXA1 Homo sapiens homeobox A1 
 
*142955 
 
AR 7p15.2 
 
28 synDRS 
BSAS 
ABDS 
HOXA1 
syndrome 
PTPRN2 protein tyrosine phosphatase, receptor 
type, N polypeptide 2 
*601698 
 
Chrm 7q36.3 
 
1 synDRS 
FGF13 Fibroblast growth factor homologous 
factor 13 
 
*300070 Chrm Xq26.3-
q27.1 
1 synDRS (WS) 
KIR killer cell immunoglobulin-like receptor 
 
 Chrm 19q13.4 
 
1 synDRS 
CHRNB3, 
Neuronal 
Cholinergic Receptor, Nictoinic, Beta-3 
 
*118508 Chrm 8p11.2 
 
1 synDRS 
XIRP2 Xin Actin-binding Repeat containing 2 
 
*609778 Chrm 2q24.3 
 
1 synDRS 
RNF34 ring finger protein 34, E3 ubiquitin 
protein ligase 
*608299 Chrm 12q24.31 
 
1 synDRS 
PPARA peroxisome proliferator-activated 
receptor alpha 
+170998 Chrm 22q13.31 
 
DMD dystrophin 
 
*300377 
 
Chrm Xp21.2-
p21.1   
2 synDRS 
COL25A1  collagen type XXV alpha 1 
 
*610004 
 
AR 4q25 
 
2 nsDRS 
Non 
pathogenic 
CNV 
     Bilateral nsDRS 
 
 
 
Chapter 3 - MBS 
 
Gene/  
Locus 
Gene full name Gene 
MIM 
Inher Cyto loc. No. 
genotyped 
Dx linked in 
dissertation 
---- -----------------------    123 MBS 
TUBB3 See chapter 4      
HOXB1 See chapter 8      
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Chapter 4 - CFEOM 
Gene/  
Locus 
Gene full name Gene 
MIM 
Inher Cyto loc. No. 
genotyped 
Dx linked in 
dissertation 
KIF21A kinesin family member 21A 
 
*608283 
 
AD 
 
12q12 
 
12 CFEOM1 > 
CFEOM3 
 
PHOX2A Aristaless Homebox, Drosophila, Homolog 
of (ARIX) 
 
*602753 
 
AR 11q13.4 
 
22 CFEOM2 
TUBB3  Tubulin, Beta-3 
 
*602661 
 
De 
novo 
AD 
16q24.3 
 
10 CFEOM3 plus 
 TUBB3 - E410K    2  
 TUBB3 – E417H    2  
 TUBB3 – R262H    1  
 TUBB3 – mutation not specified    5  
 
 
Chapter 5 - OFNF 
Gene/  
Locus 
Gene full name Gene 
MIM 
Inher Cyto loc. No. 
genotyped 
Dx linked in 
dissertation 
NF1 Neurofibromin 1 
 
*613113 
 
 
AD 
 
17q11.2 
 
96* NF1 
OFNF 
*includes all subjects having either NF1 or OFNF 
 
 
Chapter 6 - CMS 
Gene/  
Locus 
Gene full name Gene 
MIM 
Inher Cyto loc. No. 
genotyped 
Dx linked in 
dissertation 
CHRNE Cholinergic Recptor, Nicotinic, Epsilon 
Polypeptide 
*100725 
 
AR 
 
17p13.2 
 
3 CMS (3 MIM 
phenotypes) 
COLQ Collagenic Tail of Endplate 
Acetylcholinesterase 
 
*603033 
 
AR 
 
3p25.1 
 
1 CMS5 (pheno 
MIM 603034 
MUSK Muscle, Skeletal, Receptor Tyrosine 
Kinase 
 
*601296 
 
AR 
 
9q31.3 
 
 
2 CMS9 (pheno 
MIM 616325) 
 
 
 
Chapter 7 - HGPPS 
Gene/  
Locus 
Gene full name Gene 
MIM 
Inher Cyto loc. No. 
genotyped 
Dx linked in 
dissertation 
ROBO3 Roundabout, Drosophila, Homolog of, 3 *608630 AR 
 
11q24.2 25 HGPPS 
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Chapter 8 - Miscellaneous 
Gene/  
Locus 
Gene full name Gene 
MIM 
Inher Cyto loc. No. 
genotyped 
Dx linked in 
dissertation 
MtDNA N/A 
(Mitochondrial DNA deletions) 
---- Mito  3 KSS 
MRE11A Meiotic recombination 11, S. Cerevisiae, 
homolog of, A 
 
*600814 
 
AR 
 
11q21 
 
14 ATLD1 
 
C12orf57 Chromosome 12 open reading frame 57 
 
*615140 
 
AR 
 
12p13.31 
 
4 Abn brain and 
eye (Temtys) 
 
Chrm 8 Chromosome 8 Partial trisomy --- de novo 8q & p 1 Accommodati
ve ET 
SUOX 
 
Sulfite oxidase 
 
*606887 
 
AR 
 
12q13.2 
 
3 ISOD 
CA2 
 
Carbonic Anhydrase II 
 
*611492 
 
AR 
 
8q21.2 
 
23 CADS, 
Marble Brain, 
Osteopetrosis 
 
ECM1 
 
Extracellular matrix protein 1 
 
*602201 
 
AR 
 
1q21.2 
 
7 Lipoid 
Proteinosis 
 
PABPN1 Polyadenylate-binding protein, nuclear, 1 
 
*602279 
 
AD 14q11.2 
 
1 OPMD 
HOXB1 Homo sapiens homeobox B1 
 
*142968 
 
AR 17q21.32 
 
2 HCFP3 
 
 
Full spelling of diagnoses are given in legend for Table 9.6.     
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Table 9.3.3 List of candidate’s publications related to dissertation  
 
Paper Cty Accpt for 
Pub 
Reference title and journal Thesis 
Ref # 
1 2 2004 12 Neurologic features of horizontal gaze palsy and progressive scoliosis 
with mutations in ROBO3. Neurology. 2005;64(7):1196-203. 
6 
2 2 2005 10 Clinical characteristics of bilateral Duane syndrome. Journal of AAPOS. 
2006;10(3):198-201 
9 
3 2 2005 10 
Homozygous HOXA1 mutations disrupt human brainstem, inner ear, 
cardiovascular and cognitive development. Nature genetics. 
2005;37(10):1035-7 
14 
4 2 2006 01 
Fixation preference for the affected eye in patients with unilateral 
Duane syndrome. Journal of AAPOS. 2006;10(3):275-6. 
10 
5 2 2006 05 Neurological features of congenital fibrosis of the extraocular muscles 
type 2 with mutations in PHOX2A. Brain. 2006;129(Pt 9):2363-74 
44 
6 2 2007 06 Duane retraction syndrome on the Arabian Peninsula. Strabismus. 
2007;15(4):205-8 
12 
7 2 2007 09 Clinical characterization of the HOXA1 syndrome BSAS variant. 
Neurology. 2007;69(12):1245-53 
5 
8 1 2007 09 Ophthalmic features of ataxia telangiectasia-like disorder. Journal of 
AAPOS. 2008;12(2):186-9 
65 
9 2 2008 01 The clinical spectrum of homozygous HOXA1 mutations. American 
journal of medical genetics Part A. 2008;146A(10):1235-40 
15 
10 1 2008 08 Ophthalmic features of Joubert syndrome. Ophthalmology. 
2008;115(12):2286-9 
66 
11 2 2008 08 Bilateral synergistic convergence associated with homozygous ROB03 
mutation (p.Pro771Leu). Ophthalmology. 2008;115(12):2262-5 
61 
12 2 2009 08 Synergistic divergence: a distinct ocular motility dysinnervation 
pattern. Invest Ophthalmol Vis Sci. 2009;50(11):5213-6 
37 
13 2 2010 Congenital Cranial Dysinnervation Disorders. 2010. In: Encyclopedia of 
the Eye [Internet]. Elsevier; [346-55] 
42 
14 5 2010 01 Congenital myasthenic syndrome due to homozygous CHRNE 
mutations: report of patients in Arabia. Journal of neuro-
ophthalmology. 2011;31(1):42-7 
51 
15 2 2011 01 Recent progress in understanding congenital cranial dysinnervation 
disorders. Journal of neuro-ophthalmology. 2011;31(1):69-77 
26 
16 1 2011 02 Molecular and neurological characterizations of three Saudi families 
with lipoid proteinosis. BMC medical genetics. 2011;12:31 
67 
17 1,2,
4 
2011 07 When straight eyes won't move: phenotypic overlap of genetically 
distinct ocular motility disturbances. Can J Ophthalmol. 2011;46(6):477-
80 
45 
18 1 2011 09 The neurology of carbonic anhydrase type II deficiency syndrome. 
Brain.2011;134(Pt 12):3499-512 
68 
19 3 2011 10 Orbitofacial neurofibromatosis: clinical characteristics and treatment 
outcome. Eye (Lond). 2012;26(4):583-92 
47 
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Paper Cty Accpt for 
Pub 
Reference title and journal Thesis 
Ref # 
20 3 2012 04 Visual loss in orbitofacial neurofibromatosis type 1. Ophthalmology. 
2012;119(10):2168-73 
48 
21 2,6 2012 05 HOXB1 founder mutation in humans recapitulates the phenotype of 
Hoxb1-/- mice. American journal of human genetics 
38 
22 6 2012 05 Comitant strabismus: Perspectives, present and future. Saudi journal of 
ophthalmology. 2012;26(3):265-70 
73 
23 2 2012 07 Partial chromosome 7 duplication with a phenotype mimicking the 
HOXA1 spectrum disorder. Ophthalmic genetics. 2013;34(1-2):90-6. 
28 
24 2 2012 11 A novel syndrome caused by the E410K amino acid substitution in the 
neuronal beta-tubulin isotype 3. Brain. 2013;136(Pt 2):522-35 
39 
25 1 2012 12 A newly recognized autosomal recessive syndrome affecting 
neurologic function and vision. American journal of medical genetics 
Part A. 2013;161A(6):1207-13 
69 
26 6 2012 12 Ophthalmologic observations in a patient with partial mosaic trisomy 
8. Ophthalmic genetics. 2013;34(4):249-53 
70 
27 2 2013 01 Xq26.3 microdeletion in a male with Wildervanck Syndrome. 
Ophthalmic genetics. 2014;35(1):18-24 
29 
28 3 2013 03 Ocular Neostigmine Drops for Diagnosing Myasthenia Gravis. J Neurol 
Neurophysiol. 2013(S11:004) 
76 
29 3 2013 05 Variable ptosis after botulinum toxin type a injection with positive ice 
test mimicking ocular myasthenia gravis. Journal of neuro-
ophthalmology. 2013;33(2):169-71 
77 
30 2 2013 07 Partial duplication of chromosome 19 associated with syndromic 
duane retraction syndrome. Ophthalmic genetics. 2015;36(1):14-20 
30 
31 1 2013 07 Neurologic injury in isolated sulfite oxidase deficiency. The Canadian 
journal of neurological sciences Le journal canadien des sciences 
neurologiques. 2014;41(1):42-8 
71 
32 2 2013 08 Nicotinic Receptor Mutation in a Mildly Dysmorphic Girl with Duane 
Retraction Syndrome. Ophthalmic genetics. 2015;36(2):99-104. 
31 
33 2 2013 09 Congenital cranial dysinnervation disorders: a concept in evolution. 
Current opinion in ophthalmology. 2013;24(5):398-406 
27 
34 2 2013 12 CCDD Phenotype Associated with a Small Chromosome 2 Deletion. 
Seminars in ophthalmology. 2015;30(5-6):435-42. 
32 
35 2 2014 01 HOXA1 Mutations are Not Commonly Associated with Non-Syndromic 
Deafness. Can J Neurol Sci. 2014;41(4):448-51 
78 
36 2,3,
6 
2014 01 Diagnostic distinctions and genetic analysis of patients diagnosed with 
moebius syndrome. Ophthalmology. 2014;121(7):1461-8 
40 
37 2 2014 03 Microdeletions involving chromosomes 12 and 22 associated with 
syndromic Duane retraction syndrome. Ophthalmic genetics. 
2014;35(3):162-9 
33 
38 2 2014 05 Retinal Dysfunction in Patients with Congenital Fibrosis of the 
Extraocular Muscles Type 2. Ophthalmic genetics. 2016;37(2):130-6 
46 
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Paper Cty Accpt for 
Pub 
Reference title and journal Thesis 
Ref # 
39 2 2015 01 Congenital and Genetic Ocular Motility Disorders: Update and 
Considerations. Am Orthopt J. 2015;65:58-66 
74 
40 2,4 2015 04 Duane retraction syndrome in a patient with Duchenne muscular 
dystrophy. Ophthalmic genetics. 2016:1-5 
34 
41 2,4 2015 12 Duane Retraction Syndrome Associated with a Small X Chromosome 
Deletion. Can J Neurol Sci 2016;43(3):445-7 
35 
42 2 2016 06 The genetics of nonsyndromic bilateral Duane retraction syndrome. 
Journal of AAPOS. 2016;20(5):396-400 e2. 
36 
43 4 2016 12 New Observations Regarding the Retinopathy of Genetically 
Confirmed Kearns-Sayre Syndrome. Retin Cases Brief Rep 2018; 
12(4):349-358 
79 
44  2017 The orthoptic evaluation – chapter 75. In Taylor & Hoyt's pediatric 
ophthalmology and strabismus, 5th edition, Eds. Lambert SR, Lyons 
CJ.2017 
11 
45 2 2018 01 Ophthalmoplegia and Congenital Cranial Dysinnervation Disorders. J 
Binocul Vis Ocul Motil 2018;1:31-33 
75 
Publications as a consortium member – not involved in writing manuscript 
46 4 2017 07 A defect in myoblast fusion underlies Carey-Fineman-Ziter syndrome 
(Moebius Syndrome Research Consortium) 
41 
47 6 2018 08 Genome-Wide Association Study Identifies a Susceptibility Locus for 
Comitant Esotropia and Suggests a Parent-of-Origin Effect. Invest 
Ophthalmol Vis Sci 2018; 59:4054-4064 
(Strabismus Genetics Research, Consortium) 
72 
Cyt = Classification category (see category distinctions below); Accpt for Pub = date accepted for 
publication (YYYY/MM) 
Category distinctions: 
1 = Neurological or Central Nervous System Disorders  
2 = Disorders of Cranial Nerve development (CCDDs) 
3 = Disorders of Orbital development  
4 = Myopathic disorders 
5 = Disorders of Neuromuscular junction  
6 = Disorders of Simple strabismus  
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Objective 4: Provide new insight into mechanisms affecting normal development and 
function of the oculomotor system 
 
Outcome: Met 
Evidence: Table 9.4.1 
An anticipated outcome of studying a large cohort of subjects with rare disorders was to gain 
insight into mechanisms affecting the normal development and function of the oculomotor 
system.  By integrating the results of the genetic evaluation with detailed clinical evaluations 
including the orthoptic evaluation, neuro-radiology, and findings from other medical specialties, 
new and existing mechanisms were identified.  
A list of the involved gene, chromosome, mitochondrial DNA are provided in Table 9.4.1 with a 
reference to the relevant candidate publication discussing the impact on the oculomotor 
system and proposed mechanism.   The Table has been sorted into groups based on known or 
presumed impact to the function of the oculomotor system.  
 
Group 1: Genes with direct impact 
 Involved in cranial nerve development, maintenance and axonal guidance 
 Involved in neuromuscular junction function 
 Involved in cerebellum function 
Group 2: Genes with an indirect impact  
 Defective gene function leading to abnormal orbital anatomy with a secondary effect on 
binocular vision, globe position, and/or motility 
 Defective gene function leading to structural anomaly or a functional anomaly of the 
visual pathway resulting in defective visual processing or a sensory strabismus 
Group 3: Genes with an unknown role 
 Identification of a genetic mutation that could not reliably be attributed to the observed 
oculomotor dysfunction.  In many cases in this group the publication was the first 
report, or most detailed description, of a detected ocular motor anomaly when one was 
present. 
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Table 9.4.1 Grouping of genes based on known or presumed role in the development and 
function of the oculomotor system.  
 
Group 1 Ref Group 2 Ref Group 3 Ref 
HOXA1* 14 NF1 47 PTPRN2 28 
COL25A1 37, 63 C12orf57 69 FGF13 29 
KIF21A 26 SUOX 71 KIR 30 
PHOX2A 26, 44   CHRNB3, Neuronal 31 
TUBB3* 39, 40, 74   XIRP2 32 
CHRNE 51   RNF34 33 
COLQ exam   PPARA 33 
MUSK exam   DMD 34, 35 
ROBO3 6   CA2 68 
MtDNA del 79   ECM1* 67 
MRE11A 65   HOXB1* 38 
PABPN1 45     
Ref = relevant candidate publication; exam = as determined by candidate examination and literature 
Group 1 = genes when mutated having a direct impact on function of the oculomotor system 
Group 2 = genes when mutated having an indirect (secondary) impact on function of the oculomotor 
system 
Group 3 = genes when mutated having no known impact on function of the oculomotor system.  
*reported cases of full eye movements 
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Objective 5: Design a classification scheme based on mechanism accounting for 
disruption of ocular motility and/or alignment 
 
Outcome: Met 
Evidence: Objectives 1-4 
 
Addressing objective 5 is possible by meeting criteria for objectives 1-4.   
Objective 1 provided the bases in which ocular motility and alignment data could be 
standardized to ensure accurate and consistent data was collected in a population with 
complex ocular motility disorders.   
Objective 2 confirmed diagnoses in which identified phenotypes could be applied and studied.  
Objective 3 consolidated these phenotypes with identified genotypes.   
Objective 4 provided evidence about underlying mechanisms accounting for a disturbance in 
the oculomotor system in genetically confirmed diagnoses.  This established which genetic 
disorders were likely pathogenic.    
Objective 5 incorporates the information from the preceding objectives to propose a 
classification system that encompass the relevant encountered disorders.      
  
Creating a classification system:  
A review of the literature and observations of our clinical findings suggests a classification 
scheme based exclusively on clinical phenotype is not be reliable. 
Examples include unraveling of the original CFEOM classification based on ocular motility 
patterns as more genetic information was elucidated, and an overestimation of the value of 
confirming DRS to predict genotype as was determined in many of our publications. 
As a result it became apparent a scheme based on pathomechanisms would be more ideal.  
However, it requires investigations that go beyond orthoptic features.  This approach is 
presented in the following paragraphs.  Note however, objective 6 returns to the notion of 
beginning with the orthoptic phenotype as the initial approach.  
Based on known/proposed gene functions and documented phenotypes the following 
classification scheme is proposed.  
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Category 1: Neurological or Central Nervous system related disorders 
 
Involves ocular motility and alignment disorders arising from a disturbance to normal 
neurologic or central nervous system function.  Innervational connections and structure of the 
extraocular muscles are normal.  The commonest issues in our population involved abnormal 
function of the central eye movement systems due to supranuclear disturbances involving 
cerebellar, thalamic, and cortical white matter neuronal functioning.   This predominantly 
affected ocular motility rather than inducing strabismus.  Another mechanism arose from 
abnormal cortical functioning in which normal visual processing and/or binocularity may not be 
possible resulting in sensory strabismus or roving eye movements.     
Observed oculomotor anomalies usually occurred after birth and tended to be progressive.   
Key candidate publications pertaining to this category are listed in Table 9.3.3 
 
Category 2: Congenital Cranial Dysinnervation disorders 
 
This involves a heterogeneous group of neurogenic syndromes that arise from brainstem and 
cranial nerve maldevelopment.  Most result in absent or misinnervation of extraocular muscles, 
lids, and/or facial muscles.  However these can arise from congenital brainstem malformation 
involving cranial nerve nuclei or gaze centres (e.g. MBS, HGPPS); or congenitally aplastic or 
hypoplastic cranial nerves (KIF21A, TUBB3).  This is the only category involving dysinnervation 
of the extraocular muscles.  
This category comprised the diagnoses discussed in chapters 2-4 and chapter 8 (section 8.2.1 
and 8.2.2).   Key candidate publications pertaining to this category are listed in Table 9.3.3 
 
Bosley, T. M., Abu-Amero, K. K., & Oystreck, D. T. (2013). Congenital cranial dysinnervation 
disorders: a concept in evolution. Curr Opin Ophthalmol, 24(5), 398-406.27 
doi:10.1097/ICU.0b013e3283645ad6 
 The article provides the largest overview on this category.   
 Click reference above to see full PDF article 
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Category 3:  Disruption to orbital anatomy 
 
This involves conditions that predominantly affect the orbital development or disrupt the 
integrity of the orbital anatomy resulting in dysfunction to ocular motility or more commonly 
alignment.  This category does not involve pathology affecting extraocular muscle development 
or innervation.   
This category comprised the diagnosis in chapter 5.   
Key candidate publications pertaining to this category are listed in Table 9.3.3 
 
 
Category 4: Myopathic disorders 
 
This category involves disorders affecting extraocular muscle physiology or structure without 
innervational disturbances. 
This category comprised diagnoses in chapter 8 sections 8.1.2, 8.1.3, and 8.1.4  
 Key candidate publications pertaining to this category are listed in Table 9.3.3 
 
 
Category 5: Disorders of the neuromuscular junction 
 
Defects of the neuromuscular junction comprises a heterogeneous group of disorders caused 
by mutations in different genes that affect neuromuscular transmission.  Mutations in several 
genes will inhibit neuromuscular transmission by affecting structure or function of the 
neuromuscular synapse.  Several disorders within this group disrupt eye movements, however 
ocular alignment is generally not disturbed. 
This category comprised the diagnosis in chapter 6.   
Key candidate publications pertaining to this category are listed in Table 9.3.3 
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Category 6: Simple strabismus 
 
This category involves subjects with manifest strabismus that is either congenital or familial (at 
least 2 other affected family members).  This group has normal extraocular muscle function, 
innervation and structure.  Subjects are considered neurologically normal.  
This category was discussed briefly in chapter 8 (section 8.5)  
Key candidate publications pertaining to this category are listed in Table 9.3.3 
 
 
Category 7 (additional):  Multiple mechanisms 
 
This category was added to accommodate the 8 subjects that had features consistent with 
more than one of the above categories.  These individuals are extremely interesting and likely 
hold the key to additional information related to oculomotor system development. 
 
Not categorized, but also worth mentioning were two other populations of subjects.  The first 
group comprised 31 subjects in which a definitive clinical diagnosis could not be made.  These 
subjects were found within categories 1-4.  The second group consisted of 5 subjects that had 
multiple diagnoses from within the same category.  Both groups also represent interesting 
populations worth further investigations.     
 
Table 9.5.1groups all enrolled subjects by category.  It includes the clinical diagnoses and genes 
for each category as well as the number of subjects genotyped and the outcome.  This Table is 
considered a major outcome of this research.    
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Summary: 
Objective 5 represents what could be considered a penultimate classification for congenital 
and/or genetic disorders of ocular motility and alignment.  This is a scheme that incorporates 
clinical, radiological, and molecular information to elucidate the underlying pathomechanism, 
which is then used as a category.  This classification is now possible due to recent advances in 
genetics and radiology.  Incorporation of investigations by multiple specialties is required for 
this classification.  However, this should now be considered the gold standard approach within 
a research environment.  We demonstrated this approach by the large number of authors and 
medical specialties included in many of our publications.  It is anticipated as more information 
is generated through careful clinical assessments and collaborative work between multi-
disciplines this classification system will become more informative and useful to the general 
ophthalmologist.    
 
  
Stellenbosch University  https://scholar.sun.ac.za
 113 
 
Table 9.5.1 Subject classification based on underlying pathomechanism 
 
 Category 1: Neuro / CNS 
Diagnosis No. Genetics known   Genetics unknown No. 
Unable to specify  7 molecular diagnosis 48 results pending 14 
JBS 11 affected family member 13 screen negative 0 
AT  2   61 no sample 4 
ATLD 14      18 
AOA2 2       
ISOD 3 Gene   Pts Published No. 
ARSACS 4 MRE11A 14 Yes 57 
Cockayne 1 C12orf57 4    
CADS 23 SUOX 3    
TEMTYS 4 CA2 23    
LP* 7 ECM1 7    
Mul pheno same cat 1 chromosomal (no gene) 0    
Total 79 Total 51     
 
 
Category 2: CCDD 
Diagnosis No. Genetics known   Genetics unknown No. 
Unable to specify  17 molecular diagnosis 96 results pending 207 
CFEOM 105 affected family member 10 screen negative 21 
CFEOM1 (20)     106 no sample 84 
CFEOM2 (28)        312 
CFEOM3 (57)         
DRS 108 Gene   Pts Published No. 
nsDRS (56)   ROBO3 24 Yes 197 
synDRS (52)   PHOX2A 22    
MBS 123 KIF21A 12    
HGPPS 33 HOXA1 25    
MGJW 3 PTPRN2 1    
Isolated SD 2 RNF34 1    
Isolated Ptosis* 4 PPARA 1    
Isolated FP* 17 DMD 2    
CN4 palsy 1 TUBB3 10    
DEP 1 KIR 1    
Mul pheno same cat 4 CHRNB3 1    
Total 418 XIRP2 1    
  FGF13 1    
  COL25A1 2    
  Chromosomal (no gene) 2   
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      106     
 
 
Category 3: Orbit 
Diagnosis No. Genetics known   Genetics unknown No. 
Unable to specify  2 molecular diagnosis 32 results pending 5 
NF1 34 affected family member 64 screen negative 0 
OFNF 62   96 no sample 5 
Plagio 3      10 
BS 5       
Mul pheno same 
cat 0 Gene   Pts Published No. 
Total 106 NF1 96 Yes 79 
 
 
 
Category 4: Myopathy 
Diagnosis No. Genetics known   Genetics unknown No. 
Unable to specify  5 molecular diagnosis 6 results pending 2 
CPEO 2 affected family member 0 screen negative 0 
OMPD 1   6 no sample 5 
KSS 4      7 
CFZS 1     
Total 12       
  Gene   Pts Published No. 
    PABPN1 1 Yes 6 
  mtDNA del 4   
  MYMK 1   
 
 
Category 5: Neuromuscular junction 
Diagnosis No. Genetics known   Genetics unknown No. 
MG 8 molecular diagnosis 6 results pending 3 
CMS 10 affected family member 0 screen negative 0 
Total 18   6 no sample 9 
       12 
        
  Gene   Pts Published No. 
  COLQ 1 Yes 4 
  CHRNE 3    
  MUSK 2    
      6     
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Category 6: Simple strabismus 
Diagnosis No. Genetics known   Genetics unknown No. 
Eso 52 molecular diagnosis 2 results pending 160 
Inf ET 9   2 screen negative 0 
AET 94    no sample 42 
EXO 36      202 
Strab assc 12 Gene      
HT 1 HOXA1 2 Pts Published No. 
Total 204 Total 2 Yes 2 
 
 
 
 
Category 7: Multiple mechanisms  
Diagnosis No. Genetics known   Genetics unknown No. 
Multiple 8 molecular diagnosis 4 results pending 4 
Total 8   4 screen negative 0 
       4 
        
  Gene   Pts Published No. 
  HOXA1 2 Yes 7 
  HOXB1 2    
      4     
*Disorders not affecting ocular motility or alignment. These have been included in the table for 
completeness to illustrate total diagnoses encountered in this category. 
 
 
 
Legend for diagnoses/phenotypes in Table 9.5.1 
Abbrev 
Pheno 
OMIM Diagnosis 
AET  Accommodative Esotropia 
AOA2 #606002 Ataxia-Oculomotor Apraxia 2 
ARSACS #270550 Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay 
AT #208900 Ataxia Teleganectasia  
ATLD #604391 Ataxia Teleganectasia-like disorder 1 
BS %616407 Brown syndrome 
CADS #259730 Carbonic anhydrase type II deficiency syndrome 
CFEOM1 #135700 Congenital Fibrosis of the Extraocular Muscles Type 1 
CFEOM2 #602078 Congenital Fibrosis of the Extraocular Muscles Type 2 
CFEOM3 #600638 Congenital Fibrosis of the Extraocular Muscles Type 3 
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CMS  
congenital myasthenic syndrome; CMS9 MIM 616325 (CHRNE); CMS5 
MIM 603034 (COLQ); CMS9 (MUSK) 
CN4 palsy 136480 isolated congenital fourth nerve palsy 
Cockayne #216400 Cockayne syndrome 
CPEO  Chronic progressive external ophthalmoplegia 
DEP  monocular elevation deficiency (Double elevator palsy) 
DRS 126800% Duane Retraction Syndrome (unspecified) 
ESO  
Esotropia, intermittent esotropia, non accommodative esotropia with 
full ocular movements 
EXO  Exotropia, Intermittent exotropia with full ocular movements 
FP  
isolated Facial palsy; HCFP1 (#601471); HCFP2 (#604185); HCFP3 
(#614744) due to HOXB1;  
HGPPS #607313 Horizontal Gaze Palsy and Progressive Scoliosis 
HT  vertical strabismus with full ocular movements 
Inf ET  Infantile Esotropia 
ISOD #272300 Isolated Sulfite Oxidase Deficiency 
JBS #614464 Joubert syndrome (several genotypes) 
KSS #530000 Kearns-Sayre Syndrome 
LP #247100 Lipoid Proteinosis of Urbach and Wiethe 
MBS 157900% Moebius syndrome 
MG 254200 autoimmune Myasthenia Gravis 
MGJW   isolated Marcus Gunn Jaw Winking 
Multiple 
phenotypes  Features consistent with diagnoses in more than 1 category 
NF1 #162200 Neurofibromatosis, Type 1; von Recklinghausen disease 
nsDRS  Duane Retraction Syndrome (nonsyndromic); may include BSAS 
NT SPD  diagnosis not specified 
OFNF #162200 Orbitofacial Neurofibramotosis 
OPMD #164300 Oculopharyngeal muscular dystrophy 
Plagio  Plagiocephaly (Craniosynostosis) 
Ptosis 300245% isolated ptosis 
SC  isolated Synergistic Convergence 
SD  Isolated Synergistic Divergence 
Strb Assc  Strabismus associated condition 
synDRS  
Duane Retraction Syndrome (syndromic); includes BSAS (#601536) ; 
Wildervanck (%314600); Chrm 7 dup 
TEMTYS #218340 Temtamy syndrome 
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Objective 6: Designing a simplified clinical approach to these conditions 
 
Outcome: Met.  
Objective 5 determined a definitive diagnosis for ocular motility disorders often requires in 
depth investigations from multiple specialties with an increasing importance on genetics.  
However, in most cases a proband presents first to the general ophthalmologist who is then 
tasked with beginning the investigation process.  The following is a simplified approach 
recommended for the general clinician who may find him/herself in this situation.  It arises 
from our experiences examining a large number of individuals with complex strabismus.  The 
foundation is utilization of the orthoptic evaluation.  
 
Presented are two algorithms.  Algorithm 1 is meant to assign a subject into the appropriate 
category (see chapter 9 – objective 5).  Algorithm 2 is meant to help narrow down the diagnosis 
within a particular category and to help focus subsequent investigations, e.g. radiology 
protocols, genetic technique. 
Algorithm 1 can be easily utilized by the general ophthalmologist.  Algorithm 2 requires a more 
in depth assessment of the oculomotor system and quantification of confirmed anomalies.  
Therefore it may not always be feasible for the general clinician.     
  
The following sections have been discussed in part within our publications.  However, the 
concepts are amalgamated here for clarity. 
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Algorithm 1:  Getting into the right category – Clinician’s role 
 
The primary objective is for the clinician to assign a ‘new patient’ into the appropriate category.  
This is possible because most categories (based on pathomechanisms) demonstrate enough 
phenotypic distinctions (hypothesis 1 can be assumed to be at least partially correct) that 
assessment of a few key features can be utilized effectively.  
Understanding that a complete orthoptic evaluation is not always feasible, presented here is an 
abbreviated orthoptic evaluation that focuses on two components.  These are considered 
simple and reliable.  Figure 9.6.1 outlines this as a 3 step process. This algorithm can identify a 
category 2 condition in one step and category 1, 6, 4, and 5 in two steps.  However, it is not 
adequate for category 3 diagnoses because of marked variability. 
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Full excursion Limited excursion
Step 3: Onset & Progression
Step 1: Assess range of ocular excursion
Step 2: Assess for presence of strabismus
Figure 9.6.1 Step 1 – Key features to identify category  
Subject
Cat 1 Cat 3Cat 6
Cat 1 = Neuro/CNS; Cat 2 = CCDD; Cat 3 = Orbit; Cat 4 = Myopathy; Cat 5 = NMJ; Cat 6 = Simple strab
Cat 2
No
Cat 4 Cat 5
Cat 2
Cat 5
Strabismus 
Yes
If present will be  
Sensory strab
No
Cat 1
Saccade/smooth 
pursuit deficits
Cat 6
Later onset, 
progressive
Early onset,        
variable or stable
Symmetrical all directions
Yes
Cat 4
Congenital/
static
Cat 3 
OFNF
Full or limited
Strabismus may or 
may not be present
Early onset,        
progressive
Cat 3 
other
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Step 1 – Assess degree of ocular excursions 
Ocular excursions refer to the degree of ocular movement elicited with a duction.  This does not 
assess the quality of movement, but only whether the eye can achieve full movement into all 
directions.  An inability to achieve a full range of movement, regardless of direction or amount, 
separates categories 1 and 6 from 2,4,5.  Further distinction is made by judging symmetry of 
the limited movements.  Asymmetrical limitations are those in which limitation only occurs in 
specific directions or are of significantly different amounts. This is characteristic of category 2 
disorders (CCDDs).  Symmetrical limitations are approximately the same amount in both eyes 
and in all positions.  Category 4 and 5 generally have symmetrical limitations.  These can then 
be distinguished from each other by proceeding directly to Step 3.     
Outcome:   Confirms Category 2 
  Advance to Step 2 to confirm if Category 1 or 6 diagnosis 
  Advance to Step 3 to confirm if Category 4 or 5 diagnosis  
 
Step 2 – Assess for strabismus  
This distinguishes category 1 from 6.  Assessment of ocular alignment is only required in 
primary position where the goal is to detect a manifest strabismus.  Direction and size are not 
required at this time.  Category 1 conditions tend to maintain good eye alignment while 
category 6 must have the presence of a manifest deviation in association with full ocular 
excursion.  Exceptions can occur in category 1 as some patients will have variable strabismus 
secondary to profound bilateral visual loss.    
Outcome: Distinguishes between Category 1 and 6 
 
Step 3 – Onset and progression 
Although useful for all categories, determination of age at onset and history of progression of 
ocular dysmotility can distinguish between category 4 and 5.  Both tend to have symmetrical 
limitations of eye movement however age at onset tends to be later in category 4 with a 
greater preponderance of increasing severity with advancing age.  
Outcome:  Distinguishes between Category 4 and 5. 
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Algorithm 2: Narrowing down the correct diagnosis 
 
After a patient has been categorized the next step is to attempt to narrow down a specific 
diagnosis.  The orthoptic evaluation can again be valuable starting point.  However, this time a 
more in depth assessment of ocular movements, strabismus patterns, and assessment of other 
associated ocular features is required.  These are described below and were part of all subject 
evaluations in our studies.  A more in depth description of the evaluation is provided in ‘The 
Orthoptic Evaluation” chapter.11 
 
Detailed assessment of ocular movements: 
This has 3 main components, each with several sub-components.  Table 9.6.1 describes the 
significance of each to the appropriate category.  
1) Identification and quantification of ductional deficits 
 Unilateral / bilateral 
 Horizontal, vertical, combination 
 Small, moderate, marked 
 
2) Evaluation of eye movement subsystems 
 Smooth pursuit 
 Saccades 
 Vergence 
 Vestibular ocular reflex 
 Bell’s phenomenon  
 Fixation stability 
 
3) Determination of dyskinetic eye movements suggestive of dysinnervation:  
These are unintended globe and/or lid movement activated by anomalous innervation to 
the muscles. 
 globe contraction during attempted adduction 
 simultaneous divergence during attempted horizontal gaze – synergistic divergence 
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 simultaneous convergence during attempted horizontal gaze or attempted up gaze – 
synergistic convergence 
 vertical movement of an eye during attempted horizontal gaze 
 anomalous lid movement during eye or jaw movement 
 
Table 9.6.1. Assessment of ocular movements 
 
Ocular movement Remarks 
Normal  Category 6 – exclusive 
Overlap with some diagnoses in Category 1, 3, 4 (early age). 
  
Ductional deficit Category 2 - mandatory feature 
 Can be associated with globe(s) fixed in position away from 
primary position due to tight or atrophic eoms. 
 
Category 3 (OFNF) may involve ductional deficit; globe may be positioned 
away from primary due to orbital bone anomalies resulting in hypoglobus  
 
Category 4 & 5 have symmetrical deficits. 
 Category 4 tends to have later onset and progressive.  
 Category 5 can be variable but overall stable in degree of 
maximum limitations. 
 
Overlap with diagnoses in Category 2, 3, 4 (untreated), 5 (late stage) 
Abnormal ocular motility 
subsystems 
Category 1 – hallmark finding is full ocular excursions but with poor quality 
eye movements as a result of defective smooth pursuit and/or saccades.   
 
Category 2,4, and 5 may have perceived deficits of vergence however 
these are not due to primary deficit of the vergence system.  
 
Overlap with Category 4 and 5 but abnormality due to different 
pathomechanisms 
Dysinnervation Category - exclusive to this group   
 May have multiple dysinnervation patterns in same patient 
 May have similar dysinnervation patterns between different 
CCDDs 
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Detailed assessment of strabismus patterns: 
Table 9.6.2 describes strabismus patterns significant to each category.    
1) Direction: Eso, Exo, Hyper, Hypo, Torsional or combination 
2) Size: Tiny to large angle deviations 
3) Comitancy: Comitant vs incomitant 
4) Control: Latent, manifest, intermittent 
5) Globe position: Some categories have diagnoses in which one or both globes are in a fixed 
position. Movement is limited from that position  
 
Table 9.6.2 Assessment of strabismus patterns 
 
Strabismus Remarks 
Incomitant strabismus Category 2 - Pathognomonic  
Category 3 – frequent feature  
Overlap patterns between Category 2 and 3  
Comitant strabismus Category 1 – may occur as sensory strabismus 
Category 3 – may occur as sensory strabismus 
Category 6 - Pathognomonic  
 A and V pattern and distance near disparity included in the setting of 
absent ductional deficits. 
 Overlap in direction and  size between Category 1, 3 and 6 
No manifest deviation Category 1 – common in setting of good vision in either eye 
Category 3 – not uncommon in setting of good vision in either eye 
Category 4 and 5 – common feature.  Achievable as the associated limitation of 
ocular movements are symmetrical  
 Generally have associated near Exodeviations due to limited 
convergence ability. 
Globe position Category 2 
 Fixed positions may include Adduction, Abduction, Infraduction and 
Supraduction (rare).   
 Arises from tightness of a hypoplastic fibrotic extraocular muscle, or 
from secondary contracture of a normal ipsilateral antagonist muscle.  
Category 3 
 Down ward displaced globe position (hypoglobus).   
 Occurs in setting of orbital bony dysplasia.  
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Assessment of other ocular features: 
Additional features include lid function and position, pupil function and appearance, presence 
of nystagmus or intrusion to fixation, anomalous head postures, age at onset, and progression.  
Table 9.6.3 outlines these features and their significance to each category.   
 
Utilization of different orthoptic features can be used to create a multitude of diagnostic 
algorithms.  Provided here is one example that has proved effective.  This algorithm that starts 
with vertical gaze.   Figure 9.6.2 illustrates the flow pathway for a subject with limited vertical 
eye movement.  Figure 9.6.3 is the flow pathway for a subject with full vertical eye movement.  
Table 9.6.4 is another example. This one assesses degree of ocular motility in subjects with no 
manifest deviation in primary position.  What should be apparent in these examples is that no 
one pathway consistently leads to a single diagnosis.  A similar algorithm in subjects with these 
characteristics was described in our ‘straight eyes’ publication.45  The article proposed 3 key 
steps to distinguish the overlapping phenotype of having straight eyes in primary position. Step 
1 started with a detailed history focusing on age at onset of symptoms and signs. Step 2 
involved a careful assessment of ocular motility that also included looking for evidence of 
dysinnervation.  Step 3 requires looking for additional non-ophthalmological features.  In each 
case, the subject had a different diagnosis arising from a different gene mutation.  This is 
significant as it highlights the limitations of relying on diagnostic criteria arising solely from the 
orthoptic evaluation and the need to incorporate additional investigations.   
 
This then opens up discussions related to the central research question and confirming the 
hypotheses.  These is addressed in the following section - 9.7 
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Table 9.6.3 Additional ocular features 
 
Feature Remarks 
Lid position Ptosis is a feature common to most categories but with differing mechanisms 
accounting for it. 
Category Mechanism Feature 
2 Neurogenic Congenital/static 
3 
 
Pseudo when due to hypotropia 
or hypoglobus. 
True ptosis may occur secondary 
to mass effect (Neurofibroma) 
Acquired 
 
 
Progressive 
4 Myopathic process Acquired, progressive 
5 Defect of neuromuscular 
transmission 
Congenital/acquired; 
variable 
Category 1 and 6 - True ptosis not expected  
Lids – blinking Category 2 
 blink asymmetry evident in HGPPS 
 slowed lid closure on side of cranial nerve 7 weakness (MBS, HCFP-HOXB1) 
Pupils Category 2: Abnormal reactivity and shape in some forms in Category 2 
 CFEOM2 due to mutation in PHOX2A  
 CFEOM3 due to specific mutations in TUBB3 
Category 5 – slowed pupillary responses in variants due to end-plate AChE 
deficiency (mutation in COLQ) 
Nystagmus Category 1 – common, may include ocular intrusions 
Category 2 – specific to HGPPS 
Category 3 – pulsatile exophthalmos – not true nystagmus;  rare feature 
Anomalous head 
postures 
Category 1 – evident as head thrusting to compensate for defective eye 
movements 
Category 2 – Common. Serves several purposes which all may be present in the 
same subject.   
 To achieve ocular alignment permitting fusion 
 To achieve monocular fixation in an eye with severely restricted 
movement 
 To clear visual axis to avoid ptosis 
Category 3 – Common in setting of ptosis due to lid mass.  Adopted initially to avoid 
ptosis to permit bifoveal fixation. Tends to be abandoned in time due to 
progressive lid tumor size completely covering the eye. 
Category 4 and 5 – common 
 Head movement to compensate for defective eye movements 
 To clear visual axes in setting of bilateral ptosis 
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Figure 9.6.2 Flow chart for select diagnoses in category 2,4, & 5. Part A – limited vertical eye movement  
Subject
Limited vertical 
eye movement
Yes No
CFEOM1
CFEOM2
CFEOM3
CMS
OM
Limited horizontal movements 
& ptosis present in each.
Bell’s 
phenomenon
Intact but 
slowed
CMS
Absent
CFEOM1
CFEOM2
CFEOM3
OMD
Chin up AHPYes
For fixation; 
eyes infraducted
Avoid ptosis
No
Refer to Fig 
9.6.3
Manual lid elevation to see.  
AHP not useful as eyes do not 
move down
CFEOM1
CFEOM2 (rare)
CFEOM3 (rare)
CMS
CFEOM2 (rare)
CFEOM3 (rare)
Dysinnervation
CFEOM2
OPD
Yes
CFEOM1; CFEOM3
No
CFEOM2; CMS; OM
Supports further evidence 
for distinction between 
these diagnoses
PupilsNormal
CFEOM3-mutation specific
CMS; OM
Abnormal
CFEOM2
CFEOM3-mutation specific
CMS (COLQ mutation)
Flowchart based on predominantly of ocular motility features
CFEOM = congenital fibrosis of the extraocular muscles; CMS = congenital myasthenic syndrome; OM = ocular myopathy; 
AHP = anomalous head posture   
Stellenbosch University  https://scholar.sun.ac.za
 127 
 
 
 
Subject
Limited vertical 
eye movement
Yes No
HGPPS
nsDRS
BSAS
MBS
Convergence variable in each; 
Extend of horizontal limitation 
can be identical
Dysinneravation
Synergistic 
convergence
HGPPS
MBS
Globe 
retraction
Blink 
asymmetry
Yes
HGPPS
MBS 
(asymmetric facial weakness)
No
Refer to Fig 
9.6.2
nsDRS
BSAS
NystagmusYes
HGPPS
MBS (rare)
No
nsDRS
BSAS
HGPPS = Horizontal gaze palsy with progressive scoliosis; nsDRS = non-syndromic Duane retraction syndrome; BSAS = 
Bosley-Salih-Alorainy syndrome; MBS = Moebius syndrome
Figure 9.6.3 Flow chart for select diagnoses in category 2,4, & 5. Part B - full vertical eye movement  
nsDRS
BSAS
Dysinnervation can be present in all. 
When present ‘type’ is significant
Not evident in 
all cases
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Table. 9.6.4 Evaluation of Ductions in patients with ‘straight eyes’ 
 
I. Bilateral Horizontal limitation 
Complete  
 HGPPS 
 BSAS 
 MBS 
 OPMD (late) 
 CPEO (late) 
Partial 
 HGPPS 
 BSAS 
 MBS 
 CFEOM3  
 OPMD (early) 
 CPEO (early) 
 CMS 
Associated dysinnervation patterns 
 HGPPS – SC 
 BSAS – SC, GR 
 MBS – SC 
 CFEOM3 – SC, GR (rare) 
II. Isolated Vertical limitation 
 None 
III.  Vertical and Horizontal limitation 
 CFEOM3 (rare) 
 CMS 
 OPMD 
IV. Full excursion (H&V) – abnormal eye movement sub-systems 
 AT 
 ATLD 
 JBS 
HGPPS = Horizontal Gaze Palsy with Progressive Scoliosis; BSAS = Bosley-Salih-Alorainy Syndrome; MBS = Moebius 
syndrome; OPMD = Oculopharyngeal Muscular Dystrophy; CPEO = Chronic Progressive External Ophthalmoplegia; 
CMS = Congenital Myasthenic Syndrome; SC = synergistic convergence; GR = globe retraction on attempted 
adduction; CFEOM2 = Congenital Fibrosis of the Extraocular Muscles Type 2; AT = Ataxia Telangiectasia; ATLD = 
Ataxia Telangiectasia-Like Disorder; JBS = Joubert syndrome   
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Section 9.7 – Addressing research question and bi-directional algorithm  
 
Outcome:  Partially met, due to the complexity of the cases and constantly evolving knowledge. 
 
The design and testing of a bi-directional algorithm was central to this dissertation.  It was to be 
based on orthoptic features that could identify phenotypes that would effectively predict 
genotypes, and conversely when a genotype was known, predict the expectant phenotype.    
Our approach was as follows: 
Step 1: Define ocular motility phenotypes 
Step 2: Link to an already recognized diagnosis 
Step 3: Enhance accuracy of diagnosis with careful observation of other associated features 
Step 4: Obtain a genetic confirmation in as many cases as possible 
 
After examining 845 subjects with 40 identified diagnoses (several subjects without a definitive 
diagnosis) and 25 different genes, the following conclusions have been made: 
 
Regarding Hypothesis 1: There is phenotypic difference between genetically distinct conditions  
(Algorithm direction 1 – Phenotype predicts Genotype) 
 
Although our reports have identified many differences between genetically distinct conditions, 
there is too much overlap both in the orthoptic features as well as the overall phenotype to 
reliability and consistently confirm a genotype. 
 
Regarding Hypothesis 2: There is phenotypic consistency between genetically identical 
conditions (Algorithm direction 2 – Genotype predicts Phenotype) 
 
This was initially promising.  However most diagnoses did not have enough subjects genotyped.  
Of the 609 subjects with a DNA sample obtained, the genetic analysis is still pending in 62% 
(378/609).  These results would likely add valuable information to this issue. 
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This warrants some discussion involving the category with the largest number of subjects – 
category 2 CCDDs.  We felt this group had the greatest chance of establishing a feasible bi-
directional algorithm.  However, the following reasons are presented as to why this did not 
come to fruition. 
   
A new field – limited data: 
The majority of our publications described novel findings in newly elucidated genetic conditions 
or provided the first phenotypic report of previously genetically defined subjects.  This meant 
very few of our publications were actually able to add to a pool of previously reported cases.  It 
suggests there is still not enough information available in which to base a reliable algorithm.  At 
present new conditions are still arising that may further hinder this effort and the literature is 
still lacking an adequate number of detailed phenotypic descriptions in genotype subjects.  
 
Phenotypic overlap between distinct disorders:   
Table 9.7.1 provides a few examples of the overlap we identified between different CCDDs.  
The appropriate candidate publication is given that describes this in more detail.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
 131 
 
Table 9.7.1 Examples of phenotypic overlap between distinct CCDDs. 
 
CCDD Comments Ref 
Bilateral horizontal gaze 
dysfunction 
HOXA1 syndrome; HGPPS-ROBO3; MBS 
 
 
Abnormal convergence nsDRS – uni or bilateral; synDRS; MBS 
Note: convergence may also be normal in each 
 
Synergistic divergence Isolated SD; DRS-COL25A1 37, 63 
Synergistic convergence HGPPS-ROBO3; MBS 6, 40, 61 
Nystagmus HGPPS-ROBO3; MBS 6, 40 
Globe retraction on attempted 
adduction 
nsDRS; synDRS 
Note: absence in setting of a marked ipsilateral 
abduction deficit does not rule out anomalous 
innervation between horizontal recti 
HGPPS-ROBO3 – 1 case (not reported) 
5, 15 
Autism BSAS-HOXA1, synDRS-PTPRN2; MBS 14, 28, 40 
Neck/Spine anomaly HGPPS, synDRS-FGF13 (Wildervanck), synDRS-
RNF35/PPARA 
6, 29, 33 
Hearing deficit/Deafness BSAS-HOXA1, synDRS-PTPRN2, synDRS-FGF13, synDRS-
DMD, DRS+SD (pt#2), MBS, HCFP3-HOXB1 
14, 28, 29, 35, 
37, 38, 40 
Ptosis CFEOM, BSAS-HOXA1 (1pt), synDRS-XIRP2 15, 32 
Facial palsy HCFP-HOXB1, CFEOM-TUBB3, CFEOM – mutation 
negative for known CCDD genes (not reported) 
38, 39 
Ref = candidate reference; ns = non-syndromic; syn = syndromic 
 
 
Phenotypic variability between patients with the same genetic disorder: 
A key learning point was the discovery that phenotypic differences can exist within the same 
genetic disorder and even within the same family of affected family members. 
Some noteworthy examples include: 
HGPPS-ROBO3 
 Scoliosis in subjects were generally severe6 however mild forms were confirmed well.61, 
62 
 Degree of horizontal gaze limitation was not always complete and could be 
asymmetrical.6, 61 
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 Presence and size of primary position strabismus could vary even between affected 
siblings.6 
 
HOXA1 spectrum  
 More severe phenotype in ABDS15 
 Reported case with full eye movements5 
 Reported case of normal hearing5, 15 
 Several individuals examined (not reported) had other co-existing genetic disorders – 
Retinitis pigmentosa or albinism, thus further blurring the borders of the HOXA1 
spectrum. 
 
CFEOM2-PHOX2A 
 Difference in resting globe position44 
 
CFEOM3-KIF21A family 
 Five family members with CFEOM due to mutation in KIF21A.  Not all individuals met 
criteria for CFEOM1, therefore the entire family is labelled as CFEOM3 
 
 
Despite rejecting the hypotheses and falling short of constructing a bi-directional algorithm I 
feel the work in this dissertation has significantly moved this concept forward by populating the 
literature with detailed descriptions of orthoptic features for numerous conditions.  The 
resultant publications are also felt to have significantly impacted the field of congenital and/or 
genetic disorders of ocular motility and strabismus through adequately addressing all intended 
objectives.   
Published evidence has minimized the gap between clinician (general and expert) and 
researcher.  Within our research teams there is now a greater understanding and appreciation 
for the need to work more collaboratively to ensure investigations are appropriate, efficient 
and results are additive to completing the picture of any individual. 
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Summary of candidate first author publications for this section: 
 
The following publications provide evidence for the statements in the previous section.  These 
publications generally discuss the significance of certain orthoptic features in making a specific 
diagnosis both positively as well as highlighting the limitations.  They also highlight the role of 
the orthoptic evaluation within a larger investigational paradigm that is required for these 
complex disorders.   Areas frequently included involve neuro-ophthalmology, pediatric 
ophthalmology, radiology and genetics.  The take away point here is that there is no clear 
advantage of beginning with one investigational starting point over another – only that making 
a definitive diagnosis, or recognizing a novel condition (or novel phenotype in a previously 
known condition) requires input from a combination of investigators.  However, the candidate 
believes there is sufficient evidence to suggest starting with orthoptics moves the team forward 
significantly. 
  
  
Stellenbosch University  https://scholar.sun.ac.za
 134 
 
Oystreck, D. T., Engle, E. C., & Bosley, T. M. (2011). Recent progress in understanding congenital 
cranial dysinnervation disorders. J Neuroophthalmol, 31(1), 69-77.26 
doi:10.1097/WNO.0b013e31820d0756 
 
BACKGROUND: In 2002, the new term congenital cranial dysinnervation disorder (CCDD) was 
proposed as a substitute for the traditional concept of congenital fibrosis of the extraocular 
muscles (CFEOM) based on mounting genetic, neuropathologic, and imaging evidence, 
suggesting that many, if not all, of these disorders result from a primary neurologic 
maldevelopment rather than from a muscle abnormality. This report provides an update 8 
years after that original report.  
 
EVIDENCE ACQUISITION: Review of pertinent articles published from January 2003 until June 
2010 describing CCDD variants identified under PubMed MeSH terms congenital fibrosis of the 
extraocular muscles, congenital cranial dysinnervation disorders, individual phenotypes 
included under the term CCDD, and congenital ocular motility disorders.  
 
RESULTS: At present, a total of 7 disease genes and 10 phenotypes fall under the CCDD 
umbrella. A number of additional loci and phenotypes still await gene elucidation, with the 
anticipation that more syndromes and genes will be identified in the future. Identification of 
genes and their function, along with advances in neuroimaging, have expanded our 
understanding of the mechanisms underlying several anomalous eye movement patterns.  
 
CONCLUSIONS: Current evidence still supports the concept that the CCDDs are primarily due to 
neurogenic disturbances of brainstem or cranial nerve development. Several CCDDs are now 
known to have nonophthalmologic associations involving neurologic, neuroanatomic, 
cerebrovascular, cardiovascular, and skeletal abnormalities. 
 
 
 
Stellenbosch University  https://scholar.sun.ac.za
 135 
 
Recent progress 2011 
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Oystreck, D. T., Salih, M. A., & Bosley, T. M. (2011). When straight eyes won't move: phenotypic 
overlap of genetically distinct ocular motility disturbances. Can J Ophthalmol, 46(6), 477-480.45 
doi:10.1016/j.jcjo.2011.09.009 
 
OBJECTIVE: To describe the phenotypic similarity in a series of patients with genetically distinct 
ocular motility disturbances involving straight eyes and different ocular motor pathology. 
DESIGN: Retrospective case series. PARTICIPANTS: Clinical and genetic evaluation of 5 patients 
with straight eyes in the primary position and abnormalities of ocular motility.  
 
RESULTS: Patients with oculopharyngeal muscular dystrophy, congenital myasthenic syndrome, 
congenital fibrosis of the extraocular muscles type 3, Bosley-Salih-Alorainy syndrome, and 
horizontal gaze palsy and progressive scoliosis all had straight eyes in primary position and 
restricted ocular motility. History, ocular motility patterns, systemic features of individual 
syndromes, and genetic screening were important diagnostically.  
CONCLUSIONS: A number of congenital and genetic ocular motility syndromes may result in 
substantial phenotypic overlap, particularly when eyes are straight in primary position and 
nonophthalmologic features are not apparent or not observed. The range of disorders that may 
fall into this category is discussed. 
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Straight eyes 2011 
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Oystreck, D. T., & Lyons, C. J. (2012). Comitant strabismus: Perspectives, present and future. 
Saudi J Ophthalmol, 26(3), 265-270.73  
doi:10.1016/j.sjopt.2012.05.002 
 
Comitant strabismus is a common condition affecting infants, children and adults. Its impact on 
the affected patient may be severe resulting in visual loss, lack of binocularity, diplopia, social 
stigma and multiple corrective surgeries within the affected individual's lifespan. It is therefore 
important that this prevalent disorder should be better understood. We review the current 
understanding of the demographics and what is known of the etiology, risk factors and genetics 
of strabismus. We stress the importance of careful clinical assessment in classifying strabismus, 
and the common pitfalls in the measurement and pre-operative sensory work-up of the 
strabismic patient. The fact strabismus is comitant does not indicate it is benign: acute onset of 
comitant esotropia may be a presenting sign of pontine or cerebellar tumor. Lastly, we review 
the impact of genetics on our understanding of strabismus. While the causes of many types of 
congenital incomitant strabismus have been elucidated through careful observation and 
genetic screening, the genetics of comitant strabismus are more complex and multifactorial. 
Only through careful study and recruitment of large groups of affected individuals and families 
can we start to answer the question: why is this group of patients pre-disposed to develop 
strabismus. Doing so will help identify patients at risk, to spare them from the significant 
morbidity associated with this common disorder. 
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Oystreck, D. (2015). Congenital and Genetic Ocular Motility Disorders: Update and 
Considerations. Am Orthopt J, 65, 58-66.74  
doi:10.3368/aoj.65.1.58 
 
Concepts regarding certain forms of congenital eye movement disorders have recently 
changed, due in large part to new genetic evidence identifying causative genes and their role in 
the development of extraocular muscle innervation. This group is now referred to as the 
Congenital Cranial Dysinnervation Disorders (CCDDs). Careful assessment of phenotypic 
features that include both ophthalmological and non-ophthalmological features in genetically 
defined individuals has led to the development of a more robust classification system. 
Correlating phenotypes with new genetically defined syndromes has improved the ability of the 
clinician/researcher to better determine a definitive diagnosis in patients with complex ocular 
motility disorders. Nevertheless, more work is still required. 
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Oystreck, D. T. (2018). Ophthalmoplegia and Congenital Cranial Dysinnervation Disorders. 
Journal of Binocular Vision and Ocular Motility, 68(1), 31-33.75 
doi:10.1080/2576117X.2017.1416242 
 
Some forms of ophthalmoplegia are congenital and fall into the category of Congenital Cranial 
Dysinnervation Disorders (CCDDs). These disorders arise from a primary defect of cranial 
nucleus/nerve development or guidance. Many have substantial limitations of ocular motility 
with or without other associated features. The type and degree of ophthalmoplegia can be 
similar between CCDD subtypes as well as with non-congenital forms of ophthalmoplegia. 
Therefore diagnostic confirmation often requires neuro-imaging and/or genetic investigations. 
The clinician should consider this category in cases of ophthalmoplegia that are congenital and 
nonprogressive in nature. 
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Table 9.7.2 provides addition evidence supporting this section.  It includes a list of oral and 
poster presentations given on this topic.    
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Chapter 10: Conclusions 
 
Synopsis:  
There are many disorders involving dysfunction of ocular motility and alignment with most 
resulting in complex patterns of strabismus. Some of these are congenital and suspected of 
having underlying genetic causes.  Recent advances in investigational techniques have provided 
more information about the underlying mechanisms accounting for these conditions. This has 
however has resulted in an expanding knowledge gap for the front line clinician. 
 
The candidate had the unique opportunity to study a large heterogeneous group of individuals 
with these disorders at a time when technology advances were just beginning (e.g. genetics and 
radiology) to conduct this work within environments affording significant resources to actively 
investigate and define complete clinical and genetic features of these conditions. 
 
As a result the material contained in this dissertation could be considered one of the largest 
collection of subjects with congenital and genetic disorders of ocular motility and strabismus.  
 
Through careful orthoptic assessments the clinical ‘phenotype’ pertaining to ocular movements 
and alignment was defined in 845 enrolled subjects with 40 different diagnoses.  Genetic results 
would reveal these involved mutations in 25 different genes.  
 
Attainment of this information was only possible through the candidate’s involvement as a 
member of various research teams working within large institutional research projects.  The 
magnitude of this project would have been substantially less if designed as a prospective 
assessment of patients in an orthoptic clinic.  Subject population and access to resources would 
have been major limiting factors.    
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Additionally, integration into large research teams permitted the acquisition of resources to 
conduct detailed medical investigations by several specialties on a large population of these 
subjects.  
 
My main role as a member of these teams serves as the basis of this dissertation.  That is to 
evaluate the role of the orthoptic evaluation, and to determine if orthoptic features can be 
used to effectively predict the genotype in known genetic conditions or identify patterns 
suggestive of novel syndromes.  
 
This was addressed through completing several research objectives.  These are summarized as 
follows: 
 
Objective 1 - Standardization of the orthoptic evaluation was achieved.  Many of these 
disorders have complex motility patterns.  At initiation of this work there was no standardized 
approach to the evaluation of subjects or to the consistency in the reporting of features in the 
literature. 
 
Objective 2 - Identification and concise characterization of orthoptic features was completed in 
a large number of rare conditions. Again, this was possible because of the unique environment 
in the candidate worked.  Duplication of a similar project would be extremely difficult, if not 
impossible, for most clinicians. 
 
Objective 3 - Consolidation of the orthoptic features in a large number of genetically confirmed 
diagnoses was also achieved. Access to this number of genotyped subjects was a major 
accomplishment in the project.  It was crucial when assessing genotype-phenotype correlations. 
 
Objective 4 - Identification of new mechanisms or providing additional evidence of proposed 
mechanisms disrupting oculomotor function was achieved.  This was done through combining 
results of molecular testing, with detailed orthoptic examinations and results of investigations 
Stellenbosch University  https://scholar.sun.ac.za
 147 
 
from other medical specialties.  This ‘perfect environment’ permitted detailed descriptions for 
all encountered conditions, many of which were original descriptions.  This also determined 
which gene mutations were pathogenic to the oculomotor system as not all were despite initial 
suspicions.  
 
Objective 5 - Achievement of the preceding 4 objectives led to proposing a new classification 
scheme.  Through this work it was demonstrated clinical features alone, and genetic results 
alone, are not beneficial to the clinician.  Rather proposed is a scheme that combines a 
molecular diagnosis with documenting the effect on development and function of the 
oculomotor system.  This permits conditions to be categorized based on the underlying 
pathomechanism.  However, the initial categorization of subject begins with the identification 
of ocular motility patterns.  The scheme outlined requires more development, however the 6 
categories presented provide a reasonable meeting point between clinicians and researchers 
thus reducing the knowledge gap. 
 
Objective 6 - During development of the classification scheme (objective 5) the candidate was 
able to provide a simplified clinical approach for the general ophthalmologist.  This aids in 
classifying subject appropriately and again further reduces the knowledge gap.   
 
 
Hypotheses:  
Once objectives 1-6 were addressed the necessary information to accept or reject the 
hypothesis was available. 
 
Hypothesis 1 states that there are phenotypic (orthoptic) differences between 
genetically distinct conditions. 
Hypothesis 2 states that there will be phenotypic consistency between genetically 
identical conditions. 
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The analysis shows that Hypothesis 1 can be rejected.  The orthoptic features in isolation can 
adequately categorize subjects (Classification scheme 1-6) however it cannot reliability predict 
the genotype.  Prediction can be improve if additional medical information is added, e.g. 
radiology, neurology etc.  However, more genotyped subjects are required to better define the 
most consistent features.     
 
Hypothesis 2 must also be rejected.  The reports contained within the dissertation suggest 
substantial variability between subjects, and even within family members with the same 
genetic diagnosis.  This not only includes ocular motility disturbance but also for the associated 
conditions, e.g. deafness, spine/neck anomalies.  
 
As a result a bi-directional algorithm is not feasible at this time.   
 
 
Originality of research 
 
The work within this dissertation can be considered original on many accounts. 
 
First, performing orthoptic evaluations and reporting the outcomes on a large heterogeneous 
population of subjects with congenital and/or genetic disorder of motility and strabismus has 
never been done to this magnitude.  
 
Second, integrating this information with results of other investigations resulted in numerous 
publications in high impact journals reporting novel genetic findings and new syndromes 
(HOXA1 syndrome, TUBB3-E410K, HCFP-HOXB1, synDRS variants), complete descriptions of rare 
disorders (HGPPS-ROBO3; CFEOM-PHOX2A; OFNF) or proposed new diagnostic criteria for 
complex developmental disorders (MBS).  Noteworthy is the number of different journals in 
which the publications occurred.  Inclusion of ocular motility features into this variety of 
domains is a testament to the novelty of these conditions and lack of reporting that currently 
exists in the literature.  
Stellenbosch University  https://scholar.sun.ac.za
 149 
 
 
Third, formally assessing the value of the orthoptic features in the elucidation of complex ocular 
motility disorders to this degree has not been done previously.  Certainly not involving the 
number of conditions included here.  This permitted the ability to construct a classification 
scheme based, in part, on ocular motility distinctions.  It also creates the foundation on which 
to continue development a bi-directional algorithm where phenotype predicts genotype and 
genotype predicts genotype.  This will require continued careful clinical observations and more 
genotyped individuals. 
 
 
Contributions to existing knowledge 
 
A total of 41% (349/845) of enrolled subjects were published in 47 different papers.  Many were 
in high impact journals with a high number of citations. Several were within invited review 
articles. Further knowledge translation has occurred with pediatric ophthalmology and 
orthoptic colleagues through participation at national and international conferences via poster 
or oral presentations or within symposia.  This has forged new collaborations and a network of 
clinicians in which these conditions are discussed.  This work has also been acknowledge by 
invitations to write Review articles.  All of this speaks to the uniqueness and importance of 
these findings in relationship to disruptions of development and function of the oculomotor 
system. 
 
The publications provide the most detailed, and often an original description, for numerous 
complex disorders resulting in ocular dysmotility.  Critical analysis of the orthoptic features was 
vital in defining differences and similarities between conditions.  The publications also set a 
new bench mark for future publications to achieve when describing ocular motility features.     
 
We demonstrated the importance of team approach to achieve high level research outcomes.  
This was represented by the large number of authors from multiple specialties that were 
included in publications elucidating an encountered condition. 
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Information arising from this work also been taken up by the public.  It has been used by the 
HGPPS family support group that was initiated by the parents one of our Canadian subjects.  
The Moebius syndrome foundation (https://moebiussyndrome.org) has also used results from 
our MBS publication to inform the public about ocular involvement.   
 
We have identified the need for medical investigation on some forms of CCDDs. These have 
been outlined in detail in the review articles.    
 
Several novel observations were made. Examples include intorsion with fixation and volitional 
Bell’s phenomenon in MBS; asymmetric blinking in HGPPS; manual lid elevation in CFEOM2; 
and identification of several compensatory mechanism utilized by subjects.   Novel approaches 
to clinical testing were also developed.  One example was modifying the cover test in subjects 
with significant restriction of motility to detect small manifest strabismus. 
 
   
Knowledge gained by candidate 
 
I started this work as a clinician.  I ended as a clinician-scientist.  I have acquired a deep 
understanding about the requirements for conducting high level research and the keys to 
successful completion of projects. Several examples are provided. One is that I have learned the 
importance of interprofessional collaboration.  I have witnessed how a strong team can convert 
a good project into one that is world class.  From this I have gained a greater appreciation of 
the information that can be provided by other medical specialties, which in turn has provided 
me with a greater understanding about the conditions we encountered that goes well beyond 
the ‘eyes’.   I am also adept at understanding communication dynamics with collaborators, co-
authors, clinicians, geneticists, and even research assistants.   This work has also changed my 
perspective in the clinic.  I now consciously evaluate everything that I do as part of my 
evaluation to ensure the right information is being collected with on-going attention to features 
that are most characteristics to each diagnosis.  
Stellenbosch University  https://scholar.sun.ac.za
 151 
 
I have also developed skills related to generating publications.  I have mastered literature 
reviews, learned how to write manuscripts, learned how to submit manuscripts, and how to 
handle Reviewer comments (that was a tough one).  In almost all publications I was the one 
who took consent for clinical photographs, took the photograph, then photoshopped and 
edited for publication. 
   
General statements 
 
Motivation for pursing a PhD. 
I consider myself a clinician with an expertise in the evaluation of ocular motility, alignment and 
binocular vision.   Within my career I have been fortunate to have worked with expert clinicians 
and researchers in several institutions, both within North America and abroad.  This has 
provided me with a unique opportunity to engage in research projects spanning over a decade.  
The outcome of these efforts has led to new discoveries that has had a profound impact in my 
field.  The attraction to pursue a PhD with the Department of Ophthalmology at Stellenbosch 
University arose from two main reasons.  First, it provided an opportunity to work with talented 
supervisor who could provide expert guidance in the development and completion of work at 
this level.  Second, formally pursuing a PhD and completing a dissertation would permit (and 
require) high level reflection of this vast wealth of knowledge that had accumulated and was 
anticipated to continue to expand over the subsequent years.  This explains the inclusion of 
several publications preceding my enrollment in 2011.  Each was a stepping stone for a later 
publication with all eventually leading the requirements for a PhD.    
 
Hurtles and design approach: 
For this project to be as successful as it was, an unconventional approach was required.    
 
A big part of this project was assessing genotype-phenotype correlations.  In an ideal study, 
subjects would be enrolled.  Testing would be administered (e.g. phenotyping and genotyping). 
Results would then be analysis and comments made.   
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In reality this could not be controlled.  At times subjects would present for an assessment who 
were already genotyped.  Conversely, it was not uncommon for the genetic results to be 
completed several years after phenotyping.  At other times complete phenotyping could also 
take several months due to the number of additional investigations that were required as part 
of the larger institutional research project the subject was enrolled under.  Keeping track of 
what was completed, what was still outstanding, all within a constantly growing subject 
population usually fell to me.  This was not a trivial task.  
 
Additionally, it was not uncommon to have multiple active studies.  Note the accepted 
publication dates for different papers involving different topics.  This was both an advantage 
and disadvantage. The advantage was that this level of activity afforded the opportunity to 
exam large numbers of individuals with numerous (and extremely rare) disorders.  However this 
‘shot gun’ approach made it difficult to focus on a single topic at any one time.  The candidate 
spent most of his time collecting data for several studies and then writing appropriate 
publications for the appropriate journal.  This also led to the next issue – duration to complete 
dissertation. 
 
Dissertation took maximum length.   
The candidate formally left the ophthalmic genetic program at King Saud University in July 2013 
to accept a new position at Dalhousie University in Canada.  It was through this program that 
the majority of work was conducted.  However, because of the large volume of data that was 
collected during this time, manuscripts were still being designed and written for publication 
well after my departure.  Deferring completion of the dissertation therefore permitted several 
more important publications to be included.  It also permitted more genetic results to become 
known.  Patience in this regard has proven significant for some of our syndromic DRS subjects, 
atypical MBS subjects, and most recently simple strabismus subjects.     
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Breadth of topic. 
In hind sight the scope of this dissertation may have been too ambitious.  Integration of a large 
number of publications including a vast array of conditions limits the ability to take a deep dive 
into any one condition or concept.  However, after consideration I felt this dissertation in its 
present state most accurately reflects my research experience in this field.   
    
It should be pointed out that the decision to study a vast number of diagnoses was not an 
active decision on my part, but rather arose out of necessity.  Again, my work was conducted 
under several institutional research projects.  The approach taken by our research teams was to 
examine and document as many subjects as possible as there was no certainty what subject or 
condition would provide the next break through following genetic investigations.  As a result, 
the dissertation includes virtually all conditions we encountered, all genes with mutations 
identified, and very likely every orthoptic phenotype that is humanly possible to observe.  
When I analyzed all of the data collected it comprises 159GB containing 22 977 files in 2990 
folders.  The candidate is unaware of a collection of information of this magnitude anywhere on 
this subject.  
Therefore this dissertation throws a ‘net’ around the topic of congenital/genetic ocular motility 
and strabismus disorders by including a wide spectrum of reports.  This may be viewed as a 
limitation.   However, after consultation with colleagues it was felt that publications providing 
clear clinical descriptions for these extremely rare and complex disorders is helpful.  However, 
the addition of proposing a broad classification scheme and providing a simple clinical approach 
to the patient suspect of having one of these disorders was extremely beneficial, as it provides 
the clinician a foundation from which to begin.  This was identified as something missing in the 
literature and helps bridge the gap between the general clinician and the new concepts that 
now exist in this field.  
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Future directions 
 
Specific: 
 I will continue my on-going collaboration with the Strabismus Research consortium and the 
Moebius Syndrome Research Consortium. 
 Work will continue to expand a CCDD clinic at my home institution. We are now receiving 
patient referrals from across Canada and have recently established a relationship with the 
Engle lab in Boston to conduct the genetic investigations.    
 I plan to continue enhancing the classification scheme with any new subjects we report and 
from new reports arising in the literature.  The goal is to still achieve a bi-directional 
algorithm.  
 
Potential future publications: 
 On-going work with the ophthalmic genetic program in Saudi Arabia is presently on hiatus.  
However there are still several outstanding subject populations that require attention.  One 
group are additional cases of syndromic DRS who are still awaiting genetic analysis.  
Another group are subjects with CFEOM in whom an initial screen of the currently known 
CCDD genes was negative.  Another significant population involve our 204 subjects in 
category 6 with simple strabismus having at least two other affected family members.  
Detailed orthoptic and pediatric ophthalmology features for this entire group is complete.  
Status of the genetic evaluation is pending. 
   
Planned knowledge translation manuscripts:   
 Two topics identified by my general ophthalmology and orthoptic colleagues include a 
review article discussing the dysinnervational patterns we encountered, the other is a 
review of the compensatory mechanisms adopted by our subjects.  We feel this needs to be 
addressed by describing these in more detail and providing an explanation of the 
significance each feature has in the domain of complex strabismus.   
 Another ambitious endeavor is to expand the description of the classification scheme 
(objective 6) and publish each as a separate review article or textbook chapter.    
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Global aspirations: 
 Unification of research efforts in this field.  Much of this work has been done in 
collaboration with the Engle lab at Boston Children’s hospital.  Our successes have proven 
that international collaboration works, and from a resource perspective is much more 
efficient.  Designation of a single major genetic lab capable of collecting samples from 
around the world and pool rare cases together to conduct more powerful genetic 
investigations should be sought.  This is occurring now to some degree.  The candidate was 
involved in standardizing the incoming clinical information to the Engle lab which is 
expanding its role as an international collaboration site. 
  
 Development of an ocular motility gene chip.  A lot of effort went into analyzing phenotype-
genotype correlations in order to try and accurately confirm a diagnosis.  As more subjects 
are genotyped certain genes/gene mutations are now identifying as the main cause of 
certain disorders.  Development of gene chip that can screen for mutations in the most 
popular genes may become the most cost effective first step in the approach to these 
subjects.    
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Appendix Table A – Abbreviation list. 
Abbreviation Term 
ABDS Athabascan Brainstem Dysgenesis Syndrome 
ACh Acetylcholine  
AChR Acetylcholine receptor 
AD Autosomal dominant 
AET Accommodative esotropia 
AHP Anomalous head posture 
AOA2 Ataxia-Oculomotor Apraxia 2 
AR Autosomal recessive 
ARSACS Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay 
AT Ataxia telangiectasia 
ATLD Ataxia telangiectasia-like syndrome 
BS Brown syndrome 
BSAS Bosley-Salih-Alorainy syndrome 
CADS Carbonic anhydrase type II deficiency syndrome 
Cat Category 
CCDD Congenital Cranial Dysinnervation Disorders 
CFEOM Congenital Fibrosis of the Extraocular Muscles 
CFZS Carey-Fineman-Ziter syndrome 
CHB Children’s Hospital Boston 
Chrm Chromosome 
CGH Comparative genomic hybridization 
CMS Congenital myasthenic syndrome 
CN Cranial nerve 
CNS Central nervous system 
CNV Copy number variation 
CPEO Chronic progressive external ophthalmoplegia 
CT Computed tomography 
DEP Double elevator palsy 
DMD Duchenne muscular dystrophy 
DNA Deoxyribonucleic acid 
DRS Duane Retraction Syndrome 
DURS2 Locus for bilateral DRS 
ENT Ear nose and throat 
eom Extra-ocular muscle 
ESO Esotropia, intermittent esotropia, non accommodative esotropia with full 
ocular movements 
EXO Exotropia, intermittent exotropia, with full ocular movements 
FP Facial palsy 
GR Globe retraction 
GWAS Genome-wide association study 
HCFP Hereditary congenital facial paresis 
HGPPS Horizontal Gaze Palsy and Progressive Scoliosis 
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Hyper Hypertropia 
Hypo Hypotropia 
HT vertical strabismus with full ocular movements 
ICA Internal carotid artery 
Inf ET Infantile Esotropia 
ISOD Isolated sulfite oxidase deficiency 
JBS Joubert syndrome 
KACST King Abdulaziz City for Science and Technology 
KKESH King Khaled Eye Specialist Hospital 
KFS Klippel-Feil syndrome 
KSS Kearns-Sayre Syndrome 
KSU King Saud University 
LP Lipoid proteinosis 
MBS Moebius syndrome 
MDC Minimum diagnostic criteria 
MG Myasthenia gravis 
MGJW Marcus Gunn Jaw Winking  
MRA Magnetic resonance angiography 
MRI Magnetic resonance imaging 
NANOS North American Neuro-ophthalmological Society 
NEI National Eye Institute 
nsDRS Non-syndromic Duane Retraction syndrome 
NT SPD diagnosis not specified 
Obj objective 
OD Right eye 
OFNF Orbitofacial neurofibromatosis  
OMIM Online Mendelian Inheritance in Man 
OMPD Oculopharyngeal muscular dystrophy 
OPG Optic pathway glioma 
OS Left eye 
Plagio Plagiocephaly (Craniosynostosis) 
SC Synergistic convergence 
SD Synergistic divergence 
Strab assc Strabismus associated  
synDRS Syndromic Duane Retraction syndrome 
TEMTYS Temtamy syndrome 
 
Gene and gene mutation abbreviations not included.  These are provided in Tables within Chapter 9  
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